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A1
Circadian and Reward Measures Show 
Robust Bidirectional Relationships in Bipolar 
Spectrum Disorder in a 20-Day Naturalistic 
Ecological Momentary Assessment Study
Lauren B. Alloy1, Tommy H. Ng1, Madison K. Titone1, 
Laura E. Dennis2, Namni Goel2
1Department of Psychology, Temple University, 
Philadelphia, PA, USA; 2Division of Sleep and 
Chronobiology, Department of Psychiatry, University of 
Pennsylvania Perelman School of Medicine, Philadelphia, 
PA, USA
Objectives: Adolescence/early adulthood is an “age of risk” 
for bipolar spectrum disorders (BSDs). BSDs have been linked to 
circadian rhythm and reward processing disruptions; such disrup-
tions may serve as risk factors for BSD mood symptoms/episodes. 
However, the bidirectional relationships of the circadian and re-
ward systems have not been systematically examined in BSD or 
at-risk individuals.
Methods: 150 adults (ages 18–27; mean age ± SD, 21.9 ± 
2.1 y; 88 women), with high reward sensitivity and a BSD (n = 43), 
at-risk with high reward sensitivity but no BSD (n = 64), and low-
risk individuals with moderate reward sensitivity and no BSD (n = 
43) participated in a 20-day naturalistic ecological momentary as-
sessment (EMA) study, involving 3 phases: 1. Baseline; 2. Goal 
striving and 3. Goal/reward outcome. Salivary dim light melatonin 
onset (DLMO) was assessed as a circadian phase marker in each 
phase and the Morningness-Eveningness Questionnaire (MEQ) 
assessed chronotype. The Willingly Assumed Set of Statistically 
Unlikely Pursuits (WASSUP) assessed ambitious goal striving, the 
UPPS Sensation-Seeking subscale determined sensation seeking, 
and the Card Arranging Reward Responsivity Objective Test 
(CARROT) and the SPSRQ Sensitivity to Reward subscale mea-
sured reward responsiveness and sensitivity, respectively. The 
Barratt Impulsiveness Scale evaluated impulsivity. Pearson’s cor-
relations were used for statistical analysis.
Results: Baseline DLMO positively correlated with goal 
striving (r = 0.202, p < < 0.05) and sensation seeking (r = 0.543, 
p < 0.001), and with reward sensitivity ratings and reward-relevant 
events (r’s = 0.359–0.457, p < 0.005). MEQ negatively correlated 
with goal striving (r = –0.135, p < 0.05) and impulsivity (r = 
–0.174, p < 0.005). Notably, these relationships were maintained 
during the goal striving and reward outcome phases, indicating 
their stability across time.
Conclusions: Our results demonstrate for the first time that 
a number of validated circadian and reward measures have robust 
bidirectional relationships in BSD, whereby measures of greater 
eveningness/later phase (MEQ and DLMO) are related to greater 
reward sensitivity across various dimensions.
Funding/Disclosures: This work was supported by NIH 
R01 MH102310.
A2
The Effects of Exercise and Napping on 
Overnight Sleep
Karina Ando1, Hiroyuki Sagayama2, Masaki Takahashi3, 
Shigenobu Shibata3, Masako Hoshikawa1, 
Hideyuki Takahashi1
1Japan Institute of Sports Sciences, Tokyo, Japan; 2Japan 
Society for the Promotion of Science, Tokyo, Japan; 
3Waseda University, Tokyo, Japan
Objectives: To examine the effect of a 90-min daytime nap 
after high intensity intermittent exercise in the morning on over-
night sleep efficiency.
Methods: Six young male athletes (mean ± SE, age: 23 ± 2 
years VO2 max: 58 ± 3 mL/kg/min) participated in this study. They 
performed high-intensity intermittent exercise in the morning. The 
exercise session began at 10:30–11:00 am. The high intensity in-
termittent exercise consisted of 12 times × 1-min bout of cycling 
at 100% of VO2 max with 4-min at 60 rpm, and continuous cycling 
at 100% of VO2 max until exhaustion at last bout. After the exer-
cise session, the participants ate lunch at 13:00 pm. Nap/no-nap 
trials were performed at 14:30–16:00 pm randomly for cross com-
parison and were separated by at least 1 week. Participants ate din-
ner at 19:30 pm. The bedtime and wake-up time were adapted to 
each participant and kept consistent between the nap/no-nap trials. 
The sleep efficiency of the daytime nap and overnight sleep was 
monitored by a sheet-shaped body vibrometer. As physiological 
indices, heart rate and respiration rate were measured overnight.
Results: All participants went to bed at 23:30–01:00 and 
woke up at 06:30–07:30. The length of time in bed did not differ 
between the nap and no-nap trials. Overnight sleep efficiency was 
not significantly different between the nap and no-nap trials (93.8 ± 
2.0%; NAP, 93.1 ± 1.8%; No-NAP, p > 0.05). Heart rate and res-
piration rate during overnight sleeping were not significantly dif-
ferent between the nap and no-nap trials.
Conclusions: The present study suggested that a 90-min 
daytime nap after high intensity intermittent exercise in the morn-
ing does not interfere with overnight sleep efficiency in young 
athletes. Further research is required to investigate the effects of a 
90-min daytime nap for recovery after morning exercise on after-
noon performance in competing athletes.
Funding/Disclosures: None.
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A3
Synchrony between Bipolar Mood Cycles 
and Lunar Tidal Cycles Ended after Initiation 
of Light Treatment and Treatment of 
Hypothyroidism
David H. Avery1, Thomas A. Wehr2
1Psychiatric Medicine Associates, Department of 
Psychiatry and Behavioral Sciences, University of 
Washington School of Medicine, Seattle, WA, USA; 
2Intramural Research Program, National Institute of Mental 
Health, Bethesda, MD, USA
Objectives: We examined the relationship between the bi-
weekly lunar spring-neap cycle, which modulates the amplitude of 
the moon’s twice daily tidal cycle, and the timing of mood switch-
es in a 67-year old woman with rapid cycling bipol ar II disorder 
who received maintenance treatment with lithium. Rapid cycling 
had begun when nortriptyline was prescribed, and it persisted after 
the drug was discontinued. After thyrotropin levels became elevat-
ed during lithium treatment, thyroxine was prescribed.
Methods: The clinical course was documented with calendar 
records of the switches between depression and hypomania/eu-
thymia. The mood episodes were plotted in relation to the 14.8-day 
spring-neap cycle. Chi-square periodogram analyses were per-
formed for the time series, and chi-square analysis was done on the 
distribution of the times of the mood switches in relation to three 
5-day periods in the spring-neap cycle.
Results: During an initial 12-month period of observation, 
mood cycles exhibited a significant (p < 0.05) 29 to 30-day peri-
odicity that approximated the lunar synodic month. Switches back 
and forth between depression and hypomania/euthymia were non-
randomly distributed (p < 0.0001), with 14 of 15 switches occur-
ring within two days of full-moon or new-moon peaks of the 
spring-neap cycle. After light treatment was initiated and doses of 
thyroxine sufficient to treat lithium-induced hypothyroidism were 
administered, the mood cycles deviated from synchrony with the 
lunar cycle and then ceased to oscillate.
Conclusions: Findings in this patient are consistent with pre-
vious reports of associations between hypothyroidism and rapid 
cycling, antidepressant treatment and rapid cycling, and antide-
pressant treatment and lunar synchrony of mood cycles (Wehr, 
2017). The cessation of this patient’s rapid cycling during treat-
ment with thyroxine appears to be consistent with earlier findings 
that hypermetabolic doses of thyroxine can suppress rapid mood 
cycling. The introduction of regularly scheduled exposures to light 
also may have contributed to the cessation of cycling by strength-
ening entrainment of the circadian pacemaker to the solar day. The 
possibility that lunar mood cycling might be contingent on factors 
such as antidepressant treatment, decreased thyroid function and 
exposure to certain types of light-dark cycles will be important in 
the interpretation of results of research on lunar tidal influences in 
the future. 
Funding/Disclosures: DA has written topics for UpTo-
Date.
A4
Effect of Chronotype and Time of 
Assessment on Cognitive Performance
Katarína Baranyaiová1,2, Kateřina Červená1, Iveta Fajnerová1, 
Tereza Nekovářová1,2
1National Institute of Mental Health, Klecany, Czech 
Republic; 2Faculty of Arts, Charles University, Prague, 
Czech Republic
Objectives: The study focuses on the performance of healthy 
individuals in cognitive tests that are a common part of the exam-
ination and are key to determining the cognitive deficit in neuro-
psychiatric disorders. As the patient might be tested at different 
times during the day, it is important to determine whether the time 
of the day when the test is performed and chronotype of the par-
ticipant can affect performance to a clinically significant extent. 
The aim of this study is to determine 1) the extent of the effect of 
chronotype and time of assessment on cognitive performance, 2) 
whether cognitive performance depends on the day time of testing 
with respect to the subjectively preferred time, 3) identify a battery 
of tests suitable for monitoring the effects specific for extreme 
chronotypes and 4) find a battery of tests that are independent of 
the observed effects of time of testing.
Methods: The study was performed in 2 phases. Firstly, an 
online form of the Morningness Eveningness Questionnaire 
(MEQ) was used to identify individuals with extreme morning and 
extreme evening chronotype (MEQ scoring: morning (70–86) and 
evening (16–30)). During the ongoing second phase we monitor 
the performance of selected individuals in cognitive tests such as 
the Cognitive Performance Test (CPT), Trail Making Test (TMT), 
Stroop test, subtests of Wechsler Adult Intelligence Scale (WAIS-
III, etc). Body temperature using iButton thermochrons and phys-
ical activity with wrist actigraphy was assessed in order to support 
chronotype determined by the MEQ questionnaire. Testing takes 
place in the morning (8:00) and in the evening (20:00) hours, on 
two separate days (during the weekend). The order of test methods 
and the time of the first examination are pseudorandomized among 
individuals.
Results: Until now, 22 healthy volunteers of extreme morn-
ing and evening chronotype have been tested. The results of the 
preliminary analysis have shown interaction between chronotype 
and the time of day mainly in tests aimed at working memory. A 
similar interaction was obs erved in the verbal learning test, both in 
terms of learning and delayed recall. Both chronotypes had also 
shown significantly better psychomotor speed during the TMT-A 
task at their preferred time – morning types in the morning, eve-
ning types in the evening testing.
Conclusions: Preliminary results are in line with the study 
hypothesis, as well as findings from previous studies that confirm the 
chronotype effect on performance in the working memory tests 
(Schmidt, 2015; Matchock and Mordkof, 2008). Regarding the lim-
itation of the study – a small sample size, it can be assumed that in-
creased number of participants may even enhance the observed ef-
fects.
Funding/Disclosures: The work was supported by grant 
GAUK no.138217 and project No. LO1611 with financial support 
of the Ministry of Education, Youth and Sports under the NPU I 
program.
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A5
Integration of Non-Image -Forming (NIF) 
Effects of Light in Venetian Blinds and 
Electric Lighting Control
Marta Benedetti1, Jean-Louis Scartezzini1, Mirjam Münch2, 
Christian Cajochen3, Ali Motamed1
1École Polytechnique Fédérale de Lausanne (EPFL); 
2Charité Universitätsmedizin Berlin,  Institute of Physiology, 
B er lin, Germany; 3Psychiatric University Clinics Basel, 
Basel, Switzerland
Objectives: The objective of this study is to investigate the 
biological effects of a dynamic control of daylight and artificial 
lighting on humans. The Non-Image-Forming (NIF) effects of 
light are currently not sufficiently considered in lighting of indoor 
work environments, however taking these effects into account is 
important to improve the health and the productivity of users. We 
are going to evaluate the impact of different lighting conditions in 
offices on the circadian system and on visual comfort in healthy 
young subjects over several days. The aim is to show that an opti-
mal dynamic lighting control integrating both natural and artificial 
light has beneficial effects on the human physiology and psychol-
ogy, with respect to a conventional control system.
Methods: The study is carried out in two identical office 
rooms in the Laboratoire d’ Energie Solaire (LESO) experimental 
building in the École Polytechnique Fédérale de Lausanne (EPFL). 
The rooms are south-oriented and occupied by a single user. An 
advanced controller for venetian blinds and electric lighting de-
signed to follow the daylight course in terms of lighting conditions 
is implemented in the first office (test room). In the second office 
(reference room), a controller designed to keep static lighting con-
ditions for only visual requirements is applied. The lighting param-
eters assessment is performed by High Dynamic Range vision sen-
sors placed close to the workstation, which continuously record 
vertical illuminance and a glare index. Thirty-four subjects are 
going to take part in the experiment. Each subject will spend one 
week in the test room and one in the reference room, in a cross-
over-within-subjects design. During the time spent in the offic es 
– between 8h00 and 18h00 – subjects will carry out their norm al 
work and regularly perform some cognitive tests, and complete 
questionnaires throughout the day to evaluate their cognitive per-
formance, alertness, mood and visual comfort. Saliva samples will 
be taken regularly for the assessment of their cortisol concentra-
tions. Moreover, their activity and sleep/wake patterns will be con-
tinuously monitored by means of actigraphy watches.
Results: A pilot study was performed in the two offices dur-
ing 13 days in winter in order to assess the performance of the ad-
vanced controller for venetian blinds and electric lighting. The 
novel smart controller demonstrated its capabilities in terms of 
glare protection and daylight sufficiency, as both the glare index 
and vertical illuminance were kept in the desired ranges.
Conclusions: The study will allow to investigate the effects 
of a dynamic office lighting control on humans’ circadian system 
and visual comfort. The advanced controller is expected to im-
prove the alertness, cognitive performance and visual comfort of 
users. Preliminary tests of the controller showed its effectiveness 
in keeping target indoor luminous conditions.
Funding/Disclosures: The study is funded by the project 
“NEST SolAce Unit from EPFL Researchers” and by LESO solar 
experimental building at EPFL.
A6
Efficacy and Safety of Light Therapy for 
Bipolar Depression
Francesco Benedetti, Cristina Colombo
Psychiatry & Clinical Psychobiology Unit, Division of 
Neuroscience, San Raffaele Scientific Institute, Milano, 
Italy; University of Vita-Salute San Raffaele, Milano, Italy
The scientific approach to the treatment of depression with 
bright light started in the ‘80s. Soon at the beginning, in the first 
reported trials, antidepressant light therapy (LT) was administered 
to patients with bipolar depression (BD), and was given one to two 
hours before the usual time of awakening.
Since then, 45 scientific reports in peer-reviewed journals de-
scribed the clinical outcomes of 890 bipolar depressed patients 
treated with antidepressant morning LT. A historical review of all 
this wide literature, yet unpublished, shows that both randomized 
controlled trials (RCTs) (n = 8) and open trials support the rapid 
antidepressant efficacy of LT, both when given alone, and when 
combined with other chronotherapeutic techniques, such as sleep 
deprivation and sleep phase advance; or when combined with an-
tidepressant drugs and mood stabilizers.
No major side effects have been reported. In particular, the fa-
vourable safety profile of LT for BD is well evident when consid-
ering the risk of treatment-emergent mania: The switch process is 
a fundamental and defining characteristic of BD, and, based on 
available clinical trial data, the rate of switch into mania for pa-
tients with BD has been calculated at 4.2% during treatment with 
placebo, at 15–40% with antidepressant drugs, and below 3% with 
LT.
In general, meta-analyses and RCTs showed that the effect size 
of antidepressant LT, both for seasonal- and non-seasonal depres-
sion, is equivalent to those in most antidepressant pharmacothera-
py trials. However, notwithstanding this story of success, the ma-
jority of devices for the administration of LT are registered as 
medical devices for the treatment of winter depression only, and 
some user manuals even reported the diagnosis of Bipolar Disorder 
as a contraindication to morning LT for the risk of triggering man-
ic switches.
Bipolar depression is a difficult-to-treat condition, with ex-
tremely low success rates of antidepressant drugs, and with a 30% 
lifetime prevalence of completed suicide. Given the vast positive 
experience of many clinicians all over the world with morning LT 
in BD, we are concerned that this treatment will be limited by 
healthcare regulatory issues, causing problems in further clinical 
applications of light in our patients.
30th Annual Meeting of the Society for 
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A7
The Circadian Rhythm of ADHD
Denise Bijlenga1, J.J. Sandra Kooij1,2
1PsyQ Expertise Center Adult ADHD, The Hague, The 
Netherlands; 2VU Medical Center, Department Psychiatry, 
Amsterdam, The Netherlands
Objectives: Attention-deficit/hyperactivity disorder (ADHD) 
is characterized by childhood-onset symptoms of inattention, impul-
sivity, and/or hyperactivity with a cross-national prevalence of 5.3% 
in children and 2.8% in adults, and has a major impact on well-being. 
Sleep is primarily impacted in ADHD, both in children and adults. 
The most common sleep problem in ADHD is a delayed circadian 
rhythm, with a prevalence of 78% in adults with ADHD. Sleep prob-
lems may be intrinsic features, causes, or effects of ADHD.
Methods: This presentation gives an overview of existing 
evidence of the link between ADHD and sleep problems, in par-
ticular the delayed circadian rhythm, throughout the lifespan. This 
evidence stems from genetic, sleep, therapy, lifestyle, and popula-
tion studies.
Results: The strong relationship between ADHD and sleep 
problems is reflected by the functional and neuroanatomical over-
lap of brain regions involved in attention, arousal and sleep regula-
tion. Some of the variations in clock genes that are responsible for 
a lengthening of tau have also been linked to ADHD. Also, there 
is a geographical correlation between higher solar intensity and a 
lower prevalence of ADHD, which may be explained by the clock-
resetting effect of daylight. High daylight intensity is a stronger 
cue than low daylight intensity to synchronize delayed circadian 
rhythms, leading to less delayed rhythms and less ADHD symp-
toms.
Conclusions: Various sleep problems and symptoms of 
ADHD have shared etiology, genetic and environmental factors, 
that interact and influence each other. Those with a genetic dispo-
sition to a lengthening of the sleep cycle may profit from stronger 
synchronization cues such as high daylight intensity, leading to a 
better synchronized circadian rhythm, better sleep, and fewer 
ADHD symptoms.
Funding/Disclosures: None.
A8
Relationship between Diurnal Variation 
and Depression Severity in Patients with 
Unipolar Major Depression
Jonathan Jetsmark Bjerre, Signe Dunker Svendsen, 
Klaus Martiny
Psychiatric Center Copenhagen, New Interventions in 
Depression Group (NID), University of Copenhagen, 
Rigshospitalet, Copenhagen, Denmark
Objectives: The purpose of this study was to systematically 
examine diurnal mood changes and their interrelatedness to de-
pression severity, chronotype, and melancholic features, in pa-
tients with a major depressive episode. If a clear relationship be-
tween depression severity and diurnal variation (evening best) is 
found, this can be used as a clinical tool for staff at inpatient wards 
to monitor patients’ clinical state. Furthermore, we wanted to elu-
cidate the old question regarding the division between melanchol-
ic and reactive depression by incorporating chronotype and newly 
developed symptoms profiles together with depression severity 
and diurnal mood changes. This is inspired by the work of Gordon 
Parker in Australia.
Methods: We included patients from an outpatient affective 
disorders ward and from a psychiatric specialist practice.
At baseline, sociodemographics were collected, and a diagnos-
tic interview was performed. We assessed depression severity with 
the Hamilton scale, subjective depression severity with the Major 
Depression Inventory (MDI), sleep quality with the Pittsburgh 
Sleep Quality Index (PSQI), quality of life with the WHO-5, chro-
notype with the Morningness-Eveningness Questionaire (MEQ), 
and used a panel of questions designed to categorize melancholic 
and reactive depressions. In the following week patients evaluated 
depression severity every day at awakening, 9 AM, 12 Noon, 3 
PM, 6 PM, 9 PM, and before sleeping, using the Preskorn scale 
(scored from 0 to 10 with 10 = worst depression). Furthermore, 
patients logged their sleep timing, using a sleep diary. Diurnal data 
were analysed by use of a mixed model with repeated measures, 
and relations between variables were analysed with a linear regres-
sion model.
Results: Preliminary results from the first 11 patients showed 
that all patients fulfilled the criteria for a major depressive episode. 
Mean age was 45.1 (SD = 10.9) years with a duration of current 
episode of 7.5 (SD = 5.6) month. Mean MDI score was 21.4 (SD = 
11.2), and mean WHO-5 score was 34.0 (SD = 24.0) (normal val-
ues in Denmark are >70). The mean Hamilton score was 10.0 
(SD = 4.2), ranging from 3 (no depression) to 25 (moderate-severe 
depression). Self-assessed mood ratings showed that nine patients 
had a positive diurnal variation (evening best) with a mean im-
provement in mood, during the day, of 1.4 (SD = 0.9). This was 
statistically significant in seven out of nine patients (77.8%), (all 
with p < 0.05). Two patients experienced worsening during the 
day. For the nine patients with a positive diurnal variation, we 
found a statistically significant relation between the degree of di-
urnal variation and corresponding Hamilton depression score (p = 
0.05, R-square 0.45), and also between diurnal variation and cor-
responding WHO-5 score (p = 0.05, R-square 0.44).
Conclusions: There seems to be a clear relation between 
depression severity and the degree of diurnal variation and this 
might provide us with an important clinical tool for staff to access 
depression severity. The results regarding chronotype and melan-
cholia are awaiting the results from a larger sample. The study is 
ongoing with a planned sample size of 50 patients. We will present 
the final data.
Funding/Disclosures: None.
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A9
Prolonged Photoperiod Induces Changes in 
Sleep: The Impact of Blue-Enriched Light
Louise H. Bjerrum1, Torhild T. Pedersen1, Jelena Mrdalj1, 
Jonathan P. Wisor2, Andrea R. Marti1, Michael Rempe2,3, 
Tone E.G. Henriksen1,4, Janne Grønli1
1University of Bergen, Bergen, Norway; 2Washington State 
University, Spokane, WA, USA; 3Whitworth University, 
Spokane, USA; 4Valen Hospital, Helse Fonna, Norway
Objectives: Light exerts a direct effect on slow-wave sleep 
(SWS) and electroencephalogram (EEG) slow-wave activity 
(SWA; 0.5–4 Hz). It has been suggested that blue-enriched light 
promotes alertness in both humans and rodents through signaling 
via intrinsic photosensitive retinal ganglion cells (ipRGCs). Here 
we use a model of prolonged photoperiod (20 h light, 4 h dark; 20:4 
LD) of two different light spectra (white and blue-enriched) to 
characterize the effects on sleep in rats.
Methods: Rats (n = 6/group) were housed in 12:12 LD cycle 
for 5 days, followed by 7 days of exposure to prolonged photope-
riod 20:4 LD in either white or blue-enriched light, and 7 days re-
covery in 12:12 LD. Sleep (EEG and electromyogram) was re-
corded continuously by means of telemetry. We report data (% ± 
SEM change from 24 h baseline) and statistical analyses on total 
sleep time (TST), time in SWS, and SWA from day 7 of exposure 
to prolonged photoperiod (E7), and recovery day 1–7 (R1–R7).
Results: At E7, only white light increased TST (white: 8.9 ± 
3.6%, p = 0.004 vs. blue: 3.6 ± 1.5%, p = 0.155) and time in SWS 
(white: 8.9 ± 3.7%, p = 0.014 vs. blue: 4.1 ± 1.7%, p = 0.193). SWA 
in SWS was not significantly changed at E7 compared to baseline. 
During recovery in the 12:12 LD condition, TST was increased at 
R2 (prolonged white: 8.3 ± 3.4%, p = 0.023), R3 (prolonged blue: 
8.3 ± 3.4%, p = 0.030) and R4 (prolonged blue: 7.5 ± 3.1%, p = 
0.042) compared to baseline. Time in SWS and SWA in SWS 
showed no significant differences at R1-R7 compared to baseline.
Conclusions: Prolonged photoperiod has short and long-
term effects on sleep in the rat, and the effects are dependent upon 
light spectra. Prolonged exposure to white light increased total 
sleep time and time spent in slow-wave sleep, whereas prolonged 
exposure to blue-enriched light increased total sleep time in recov-
ery only.
Funding/Disclosures: The work was funded by Helse Vest 
(ID HV911 893) and the Faculty of Psychology, University of Ber-
gen (Småforsk, ID 173200-270452).
A10
The Effect of Bright Light on Blood Pressure 
and Heart Rate in Essential Hypertension
Mikhail L. Blagonravov, Anna A. Bryk, 
Evgenia V. Medvedeva, Vyacheslav A. Goryachev, 
Sergey M. Chibisov, Sergey P. Syatkin, Madina M. Azova, 
Tatyana Y. Zotova
Peoples’ Friendship University of Russia (RUDN University), 
Moscow, Russia
Objectives: Bright light therapy (BLT) showed positive re-
sults with respect to seasonal affective disorders, non-seasonal de-
pression, sleep disorders and so on. Meanwhile, there is still little 
data concerning the effects of light therapy on functional activity 
of the cardiovascular system and particularly in case of hyperten-
sion. We therefore studied the features of daytime and nighttime 
blood pressure (BP) and heart rate (HR) in genetically hyperten-
sive and normotensive rats under the action of bright light (BL).
Methods: We performed our experiments on 32–34 weeks 
old male rats of SHR (hypertensive, n = 5) and Wistar-Kyoto (nor-
motensive, n = 5) strains. Animals were kept in individual cages 
under 12:12 h light-dark schedule with light on at 7.00 am and off 
at 7.00 pm, daytime ~ 300 lux white light at eye level and night-
time absolute darkness. To estimate the effect of BL the animals 
were exposed to 1 hour action of ~ 10,000 lux white LED light 
from 10.00 am to 11.00 am. Systolic and diastolic blood pressure 
(SBP and DBP), heart rate (HR) were monitored continuously for 
24 hours the day before (controls) and on the very day of BL ex-
posure. BP and HR monitoring was carried out with the use of 
radio-telemetry system (DSI, USA) which consists of radio-trans-
mitter (sensor) DSI HD-S11 implanted in the animal body, receiv-
er, data exchange matrix and computer for storing data. BP was 
monitored in the lumen of the abdominal aorta. Thanks to the use 
of implantable sensors animals were totally freely moving the 
whole duration of the experiment. The data was processed with 
software Dataquest A.R.T. 4.33 (DSI, USA).
Results: It was found that SBP and DBP were significantly 
higher in the SHR rats compared to the normotensive rats for the 
whole 1 hour period of BL exposure in comparison with the same 
time interval (from 10.00 to 11.00 am) of the previous day when 
BL was not used. The average levels of daytime (10.00 am – 7.00 
pm) SBP and DBP were significantly increased in the hypertensive 
rats compared with the control rats which might indicate that the 
effect of BL remains notable even after the end of its exposure. For 
HR only a clearly defined tendency to an increase was seen. For 
the nighttime period after the day of BL exposure all of the moni-
tored parameters of the hypertensive rats had the same values as in 
the controls. In normotensive rats the action of BL induced no sig-
nificant changes in BP or HR.
Conclusions: Our data shows that BL induces an increase in 
BP in hypertensive but not in normotensive rats both at the time of 
BL exposure and after it. This should be taken into account when 
using BLT in case of concomitant hypertension.
Funding/Disclosures: The publication was prepared with 
the support of the “RUDN University Program 5-100”.
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A11
Estimating Parameters in a Model of the 
Human Circadian Rhythm Using a Particle 
Filter
Jochem H. Bonarius1, Jean-Paul M.G. Linnartz1,2
1Signal Processing Systems Section, Department of 
Electrical Engineering, Eindhoven University of Technology, 
Eindhoven, The Netherlands; 2IoT Systems, Philips Lighting 
Research, Eindhoven, The Netherlands
Objectives: We address the challenge of tracking an indi-
vidual’s circadian phase and -amplitude in real-time using imper-
fect sensors. We extend existing mathematical models of the hu-
man circadian rhythm using Bayesian inference: as more observa-
tions of the response of an individual’s circadian rhythm to light 
exposure become available, we can update the values of the mod-
els’ function parameters to better fit the characteristics of that in-
dividual. As we ultimately want to improve human-centric lighting 
control, we do not aim for a clinically accurate estimate, but we 
need an estimate that is adequate for choosing between different 
options for light settings.
Methods: In our work we combine the Kronauer et al. mod-
el of the circadian pacemaker with the Phillips et al. model of the 
homeostatic sleep drive to form a model of sleep regulation. As 
these models were developed by fitting mathematical functions to 
the average of data collected in studies with human subjects, they 
will always give the same response to an input, which does not ac-
curately represent the response of an individual. Instead, we con-
sider that the function parameters in the models differ between 
individuals, as they reflect physiological characteristics, such as 
age, chronotype and light sensitivity. We show that the mathemat-
ical technique of a Particle Filter, a sequential Monte Carlo meth-
od, can estimate parameter values that best correspond with an 
individual’s physiological characteristics by minimizing the error 
between model output and the real-life response of that individual, 
thereby reducing the modeling error.
Results: We illustrate our method by applying it to data from 
a field trial with 20 subjects. By processing light exposure- and 
actigraphy data recorded over several days with the proposed Par-
ticle Filter, we estimate every subject’s intrinsic circadian period 
(tau). When correlating these to their Munich Chronotype Ques-
tionnaire midsleep time, a significant relationship was found: r > 
0.6 and p < 0.01.
Conclusions: We have shown that it is possible to estimate 
the intrinsic circadian period of several human test subjects with 
reasonable accuracy using only light exposure- and actigraphy 
data as reference. This demonstrates how a Particle Filter can es-
timate parameter values in a model of sleep regulation, to be able 
to more accurately track an individual’s circadian phase and am-
plitude.
Funding/Disclosures: Financial support was obtained 
from the NWO Domain Applied and Engineering Sciences under 
project Optilight. This project has been funded under a program 
co-financed by Philips Lighting Research. However, it was carried 
out and reported as an independent party by the Eindhoven Uni-
versity of Technology.
A12
From Space Flight Lighting 
Countermeasures to the Patient Bedside: 
Developing Light Therapy for Sleep and 
Mood Disruption in Brain Injury
George Brainard, Samer Jasser, Benjamin Warfield, 
Sreeramya Kanumilli, Leanna Panepinto, Fadee Disoke, 
Talia Glodjo, Kimberly Atkinson, Colette Glatts, 
Mijail Serruya, Lisa Bowman, Carissa Pineda, John Hanifin
Neurology Department and the Rothman Institute, Thomas 
Jefferson University, Philadelphia, PA, USA
Objectives: Sleep deficiency has been documented in astro-
nauts during International Space Station (ISS) missions (Barger et 
al., Lancet Neurol., 2014). Light can be a powerful countermeasure 
for circadian misalignment and sleepiness. The ISS interior is be-
ing retrofitted with Solid-State Light Assemblies (SSLAs) that 
have three color temperature modes (NASA S684-13489, 2013). 
Ground-based and in-flight studies are being done to test the effi-
cacy of SSLAs for supporting astronaut vision as well as effects 
on circadian, neuroendocrine, neurobehavioral and sleep physiol-
ogy (Brainard et al., Acta Astronautica, 2013; COPM, 2016). The 
broad goal of the following project is to determine if this new space 
flight technology can be adapted for use in hospitals. A study on 
patients with traumatic brain injury showed the benefits of light 
therapy in alleviating fatigue and daytime sleepiness (Sinclair et 
al., Neurorehab. and Repair, 2014). The specific aim of the re-
search reported here is to characterize sleep and mood disruption 
in patients with brain injury to determine if light therapy can im-
prove such symptoms.
Methods: Two separate, two-week observational trials have 
been completed: 1) patients with concussion and age/sex matched 
control subjects (N = 26); and 2) stroke patients and age/sex 
matched control subjects (N = 20). A third, five-week lighting in-
terventional study is in progress. The interventional study involves 
a randomized, controlled trial of daily 45 minute morning light 
therapy exposures. Light therapy was from solid-state devices. 
Placebo light units are accentuated light in the long wavelengths, 
hypothesized to be less active for stimulating the circadian system. 
Active light units are rich with light in short wavelengths, hypoth-
esized to be more active for circadian stimulation. In all studies 
measurements include actigraphy and validated mood, fatigue, and 
sleep quality tests. Statistical analyses include ANOVA with post-
hoc multiple range tests.
Results: Actigraphy provided objective measures of circa-
dian and sleep stability. For example, in the completed studies, 
actigraphy demonstrated that concussion patients had statistically 
and clinically meaningful longer sleep latencies compared to con-
trol subjects (p < 0.02). Similar significant results were observed 
in the study with stroke patients (p < 0.005). Measurement of mood 
disturbance with the Beck Depression Inventory showed that con-
cussion patients had significantly increased mood disturbance (p < 
0.001) compared to control subjects. Stroke patients also showed 
significant increased mood disturbances (p < 0.0001) compared to 
their matched control subjects. The light therapy trial is ongoing.
Conclusions: The results are potentially important to the 
medical care of patients with brain injury. These studies will con-
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tribute to the design of future, built-in smart lighting interventions 
for hospitals and home care environments to foster patient health 
and well-being.
Funding: NSF #EEC-0812056; PhotoPharmics, Inc.; TJU 
Dean’s Transformational Science Award; The Institute for Inte-
grative Health; and the Philadelphia Section of IESNA.
A13
Impact of Light’s Origin on Acute Alertness
Kai Broszio, Martine Knoop, Stephan Völker
Lighting Technology, Technische Universität Berlin, Berlin, 
Germany
Objectives: Studies under nighttime conditions addressing 
melatonin suppression and phase shift as well as research into the 
human retina showed that the intrinsically photosensitive Retinal 
Ganglion Cells (ipRGCs) are not evenly distributed. Their density 
respectively their sensitivity is highest at the lower and at the nasal 
part of the retina. Beyond that, light illuminating both eyes is more 
efficacious in melatonin suppression if compared to illumination of 
only one retina. Our earlier analysis of lighting scenes confirmed 
that scenes with the same vertical illuminance can have very di-
verse luminance patterns within the visual field. This might influ-
ence the effective radiation for non-image forming (NIF) effects. 
Thus, illuminance at the eye is not the adequate measure to quan-
tify the light’s potential to induce NIF effects. The aim of this study 
is to investigate the impact of two very different luminance distri-
butions with the same illuminance and the same melanopic-weight-
ed irradiance at the eye on NIF effects, in this case acute alertness. 
Whereas the results might be used to validate the impact of light’s 
origin on a nighttime NIF effect, they will also give insight into the 
importance of this design parameter on alertness during daytime.
Methods: In this study, subjects will be exposed to different 
lighting scenes in an office-like test room. The experiments will 
be conducted at day- and nighttime. Our previous analysis indi-
cated what specific luminance distributions can be more effective 
in causing NIF effects, when a higher sensitivity or density of 
ipRGCs in specific retinal areas or a higher effectiveness of illu-
mination of both retinas is assumed. From this, two very different 
luminance distributions in the visual field will be defined for this 
study. One lighting scene with assumed high and one lighting 
scene with assumed low NIF efficacy; both with the same illumi-
nance, respectively melanopic-weighted irradiance, at the eye. 
These luminance distributions will be adjusted to three absolute 
levels: a dim, a medium and a bright light condition. The medium 
level will be the ‘bright’ nighttime and the ‘dim’ daytime level. 
The spectrum respectively the CCT of the light will not be modi-
fied. Acute alertness will be assessed in both the night- and day-
time condition. A pilot study, preceding the main study, should 
address the following questions: Which method is adequate for 
measuring acute alertness in a setting investigating the light’s ori-
gin impact? Which illuminance levels are suitable to induce and 
detect daytime and nighttime NIF effects?
Results: Results of the pilot study are expected by fall 2018 
and preliminary results of the main study are expected in summer 
2019.
Conclusions: This study will give insight into the impact of 
light’s origin on acute alertness during day- and nighttime.
Funding/Disclosures: None.
A14
Effects of Light Therapy on Mood and 
Glucose Metabolism in Patients with 
Depression and Type 2 Diabetes
Annelies Brouwer1, Daniel H. van Raalte2, Femke Rutters3, 
Peter M. van de Ven3, Petra J.M. Elders4, 
Eus J.W. van Someren5, Frank J. Snoek6, 
Aartjan T.F. Beekman1, Marijke A. Bremmer1
1Department of Psychiatry, Amsterdam Public Health 
Research Institute (APH), VU University Medical Centre 
(VUmc) and GGZ inGeest, Amsterdam, The Netherlands; 
2Diabetes Center, VUmc, Amsterdam, The Netherlands; 
3Department of Epidemiology and Biostatistics, APH, 
VUmc, Amsterdam, The Netherlands; 4Department 
of General Practice and Elderly Care Medicine, APH, 
Amsterdam, The Netherlands; 5Department of Integrative 
Neurophysiology and Medical Psychology, Centre for 
Neurogenomics and Cognitive Research, Neuroscience 
Campus Amsterdam, VUmc, Amsterdam, The Netherlands; 
6Department of Medical Psychology, VUmc and Academic 
Medical Center, Amsterdam, The Netherlands
Objectives: Depression and type 2 diabetes often co-occur. 
Novel treatment strategies for depression in this patient population 
are warranted, as depression is associated with poor prognosis and 
treatment results. Light therapy has shown to be an effective anti-
depressant, possibly by entrainment of the circadian rhythm and 
improvement of sleep. The circadian system is also involved in the 
regulation of glucose metabolism, in particular by modulating pe-
ripheral insulin sensitivity. Hence, we aimed to evaluate the effects 
of light therapy on mood and glucose metabolism in patients with 
depression and type 2 diabetes.
Methods: We conducted a randomized, double-blind, paral-
lel trial in which 83 patients with depression and type 2 diabetes 
were exposed to active light (10,000 lux, broad-spectrum white-
yellowish) or placebo light (450 lux, monochromatic 545 nm 
green) half an hour every morning for 4 weeks at home. Numerous 
psychological, circadian and metabolic measures were obtained 
during the light therapy treatment period, and four weeks after 
completion of the treatment.
Results: Data collection has been concluded in November 
2017 and data-analysis started in March 2018. At the SLTBR 
meeting June 2018 we will present the effects of light therapy on 
absolute and significant reduction in depressive symptoms, de-
pression remission, and subjective and objective sleep measures. 
Additionally, we will present the effects of light therapy on HbA1c 
and insulin sensitivity, as measured with a hyperinsulinemic eug-
lycaemic clamp procedure – the golden standard for measuring 
peripheral insulin sensitivity.
Conclusions: If light therapy improves mood and has posi-
tive effects on glucose metabolism, it may be a valuable patient 
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friendly addition to the currently available treatment strategies for 
depression in patients with type 2 diabetes.
Funding/Disclosures: This study is supported by a Euro-
pean Foundation for the Study of Diabetes (EFSD)/Lilly Mental 
Health award. Aartjan T. F. Beekman has received unrestricted 
funding from Lundbeck (speakers bureau).
A15
Light Therapy: Is it Safe for the Eyes? 
A Systematic Review
Annelies Brouwer1, Huang-Ton Nguyen2, Frank J. Snoek3, 
Daniel H. van Raalte4, Aartjan T.F. Beekman1, 
Annette C. Moll2, Marijke A. Bremmer1
1Department of Psychiatry, Amsterdam Public Health 
Research Institute (APH), VU University Medical Centre 
(VUmc) and GGZ inGeest, Amsterdam, The Netherlands; 
2Department of Ophthalmology, VUmc, Amsterdam The 
Netherlands; 3Department of Medical Psychology, VUmc and 
Academic Medical Center, Amsterdam, The Netherlands; 
4Diabetes Center, VUmc, Amsterdam, The Netherlands
Objectives: Light therapy has become an increasingly popu-
lar treatment for depression and a range of other neuropsychiatric 
conditions. Yet, concerns have been raised about the ocular safety 
of light therapy.
Methods: We conducted a systematic review into the ocular 
safety of light therapy. A PubMed search on January 4, 2017, iden-
tified 6708 articles, of which 161 were full-text reviewed. In total, 
43 articles reporting on ocular complaints and ocular examinations 
were included in the analyses.
Results: Ocular complaints, including ocular discomfort and 
vision problems, were reported in about 0% to 45% of the partici-
pants of studies involving light therapy. Based on individual stud-
ies, no evident relationship between the occurrence of complaints 
and light therapy dose was found. There was no evidence for ocular 
damage due to light therapy, with the exception of one case report 
that documented the development of a maculopathy in a person 
treated with the photosensitizing antidepressant clomipramine.
Conclusions: Results suggest that light therapy is safe for the 
eyes in physically healthy, unmedicated persons. The ocular safety 
of light therapy in persons with preexisting ocular abnormalities or 
increased photosensitivity warrants further study. However, theo-
retical considerations do not substantiate stringent ocular safety-re-
lated contraindications for light therapy. The systematic review of 
the ocular safety of light therapy was complicated due to varying 
and often poor reporting of light therapy treatment characteristics in 
research articles. We believe that concise reporting of light therapy 
treatment characteristics may enhance the comparability of different 
light therapy treatments, particularly in the meta-analysis of clinical 
trials. We envision that a consensus statement on the topic, prefer-
ably supported by the Society for Light Treatment and Biological 
Rhythms (SLTBR), may contribute to better reporting in future.
Funding/Disclosures: This study is supported by a Euro-
pean Foundation for the Study of Diabetes (EFSD)/Lilly Mental 
Health award. Aartjan T. F. Beekman has received unrestricted 
funding from Lundbeck (speakers bureau).
A16
Impact of Light on Functional Brain 
Connectivity in Young and Older Individuals
Julie Carrier
Université de Montréal, Montréal, QC, Canada
Beyond being essential for vision, light has numerous non-vi-
sual effects, including stimulating cognitive functions and alert-
ness. Non-visual effects of light could decrease with aging, and 
may contribute to cognitive complaints and sleepiness in older 
individuals. However, both the brain and the eye (lens yellowing, 
senile miosis) profoundly change in aging. Whether the effect of 
light on cognitive brain functions varies in aging and whether age-
related ocular changes contribute to the variations are not estab-
lished. We compared the impact of light on non-visual cognitive 
brain activity using functional magnetic brain imaging in younger 
and older individuals with their natural lenses or with intraocular 
lens replacement following cataract surgery. Brain responses to 
executive tasks and cerebral connectivity were analysed during 
either blue (480 nm) or orange (620 nm) monochromatic light ex-
posures. Analyses reveal that light modulates executive brain re-
sponses in both young and older individuals. The effects of light 
were, however, stronger in young individuals including in the hip-
pocampus and frontal and cingular cortices. Light effects did not 
significantly differ between older individuals with their natural 
lenses and older individual with intraocular replacement. Prelimi-
nary analyses also indicate that light wavelength modulate cerebral 
functional connectivity. These findings show that light can affect 
non-visual cognitive brain activity in aging but less than in young 
adults. The absence of differences between older individuals with 
clear or natural lenses supports that the aging brain adapts to pro-
gressive changes in light and show therefore plasticity in its non-
visual light sensitivity.
A17
Differences in Energy Expenditure 
during Morning and Evening Maximal 
Ergospirometry in Extreme Chronotypes
Kateřina Červená1,2, Roman Šolc2, Katarína Baranyaiová3, 
Zdeňka Bendová1,2
1Department of Sleep Medicine and Chronobiology, 
National Institute of Mental Health, Klecany, Czech 
Republic; 2Faculty of Science, Charles University, Prague, 
Czech Republic; 3Faculty of Arts, Charles University, 
Prague, Czech Republic
Objectives: The main objective of this project is to evaluate 
the effect of chronotype on cardiopulmonary and metabolic re-
sponses to exercise during early morning and late evening testing 
conducted during the long and short photoperiod using maximal 
exercise ergospirometry.
As a behavioral manifestation of the innate circadian period, 
chronotype can be influenced by many other factors. Our next goal 
is to distinguish the genetic basis of chronotype from other factors 
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by genotyping DNA samples from tested subjects, as well as from 
a larger population sample to determine polymorphic variants of 
selected clock genes involved in the genetic basis of chronotype 
formation.
Methods: 15 morning types and 18 evening types partici-
pated in the winter testing and 17 morning types and 15 evening 
types participated in the summer testing. Chronotype of the par-
ticipants was determined using the Morningness – Eveningness 
Questionnaire (MEQ). Prior to the ergospirometry testing each 
participant performed a 10 min PEBL Perceptual Vigilance Task 
(PPVT) to assess reaction time, sleepiness and arousal. Cardio-
metabolic parameters were measured during maximal exercise er-
gospirometry. Heart rate, blood pressure, inhaled O2 and exhaled 
CO2 at rest and during all stages of the exercise protocol were 
obtained, including the time of Anaerobic Threshold (AT) and 
maximum rate of oxygen consumption (VO2 max), as well as post-
exercise heart rate recovery rate.
Results: Preliminary results indicate more pronounced dif-
ferences between morning and evening cardiopulmonary response 
to exercise performed in winter and relatively worse performance 
of evening types during morning exercise than morning types dur-
ing evening exercise. Full results are expected in June 2018.
Conclusions: Our society largely favors extreme morning 
types in terms of work schedules. Given that extreme morning 
types comprise only few percent of the population and the result-
ing social jet-lag in many other individuals, actual data comparing 
early morning and late evening performance capacity are useful 
for the possible debate on potential work schedule adjustments 
based on individual chronotype.
Funding/Disclosures: None.
A18
Application of Mathematical Modeling for 
Faster Circadian Entrainment
Philip Cheng1, Olivia Walch2, Christopher Drake1
1Henry Ford Health System, Detroit, MI, USA; 2University of 
Michigan, Ann Arbor, MI, USA
Objectives: In a fast-paced and globalizing economy, there 
is growing demand for non-traditional work schedules (e.g., night 
shift work) and flexible travel; however, these are often accompa-
nied by the adverse consequences of circadian misalignment (e.g., 
shift work disorder, jet lag, etc.) Though phototherapy can have 
robust effects in shifting circadian phase, large phase shifts (e.g. 
10–12 hours) often require repeated doses over approximately one 
week.
One solution is to use mathematical modeling to derive photo-
therapy schedules optimized for large phase shifts in minimal time. 
These schedules have been released through the mobile applica-
tion, Entrain, since 2014, and have shown promise; however, their 
efficacy has never been tested in controlled laboratory conditions. 
This study aims to test the feasibility and efficacy of a mathemat-
ically optimized phototherapy schedule to create larger phase 
shifts than traditional phototherapy.
Methods: A total of 10 participants will be recruited and ran-
domized into either the traditional phototherapy schedule or the 
mathematically optimized phototherapy schedule. In both condi-
tions, participants will receive three large doses of bright light 
across three days in a laboratory environment controlled for ambient 
temperature and light. Participants in the traditional phototherapy 
condition will receive bright light in the phase delay portion of the 
phase response curve and darkness (<10 lux) in the phase advance 
portion. Light/dark exposure in the mathematically optimized 
schedule will be determined using the Kronauer model. Circadian 
phase will be assessed via dim light melatonin onset (DLMO) be-
fore and after the light interventions. Bright light (10,000 lux) will 
be delivered via light box for periods of 30 minutes that are alter-
nated with 500 lux of ambient light. Darkness is operationalized as 
<10 lux during wakefulness, and complete darkness during sleep.
Results: Though data collection is still on-going, preliminary 
analyses indicate that the optimized phototherapy schedule will 
induce larger phase delays (10–12 hours) compared to the tradi-
tional phototherapy condition (4–6 hours).
Conclusions: This study takes the first steps in translating 
mathematically optimized phototherapy into real-world interven-
tions.
Funding/Disclosures: This study is funded by the Henry 
Ford Health System Proposal Development Grant. Funding for PC 
is also provided through the National Institutes of Health 
(K23HL138166).
A19
Assessing the Impact of Light-at-Night on 
Sleep, Circadian Function and on Physical 
and Mental Well-Being
Michael Cleary-Gaffney, Andrew N. Coogan, Brian Espey
Maynooth University, Maynooth, Ireland
Objectives: The negative effects that both continuous light-
at-night and dim light-at-night (LAN) exposure has on sleep and 
health has been well documented in experimental studies. How-
ever, it is unclear how an individual’s routine nighttime lighting 
habits in their home environments impacts on their sleep and 
health. This study aims to gain a better understanding of the main 
sources of light-at-night in home settings and whether individuals 
perceive light-at-night as impacting on their sleep, cognitive func-
tion, physical and mental well-being. In addition, the study aims 
to understand whether our geographical location has an impact on 
light-at-night exposure.
Methods: In this ongoing cross-sectional study, participants, 
(n = 477, males = 148/females = 329, age (M = 37.97, SD 13.29) 
completed a developed questionnaire addressing the perception of 
the impact of LAN and perceived sources of LAN alongside vali-
dated measures of sleep quality (Pittsburgh Sleep Quality Index; 
PSQI), cognitive function (Cognitive Failures; CFQ) and physical 
and mental well-being (General Health Questionnaire). Astrophy-
ical data was used to provide an objective measure of outdoor light 
exposure. This allows to cross-reference the individuals subjective 
perception of outdoor light against the objective measure of out-
door light.
Results: We found that individuals who subjectively perceive 
having outside light entering their bedroom report higher GHQ 
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scores (p = 0.017, Cohen’s d = 0.21), have poorer sleep quality (p < 
0.001, Cohen’s d = 0.41), and higher cognitive failures (p = 0.017, 
Cohen’s d = 0.359) compared to those who perceive low level out-
door light. However, when the GHQ is examined under its spe-
cific subscales the subjective perception of outdoor light is only 
having an effect on somatic symptoms (p = 0.008, Cohen’s d = 
0.24) and anxiety/insomnia (p = 0.001, Cohen’s d = 0.30). Sig-
nificant effects are not observed in the domains of social dysfunc-
tion and severe depression. When examining objective measures 
of outdoor light and the subjective perception of outdoor light, no 
relationship is found. Results also indicate that the perception of 
indoor light from outside the bedroom (e.g., light from bathroom) 
has no effect on psychological distress, sleep quality or cognitive 
failures. The perception that light emitting devices disrupt sleep 
has significant negative effects on total GHQ scores (p = 0.001, 
partial n2 = 0.027), sleep quality scores (p = 0.001, partial n2 = 
0.066) and cognitive failure scores (p = 0.001, partial n2 = 0.045).
Conclusions: The subjective perception of LAN exposure 
yielded mixed results with the perception of outdoor light having 
a negative effect on sleep quality and health. However, the same 
effects were not observed for indoor light outside the bedroom. 
There was a mismatch between the objective measures of outdoor 
light and the subjective perception of outdoor light. It may be that 
individuals who report having poor sleep and poor health have a 
heightened negative perception of light-at-night in the bedroom.
Funding/Disclosures: John & Pat Hume Doctoral Scholar-
ship.
A20
Actimetric Day/Night Index as a Predictor of 
Treatment Response in Depression
Konstantin V. Danilenko1,2, Kristina A. Mazhara2, 
Sergei V. Yarosh1, Maria Y. Lebedinskaia1, 
Evgenia V. Gadetskaia1, Lyubomir I. Aftanas1,2
1Institute of Physiology and Basic Medicine, Novosibirsk, 
Russia; 2Novosibirsk State University, Novosibirsk, Russia
Objectives: Actimetry provides objective measures of rest-
activity cycles. It yields indirect measures of certain sleep param-
eters, and when measured over several days, it may also approxi-
mate circadian measures, such as circadian phase (based on mid-
sleep), circadian amplitude (based on the day/night activity index) 
and day-to-day sleep-wake cycle variability. We analysed actime-
try-based circadian measures in depressed patients during xenon 
treatment.
Methods: Actimeters MotionWatch 8 (CamnTech, England) 
were worn on the non-dominant arm in depressed patients with 
MDD or dysthymia (according to DSM-5 criteria) hospitalised for 
a randomised, double-blind, placebo-controlled xenon (Xe) thera-
py study. Xe (an antagonist of NMDA receptors) in combination 
with nitrogen/oxygen was inhaled in sub-anesthetic doses for 15 
minutes daily for 10 days (excluding weekends). In the placebo 
group, only nitrogen/oxygen was used. Actimeters were usually 
worn during pre-treatment (2–5 days) and for the first half of the 
treatment session (4–5 days). The actimetric indices were calcu-
lated manually (mid-sleep) or using the MotionWare 1.1.20 tool 
(day/night activity index and sleep-wake cycle variability). De-
pression was scored using the Hamilton Depression Rating Scale 
(HDRS-17) before and at the end of treatment.
Results: Actimetric data were available from 30 patients, 
aged 19–66 y. The day/night activity index correlated significant-
ly with the HDRS-17 score reduction (either for absolute or rela-
tive values, p < 0.04, Spearman test): a greater day/night index was 
associated with greater reduction. The result was mainly due to the 
active (Xe) group who improved more than the placebo treated 
patients. Circadian phase or circadian rhythm variability did not 
correlate significantly with the score reduction.
Conclusions: The result is in line with previous findings of 
an association between greater circadian day night amplitude in 
depression with better treatment outcome. Actimetry thus provides 
an easy-to-document predictive objective measure.
Funding/Disclosures: Budgetary fund.
A21
Caffeine or Light at Night; Effects on Sleep 
and Circadian Rhythms in Rodents
Tom Deboer
Laboratory for Neurophysiology, Department of Cell and 
Chemical Biology, Leiden University Medical Center, 
Leiden, The Netherlands
The presentation will summarize recent data regarding the in-
fluence of sleep deprivation, light and caffeine on circadian clock 
functioning. These can be single influences, but it has also been 
shown that they can interact.
Light is the most important zeitgeber for the circadian clock. 
Sleep deprivation was shown to reduce the phase shifting capacity 
of the circadian clock in reponse to light. Also neurons in the su-
prachiasmatic nucleus (SCN) were shown to respond less to light 
after sleep deprivation.
Caffeine has been used for many centuries and in different 
cultures to alleviate the effects of sleep deprivation and to in-
crease alertness. We showed that the effect of sleep deprivation 
on the light-induced increase in SCN neuronal activity was also 
normalized after application of caffeine. More recently it was 
shown that caffeine not only decreases sleep pressure, but also 
slows down the circadian clock. Both in cell cultures and in intact 
mice and humans it was shown that the clock is delayed or circa-
dian period is increased under influence of caffeine. The effects 
in vivo were particularly strong when combined with constant 
light exposure. Thinking of Aschoff’s rule it may be that in intact 
mice caffeine slows down the clock by increasing the effect of 
light on the clock.
In addition, application of caffeine into the medium of cell cul-
tures or chronically in the drinking water can increase day-night 
amplitude. We have new data, extending this research, which 
shows that the amplitude in the sleep-wake cycle is also increased 
under chronic caffeine consumption in mice. Most remarkably, the 
animals slept deeper in the first hours of the rest phase than animals 
consuming normal water.
Finally, constant light or dim-light at night disturbs sleep in 
humans and rodents and was shown to disturb circadian rhythms, 
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resulting in splitting of rhythms or in arrhythmia in rodents. We 
have now performed additional experiments in older mice and 
show that the effect of dim light at night is less strong in aged mice.
The data show that a clear difference between day and night in 
lighting conditions is important for a strong and healthy sleep-
wake rhythm. The effects of chronic caffeine in rodents suggest 
that caffeine may have a supportive role for the central circadian 
pacemaker by increasing its amplitude, possibly by increasing the 
influence of light on the circadian clock.
A22
Polychromatic White Light Exposure 
Reduces Objective Sleepiness Depending 
on Melanopic Lux at Low Light Intensities 
During Daytime
Jan de Zeeuw1,4, Alexandra Papakonstantinou1,3, 
Claudia Nowozin1,3, Sophia Wisniewski1,3, Mandy Zaleska4, 
Theresa Fox4, Sven Hädel1, Frederik Bes1,3, Dieter Kunz1,3,4, 
Mirjam Münch1,2,3
1Charité – Universitätsmedizin Berlin, Corporate Member 
of Freie Universität Berlin, Humboldt-Universität zu Berlin, 
and Berlin Institute of Health, Institute of Physiology, 
Sleep Research & Clinical Chronobiology, Berlin, Germany; 
2Institute of Medical Immunology; 3Clinic for Sleep 
& Chronomedicine, St. Hedwig-Krankenhaus, Berlin, 
Germany; 4Intellux GmbH, Berlin, Germany
Objectives: This study aimed to determine how subjective 
and objective sleepiness under well controlled conditions were af-
fected by different light exposures during daytime. The polychro-
matic white light conditions differed in peak wavelength of the 
blue light spectrum and/or light intensity.
Methods: In a mixed within-between-subject design, 72 
healthy participants (48 female; 24.4 ± 2.7 yrs; mean ± SD) visited 
the laboratory four times, arriving one hour after habitual wake-up 
times while wearing dark goggles. They were exposed for 3 h to a 
lighting condition, starting ~3 h after wake-up. The lighting condi-
tions differed in peak wavelength of the blue portion of the light 
spectrum, while having similar CCT (=3500 K; blue light peak at 
435 nm or at 480 nm), or they differed in illuminance (100 lx, 200 
lx, 600 lx, 1200 lx), and included a dim light condition (DL; ran-
domized order of conditions). Objective sleepiness, as assessed in 
the electroencephalogram (EEG) by the Karolinska drowsiness 
test (i.e. 5 min closed and 5 min open eyes) and subjective sleepi-
ness by visual analogue scales were measured hourly and analyzed 
with mixed linear models.
Results: During three hours of light exposure, objective 
sleepiness (determined by the EEG alpha attenuation index) 
showed significant differences such that at 100 lx, it was most 
strongly reduced by light with a spectral peak at 480 nm when 
compared to 435 nm or DL (F3,769 = 28.56; p < 0.001). We also 
found a trend for a reduction of objective sleepiness by higher light 
intensities, which was greatest at 1200 lx (F2,882 = 2.65; p = 0.071). 
In addition, there were significant differences between the lighting 
conditions in the EEG delta, theta, sigma and beta ranges depend-
ing on the peak wavelength and light intensity (p < 0.05). Subjec-
tive sleepiness was significantly reduced in the first hour of light 
exposure, by light with a spectral peak at 480 nm compared to 435 
nm or DL (F1,81 = 4.14; p = 0.045).
Conclusions: The impact of the different spectral composi-
tions of light on the waking EEG (a marker for objective sleepi-
ness) was most pronounced at low light intensities (100 photopic 
lux). Our results indicate that lighting conditions with higher mela-
nopic lux (i.e. greater blue portion at 480 nm) had stronger alerting 
effects during daytime in well-rested participants. At higher light 
intensities the alerting effects are mixed and interact with spectral 
compositions, and thus are less obvious.
Funding: This study was funded by the German Federal Min-
istry of Education and Research (OLIVE project) and Intellux 
GmbH (Berlin), Germany.
Disclosures: None.
A23
Documentation of Mixed Lighting 
Conditions in Non-Image Forming Studies
Aicha K. Diakite, Nils Weber, Martine Knoop
Technische Universität Berlin, Berlin, Germany
Objectives: Non-image forming (NIF) effects of light are 
affected by a number of factors, such as light level, spectral pow-
er distribution of the light, duration, timing, light history, and 
spatial distribution of the light. Due to this complexity, proper 
documentation of experimental conditions and procedures to en-
sure future applicability and reproducibility seems to be of utmost 
importance. The poster will indicate that studies looking into NIF 
effects of light during daytime require an extended description of 
the considered lighting conditions. Until now, some of the rele-
vant parameters are included in the description of the experimen-
tal procedure, such as the duration of light exposure and the tim-
ing of the experiment during the day. The lighting conditions are 
typically included in the description of the experimental set-up, 
reflected in vertical illuminances or melanopic-weighted irradi-
ance and the correlated color temperature or spectral power dis-
tribution (SPD). When included, the origin of the light is de-
scribed qualitatively with the position of the luminaires and the 
windows in the room. Even though the scientific basis is small, 
there is some indication that the incident angle of light could mat-
ter. Literature on melatonin suppression or phase shifts shows that 
inferior and nasal retinal light exposure is more effective than 
light falling on the superior or temporal side of the retina. In ad-
dition, binocular light exposure realizes a higher melatonin sup-
pression than monocular light exposure. It is not clear yet, wheth-
er this is relevant for daytime NIF effects, but as daylight gener-
ally differs from the electric light sources in intensity, SPD and 
position of the light source, making a distinction between contri-
butions from both light sources is required. Integral measure-
ments, such as the vertical illuminance or melanopic-weighted 
irradiance are not suitable to describe the studied lighting condi-
tions.
Methods and Results: To allow the subsequent incorpora-
tion of future spectral weighting functions for NIF responses and 
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relevant retinal areas, the TU Berlin has looked into an approach 
to conduct spatially and spectrally resolved measurements of 
lighting conditions. This is especially relevant in situations with 
various SPDs from light sources, possibly altered through reflec-
tion. Two novel colorimetric measurement devices for conditions 
with daylight and artificial lighting are currently being considered 
at the TU Berlin. A modified ‘luminance’ camera with filters 
adapted to the five photoreceptor types of the human retina, as 
well as a room scanner with a spectroradiometer. The poster will 
present the measuring approach, the devices, as well as examples 
of its application.
Conclusions and Outlook: Detailed documentation of 
lighting conditions is essential to allow future retrospective analy-
sis of research results with adjustments to retinal areas of interests 
and their specific sensitivities. The proposed measurement devices 
will provide high-resolution data. The measurements will be used 
to look into the development of simplified sensors that can be ap-
plied at a larger scale.
Funding/Disclosures: The presented work is supported by 
TU Berlin and the Velux Stiftung [grant number 1087].
A24
Physical Activity, Sleep and Circadian 
Rhythm Patterns in Depressive and 
Anxiety Disorders: A 2-Week Ambulatory 
Assessment Study
Sonia Difrancesco1, Femke Lamers1, Harriëtte Riese2, 
Kathleen R. Merikangas3, Aartjan T.F. Beekman1, 
Bert A.M. van Hemert4, Robert A. Schoevers2, 
Brenda W.J.H. Penninx1
1Department of Psychiatry, Amsterdam Public Health 
Research Institute, VU University Medical Center, 
Amsterdam, The Netherlands; 2Department of Psychiatry, 
University Medical Center Groningen, Interdisciplinary 
Center for Psychopathology and Emotion Regulation, 
University of Groningen, Groningen, The Netherlands; 
3Genetic Epidemiology Branch, Intramural Research 
Program, National Institute of Mental Health, Bethesda, 
MD, USA; 4Department of Psychiatry, Leiden University 
Medical Center, Leiden, The Netherlands
Objectives: Traditional assessment of physical activity 
(PA), sleep and circadian rhythms (CR) in depression/anxiety 
mostly relies on self-reported questionnaires, however, it may be 
biased by patient cognitive impairment and negative perception. 
Actigraphy may improve the assessment of PA, sleep and CR pro-
viding objective estimates. The objectives are: (1) study the rela-
tionship of actigraphy estimates of PA, sleep and CR with depres-
sion/anxiety; (2) study the association of objective estimates of 
PA, sleep and CR with clinical characteristics.
Methods: Data of 360 participants with current (n = 94), re-
mitted (n = 176) and no (n = 90) depression/anxiety was obtained 
from the Netherlands Study of Depression and Anxiety. Depres-
sion/anxiety was diagnosed with the DMS-IV based Composite 
International Diagnostic Interview. Clinical characteristics includ-
ed severity of depressive/anxiety symptoms, duration and number 
of psychiatric diagnoses, age of onset and, antidepressant use. Ac-
tigraphy estimates of PA, sleep and CR were Euclidean Norm Mi-
nus One (ENMO) and moderate-to-vigorous PA (MVPA), sleep 
duration (SD) and sleep efficiency and, relative amplitude between 
daytime and night-time activity level (RA) and sleep midpoint on 
free days (SMF), respectively.
Results: Compared to controls, persons with depression/anx-
iety had significantly reduced ENMO (median (IQR) = 28.83 
(9.73) mg, p = 0.022), MVPA (median (IQR) = 35.32 (35.11) min/
day, p = 0.023) and RA (median (IQR) = 0.82 (0.08), p = 0.033). 
Severity of depressive/anxiety symptoms and number of psychiat-
ric diagnoses were associated with reduced ENMO and MVPA, 
longer SD and lower RA. A tendency in delayed SMF was found 
among those with more depressive symptoms.
Conclusions: Actigraphy may be a complementary tool to 
clinical interview and self-reported questionnaires in the assess-
ment of PA, sleep and circadian rhythms in depression and anxiety. 
PA and CR interventions in depression and anxiety may especial-
ly focus on patients with higher severity of depressive/anxiety 
symptoms and with more psychiatric comorbidity.
Funding/Disclosures: This work was supported by Innova-
tive Medicines Initiative 2 Joint undertaking under grant agree-
ment No 115902.
A25
Novel Biomarkers for Circadian Rhythms 
and Sleep
Derk-Jan Dijk
Surrey Sleep Research Centre, Faculty of Health and 
Medical Sciences, University of Surrey, Guildford, UK
Insufficient and mistimed sleep as well as circadian misalign-
ment are associated with various adverse health outcomes. Assess-
ment of sleep and circadian rhythmicity has traditionally relied on 
subjective measures of sleep, sleepiness and circadian preference, 
polysomnography, long term assessment of rest-activity cycles, 
and time series of markers of circadian rhythmicity such as mela-
tonin or core body temperature. These traditionally measures have 
their drawbacks because they are either subjective or too labour 
intensive or costly to implement on a large scale in real life situa-
tions. The human blood transcriptome is sensitive to both acute 
total sleep loss and chronic insufficient sleep as well as mistimed 
sleep and also contains information about the circadian phase of 
the SCN and maybe other organs. Recent progress in the discovery 
and validation of blood-based biomarkers derived from one or a 
few blood samples, for circadian phase and insufficient sleep will 
be presented.
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A26
Actigraphy in Combined Chronotherapy to 
Determine Predictors of Response in the 
Treatment of Depressive Disorder
Stella J.M. Druiven1, Jeanine Kamphuis2, 
Benno C.M. Haarman2, Ybe Meesters3, 
Robert A. Schoevers3, Harriëtte Riese1
1University of Groningen, University Medical Centre 
Groningen, Department of Psychiatry, Interdisciplinary 
Centre for Psychopathology and Emotion Regulation (ICPE), 
Groningen, The Netherlands; 2University of Groningen, 
University Medical Centre Groningen, Department of 
Psychiatry, Research School of Behavioural and Cognitive 
Neurosciences (BCN), Groningen, The Netherlands; 
3University of Groningen, University Medical Centre 
Groningen, Department of Psychiatry, Groningen, The 
Netherlands
Objectives: Combined chronotherapy includes sleep depri-
vation and morning light therapy and has been successfully used 
to treat severe depressive episodes. However, it is still largely un-
known when chronotherapy should be indicated in the treatment 
of a depressive patient and therefore not yet part of regular treat-
ment protocols. Some predictors of response to chronotherapy 
have been identified, such as diurnal mood variability and higher 
levels of clinician-observed arousal. It is worthwhile to search for 
other predictors in order to improve the use of chronobiological 
interventions in treatment of depressive disorders. By using actig-
raphy, post-treatment changes in physical activity levels and vari-
ability have been documented for those who responded to chrono-
therapy. It is of great interest to measure activity-rest rhythms pri-
or to chronotherapy as this may provide more answers. For 
example, it may be possible that individuals with high variability 
in their day-to-day activity rhythm may be particular susceptible 
to chronobiological influences. Therefore, the aim of this study is 
to examine whether possible predictors of response can be identi-
fied by assessing activity-rest rhythm in addition to mood patterns 
of patients suffering from a depressive disorder.
Methods: Fifty patients diagnosed with a depressive episode 
in the context of a major depressive disorder or a bipolar depres-
sive disorder, as assessed with the Mini-International Neuropsy-
chiatric Interview, will be included. The patients will be treated 
according to our chronotherapy protocol including three nights of 
total sleep deprivation, each followed by a recovery night, and 
daily morning light therapy for two weeks. The level of depressive 
symptoms will be assessed weekly using the Inventory of Depres-
sive Symptoms – Self Report (IDS-SR). Additionally, mood vari-
ability is assessed with daily Ecological Momentary Assessment 
(EMA). Starting one week before the start of the chronotherapy, 
wrist actigraphy measurements will be recorded until the end of 
the therapy.
Discussion: Discussion about the protocol with SLTBR 
members may be helpful for improving the design.
Funding/Disclosures: None.
A27
Benefits of Evening versus Morning Training 
in the Acquisition and Consolidation of 
Motor Skill in Older Adults
Carmit Gal1,2, Avi Karni1,2, Maria Korman1
1The Edmond J. Safra Brain Research Center for the 
Study of Learning Disabilities, University of Haifa, Haifa, 
Israel; 2Laboratory for Human Brain and Learning, Sagol 
Department of Neurobiology, University of Haifa, Haifa, 
Israel
Objectives: Using a training protocol that effectively induc-
es skill memory in young and older adults, we examined whether 
training during evening hours compared to morning training would 
result in different time courses of skill learning (acquisition, con-
solidation and retention) in typical healthy elderly individuals.
Methods: We tested the effects of a single session training 
on motor finger tapping sequence learning (FTSL) task, scheduled 
to either morning or evening hours, in 29 healthy elderly partici-
pants (60–75 years). Contribution of three parameters to learning 
was assessed: (a) time of training (morning vs. evening) (b) sleep 
quality (actigraphy) and (c) chronotype.
Results: Our results showed that: (1) Older adults have the 
potential for effective procedural motor within-session and be-
tween-session (consolidation phase) learning and fully retain prac-
tice-dependent performance gains attained at the end of practice 
session a week after training; (2) The initial level of speed of motor 
performance and the course of learning of older adults are different 
from young adults – baseline of performance is lower and the prac-
tice-related gains are smaller. However, accuracy of performance 
is similar to that of the younger peers; (3) Participants trained in 
the evening expressed overnight consolidation phase gains, in ad-
dition to online within session gains in performance. In contrast, 
participants trained in the morning showed only maintenance of 
performance level attained at the end of training. (4) Benefits of 
evening training are surprising in the light of the fact that all study 
participants were moderately morning type (except for the two 
subjects exhibiting neither type). Evening group mean MEQ score 
was 63 ± 5.33, Morning group mean MEQ score was 59.7 ± 8.7); 
(5) All participants had sleep patterns typical of age, with average 
sleep efficiency of ~82%, and approximately 6 hours of sleep.
Conclusions: Our results suggest that procedural motor 
memory consolidation processes are preserved in healthy elderly 
individuals, but these processes are under-engaged if the practice 
session is scheduled to morning hours. Although all participants 
(irrespective of the time-of-training) were moderate morning 
types, suggesting that morning training should be optimal for these 
individuals, other factors precluded the evolution of the delayed 
off-line gains in performance. We conjecture that if practice ses-
sion took place in the morning, post-training consolidation pro-
cesses are disrupted by unspecific interference as a result of nu-
merous task-irrelevant motor behavioral experiences during the 
long awake period prior to night sleep. Training in the evening 
hours can relax some of these constraints on overnight consolida-
tion in older adults. The current results are in line with the notion 
that the control of what is to be retained in procedural memory is 
atypical or more stringent in the elderly.
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The Influence of Daytime Light on Nighttime 
Sleep
Moniek Geerdink1,2, Tom Woelders1, 
Domien G.M. Beersma1, Marijke C.M. Gordijn1,2
1Department of Chronobiology, GeLifes, University of 
Groningen, Groningen, The Netherlands; 2Chrono@Work 
B.V., Groningen, The Netherlands
Objectives: Light is not only crucial for vision but also influ-
ences other aspects of physiology and behavior. One well studied 
aspect of light is its effect on our biological clock which is also 
linked to sleep timing. Yet, the effect of daytime light on nighttime 
sleep itself has hardly been studied in humans. In our within-sub-
ject design laboratory study we examined the influence of daytime 
light on the subsequent nighttime sleep. We measured effects on 
the biological clock as well as on sleep homeostasis.
Methods: Participants with mild sleep complaints were ex-
posed to three conditions: Either to one day (9–17 h) with moder-
ate intensity polychromatic ‘office light’, one day with high inten-
sity polychromatic light ‘bright light’, or one day with extra blue 
LED light on top of the ‘office light’. The influence of this daytime 
light on the biological clock was measured via analysis of the mel-
atonin rhythm and on sleep quality/homeostasis via sleep-EEG 
measurements. Multilevel regression analyses were used to quan-
tify the effects on the accumulation rate of slow wave activity.
Results: Compared to melatonin onset in the office light con-
dition, the onset was earlier in the bright light condition (0.35 h, 
p < 0.05) and there was a trend for an earlier onset in the blue light 
condition (0.30 h, p = 0.07) compared to the office light condition. 
Sleep efficiency was higher (95.8% vs. 92.1%, p < 0.05) and the 
percentage of REM sleep was larger (23.3% vs. 19.7%, p < 0.05) 
in the bright light condition compared to the office light condition. 
The accumulation rate of slow wave activity during sleep, a mea-
sure of sleep pressure decay, was significantly higher in the bright- 
as well as in the blue light condition compared to the office light 
condition.
Conclusions: Light intensity during the day affects sleep via 
an effect on the clock and by influencing sleep homeostasis, with 
higher light intensities leading to more consolidated, deeper sleep.
Funding/Disclosures: This study was financially support-
ed by an unrestricted research grant of Philips Consumer Lifestyle 
B.V. Drachten, The Netherlands, developed by the legal authori-
ties of both parties.
A29
Circadian Measures Are Not Phase Delayed 
in Bipolar Spectrum Disorder in a 20-
Day Naturalistic Ecological Momentary 
Assessment Study
Namni Goel1, Madison K. Titone2, Tommy H. Ng2, 
Laura E. Dennis1, Lauren B. Alloy2
1Division of Sleep and Chronobiology, Department of 
Psychiatry, University of Pennsylvania Perelman School 
of Medicine, Philadelphia, PA, USA; 2Department of 
Psychology, Temple University, Philadelphia, PA, USA
Objectives: Prior work demonstrates circadian rhythm dis-
ruptions of sleep/wake, activity, hormones, and melatonin in indi-
viduals with bipolar spectrum disorder (BSDs). Such disruptions 
may be a key mechanism underlying neurobiological vulnerability 
to BSDs.
Methods: 150 adults (ages 18–27; mean age ± SD, 21.9 ± 2.1 
y; 88 women), with high reward sensitivity and a BSD (n = 43), 
at-risk individuals with high reward sensitivity but no BSD (n = 
64), and low-risk individuals with moderate reward sensitivity and 
no BSD (n = 43) participated in a 20-day naturalistic Ecological 
Momentary Assessment (EMA) study. The EMA study involved 
3 phases: 1. Baseline; 2. Goal striving and 3. Goal/reward out-
come; salivary dim light melatonin onset (DLMO) was assessed 
as a circadian phase marker in each phase. The Morningness-Eve-
ningness Questionnaire (MEQ) assessed chronotype, iButtons 
measured skin temperature continuously, and wrist actiwatches 
measured sleep-wake cycles. Multilevel linear models and Pear-
son’s correlations were used for statistical analysis.
Results: In our large sample, MEQ scores, DLMOs, skin tem-
perature maximum acrophases and actigraphic sleep midpoints 
were not significantly different across the three groups at baseline 
(all Ps > 0.05). Notably, throughout the study, these variables 
showed the expected phase relationships, whereby MEQ was neg-
atively correlated with DLMO (r = –0.562, p < 0.05) and DLMO-
sleep onset phase angle was positively correlated with skin tem-
perature maximum acrophase (r = 0.577, p < 0.001), thus validat-
ing our circadian measures in a naturalistic EMA design.
Conclusions: Our results show for the first time that BSD, 
individuals at-risk for BSD, and low-risk individuals did not differ 
across multiple objective circadian markers in a naturalistic EMA 
study. We contend that reported delays in circadian rhythms in 
BSD may emerge with greater bipolar severity (e.g., bipolar I dis-
order), after multiple episodes, and/or with increasing age, among 
other factors. Our results are relevant for the treatment of BSDs 
using chronotherapeutic modalities such as light and/or sleep de-
privation.
Funding/Disclosures: This work was supported by NIH 
R01 MH102310.
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A30
Light and Darkness; From Clinical Treatment 
to Healthy Lifestyle Approach
Marijke C.M. Gordijn
Chrono@Work B.V. Groningen, University of Groningen, 
Groningen, The Netherlands
Thirty years of SLTBR; thirty years in which scientists and cli-
nicians met on an annual basis to discuss the role of light and bio-
logical rhythms for mood, sleep and wellbeing. During these years, 
the field of chronobiology rapidly evolved and the awareness of 
the importance of light increases. In some cases we were probably 
too optimistic: exactly 30 years ago I started as a PhD student and 
I studied the role of sleep and the biological clock in non-seasonal 
depressed patients. After many years, trying to improve mood by 
shifting sleep or shifting rhythms of the biological clock, I had to 
conclude that the role of the biological clock in mood regulations 
in these severely depressed patients was not that clear. Neverthe-
less the mood improving effect of light, especially for seasonal 
depression, was very clear and also the potential of light to shift 
the clock was undisputed.
New data from animal research show that there are direct path-
ways of light from the retina to brain areas involved in mood- and 
sleep regulation, not necessarily through the biological clock. This 
supports the idea that light has direct effects on mood and sleep 
and it is not only important to keep sleep-wake rhythms in synch 
with the environmental light-dark cycle, and so be an effective 
treatment for circadian rhythm sleep-wake disorders. Recent evi-
dence shows indeed that light during the day is related to more 
consolidated, deeper sleep at night and the clear therapeutic effects 
of light in mood disorders is not necessarily explained by shifting 
circadian rhythms. After the discovery of the extra type of photo-
receptor in the retina responsible for the effects on mood and cir-
cadian rhythms, recent data show the complex interactions be-
tween these cells and the classical photoreceptors. More studies 
investigating these fundamental properties are still needed.
The growing dataset showing the benefits of light also increas-
es the knowledge about the downside of light at the wrong time; 
e.g. light at night. In the Netherlands the ‘theme’ of the Light Chal-
lenge 2018, a contest for students developing innovative solutions 
in society related to light, is “feel the night”. Translating our sci-
entific knowledge to prevent disturbances in society should be an 
important part of educational programs in the future. Recently we 
made a first step and developed educational material for Dutch 
teenagers, to be used at high schools: Charge Your Brainzzz. It 
contains information about sleep regulation and the role of light-
dark exposure for healthy sleep. The interest in the package was 
huge and the material was downloaded by more than 150 schools 
(~25%) in the first 6 months since release, again showing the still 
growing interest in sleep and light in society.
Funding/Disclosures: Marijke Gordijn works as a consul-
tant for Philips Consumer Lifestyle and was sponsored by the 
Brain Foundation to develop the educational package Charge Your 
Brainzzz.
A31
Characterisation of Non-Visual 
Responses in Humans, Accounting for 
Response Dynamics, Spectral and Spatial 
Characteristics of Light Exposure
Abhishek S. Prayag1, Sophie Jost2, Pascale Avouac2, 
Howard M. Cooper1, Dominique Dumortier2, 
Claude Gronfier1
1Univ Lyon, Université Claude Bernard Lyon 1, Inserm, 
Stem Cell and Brain Research Institute U1208, Bron, 
France; 2Univ Lyon, ENTPE, LGCB, Vaulx-en-Velin, France
The eye drives non-visual (NV) responses to light including 
circadian resetting, pupillary reflex and alerting effects. Initial-
ly thought to depend on melanopsin-expressing photosensitive 
retinal ganglion cells (ipRGCs), classical photopigments can also 
play a modulatory role in these responses. As most studies have 
been conducted for a limited number of NV functions, generally 
under conditions of relatively high light levels and long duration, 
it is unknown whether NV functions share similar spectral/irradi-
ance sensitivities and response dynamics during light exposure. 
We addressed this issue using light exposure paradigms spectrally 
and spatially tuned to target either cones or ipRGCs, and by mea-
suring simultaneously and longitudinally several NV responses in 
humans. Here we demonstrate that the response dynamics of sev-
eral NV functions are faster than previously thought. We find that 
the brain and the heart are activated within 1–2 minutes of light 
exposure. Further, we show that NV functions do not share the 
same threshold sensitivities. While cognitive responses appear to 
be saturated around 500 melanopic lux after 20 minutes of light 
exposure and pupillary reflex after 5 minutes, the brain and the car-
diovascular system are increasingly activated after 40 minutes. 
The effectiveness and response dynamics of light in driving non-
visual responses can have important real-life implications.
A32
The Metabolic Cost of Daily Entrainment 
Under High Fat Diet in Mice
Roee Gutman, Anat Neuman
Laboratory of Integrative Physiology, MIGAL – Galilee 
Research Institute, and Departments of Animal Sciences 
and Nutritional Sciences, Tel-Hai College, Kiryat Shmona, 
Israel
Objectives: Disruption of circadian homeostasis is accom-
panied by elevated high-fat-diet (HFD) induced obesity (DIO). 
Endogenous circadian rhythms show a period length (tau) that usu-
ally deviates from 24-h. By descriptive studies, deviation of tau 
from the environmental photic cycle (T-cycle) of 24-h is related 
positively with DIO in mice. These studies support the hypothesis 
that misalignment between tau and T-cycle results in a constant 
need to entrain increasing susceptibility to DIO. However, this hy-
pothesis was never tested in a controlled setup. Hence, our goal 
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was to conduct controlled animal experiments examining the role 
of the misalignment between tau and the T-cycle in propensity to 
DIO.
Methods: Three-week old B6 female mice were fed regular 
chow and hold under one of four symmetrical (half-dark half-light 
hours) T-cycles: 1. 24-h T-cycle; 2. constant darkness, enabling 
the measurement of the age appropriate tau, that was used to set 
up the third T-cycle (tau); and 4. T-cycle with a period length 
faster than tau by the deviation of tau from 24-h (Δ tau). Two 
weeks following experiment initiation, half of the mice from each 
regime were fed on HFD or low-fat-diet (LFD). T-cycle of tau and 
Δtau was adjusted biweekly acording tau of LFD-fed mice. Body 
weight and total 24-h energy intake were measured weekly, while 
cage locomotor activity was continual. T-cycle didn’t affect en-
ergy homeostasis of LFD-fed mice.
Results: Under the regular 24-h T-cycle, HFD-fed mice de-
velop the expected DIO, compared to LFD-fed mice. However, 
when raised under the tau-resmbling and faster-than -tau T-cycle, 
HFD-fed mice exhibit delayed onset of DIO and reduced HFD-
induced weight gain, compared to the slower-than-tau T-cycle of 
24-h. This attenuated weight gain did not result from lower energy 
intake, hence seem to result from higher energy expenditure, as 
supported by locomotor activity data.
Conclusions: These results provide additional evidence for 
the interconection between circadian homeostasis and energy ho-
meostasis. More specifically, they show that entrainment-related 
mechanisms interfere with energy homeostasis under HFD affect-
ing susceptibility to DIO. As such, these results support further 
exploration of the interconnection between entrainment-related 
mechanisms and energy homeostasis that may provide novel in-
sights on etiology and prevention of DIO.
Funding/Disclosures: German-Israeli Foundation for Sci-
entific Research and Development.
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Bright Light Therapy in Rheumatoid Arthritis 
to Improve Symptoms of Fatigue and 
Other Disease Outcomes: A Randomized 
Controlled Pilot Trial
G. Esther A. Habers1, D.S. Veldhuijzen1, C.F. Allaart2, 
A.H.M. van der Helm2, E. Vreugdenhil3, T.W.J. Huizinga2, 
A.W.M. Evers1
1Health, Medical and Neuropsychology Unit, Faculty 
of Social Sciences, Leiden University, Leiden, The 
Netherlands; 2Department of Rheumatology, Leiden 
University Medical Center, Leiden, The Netherlands; 
3Department of Molecular Cell Biology, Leiden University 
Medical Center, Leiden, The Netherlands
Objectives: Rheumatoid arthritis (RA) is often associated 
with symptoms, including fatigue, which reduce quality of life 
negatively. Unfortunately, treatments for these symptoms are not 
adequate for all patients. A disturbed circadian rhythm has been 
found in patients with RA and may be an important underlying 
mechanism for those symptoms. In the current study, the efficacy 
of a 4-week Bright Light Therapy (BLT) program is examined for 
the first time in patients with RA. This study is a randomized, 
double blind, parallel-arm, placebo controlled pilot study that 
could serve as preparation for a future larger full-scale randomized 
controlled trial (RCT). The primary study objective is to explore 
the difference between an intervention group that receives active 
BLT and a control group that receives sham BLT in fatigue while 
taking into account baseline fatigue levels. As a secondary objec-
tives, we explore a) secondary efficacy outcomes, b) the potential 
of the therapy in delaying the circadian entrainment, c) the 4-week 
follow-up effects, and 4) (barriers to) therapy adherence, therapy 
acceptability as well as study feasibility and acceptability.
Methods: Forty-eight adult patients with RA from the De-
partment of Rheumatology of the LUMC are being recruited for 
this study. Eligible patients have elevated feelings of fatigue (CIS-
8 ≥27) and low disease activity or are in remission. In both therapy 
arms, light therapy glasses are worn in the home of the participant 
every day for 30 minutes in the evening (between 20:00–21:00 h) 
during four consecutive weeks. The arms differ in the wavelength 
of light that is emitted by the glasses. The primary outcome is as-
sessed by the Checklist Individual Strength – Subscale Fatigue 
(CIS-8). Secondary outcomes are: pain and morning joint stiffness 
(IRGL; subscale Pain), sleep (diary and ISI), emotional well-being 
and general health status (RAND-36), depression (HADS), and 
disease activity (DAS). Circadian entrainment is assessed by the 
melatonin onset in saliva (as tested with Dim Light Melatonin On-
set) and a sleep diary.
Results: Data collection is expected to be just finished in June 
‘18. At the conference we will discuss the background of the study, 
the used methods, and the experiences we have gained.
Conclusions: This study evaluates in RA preliminary effi-
cacy, feasibility, and acceptability of BLT in RA, which directs at 
the disturbed circadian rhythmicity observed in this population.
Funding/Disclosures: The study is funded by the Dutch 
Arthritis Association.
A34
A Multicenter Randomised Controlled Trial 
with Bright Light Therapy to Decrease 
Depressive Symptoms in Adults with 
Intellectual Disabilities: Preliminary Results
Pauline C.M. Hamers1,2, Dederieke A.M, Festen1, 
Heidi Hermans1,2
1Intellectual Disability Medicine, Department of General 
Practice, Erasmus University Medical Center, Rotterdam, 
The Netherlands; 2Amarant Group, Healthcare Organization 
for People with Intellectual Disabilities, Tilburg, The 
Netherlands.
Objectives: Treatment options to decrease depressive symp-
toms in adults with intellectual disabilities (ID) are scarce, espe-
cially in the severe/profound ID population. The primary objective 
of this study is to examine the effect of Bright Light Therapy 
(BLT) on depressive symptoms in adults with ID in two different 
light therapy groups compared to care as usual (control group). The 
secondary objectives are investigating the difference in effect of 
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BLT in the two different intervention groups and examine if the 
effect of BLT is still visible four weeks after the end of the BLT 
(follow-up).
Methods: Participants with ID (IQ ≤70) and depressive 
symptoms (ADAMS Depression subscale score ≥14) were includ-
ed in a multicenter randomized controlled trial (RCT) with three 
different study groups. Participants in Group I received two weeks 
of BLT (10,000 lux, 30 minutes a day) in the morning, additional 
to their regular care. Participants in Group II received BLT (app. 
300 lux, 30 minutes a day), additional to their regular care. Par-
ticipants in Group III did not receive BLT but only their regular 
care (control group). The main outcome measures of this study are 
depressive symptoms measured with the ADAMS Depression sub-
scale at baseline, within one week after BLT and four weeks after 
the end of BLT.
Results: In total, 41 participants (>18 years, 21 females) were 
included. 12 participants were included in Group I, 15 participants 
were included in Group II and 14 participants were included in 
Group III. The outcomes of the preliminary analyses showed more 
decrease in depressive symptoms in Group I compared to the oth-
er groups. More results are expected in May 2018.
Conclusions: It is difficult and challenging to perform an 
RCT to investigate the effect of BLT in adults with ID and depres-
sive symptoms. As far as we know, this study is the first multi-
center RCT investigating the effect of BLT in adults with ID and 
depressive symptoms.
Funding/Disclosures: This study is funded by three care 
provider services (the HA-ID consort: Amarant Group, Abrona 
and Ipse de Bruggen), the Dioraphte Foundation and the Founda-
tion for support VCVGZ. We thank all participants, their legal 
guardians and professional care givers for their collaboration.
A35
Additive and Opponent Spectral Effects on 
Melatonin Regulation in Healthy Humans
John Hanifin1, Michael Jablonski1, Robert Levin1, 
Benjamin Warfield1, Kate Cecil1, Kat West1, Joel Pokorny3, 
George Brainard1
1Department of Neurology, Thomas Jefferson University, 
Philadelphia, PA, USA; 2Osram Sylvania, Boston, MA, USA; 
3University of Chicago, Chicago, IL, USA
Objectives: Different models of interaction between the 
melanopsin ganglion cells and classical rod and cone visual pho-
toreceptors have been proposed, including the ideas that these 
photoreceptors are additive, opponent, complementary or dynam-
ic over time and intensity. The goal of this study was to test wheth-
er specific combinations of wavelengths indicate an opponent 
cone contribution to the suppression of nighttime synthesis of the 
pineal hormone, melatonin, in healthy human subjects. Specifi-
cally, we tested the hypothesis that acute suppression of melato-
nin by short-wavelength light at 460 nm and 500 nm could be 
reduced by simultaneous exposure of long-wavelength light at 
570 nm.
Methods: A 1000 W Xenon compact arc lamp source with a 
grating monochromator was fitted with an optical mask system 
capable of providing two variable narrow spectral bands simulta-
neously. A total of 8 participants (4 females) with a mean age (± 
SEM) of 24.0 ± 1.0 years were included. Light exposure (90 min, 
02:00–03:30 h) conditions were given in a ganzfeld dome includ-
ed: 1) no light exposure, 2) narrow bandwidth light with a peak of 
460 nm at 12.1 μW/cm2, 3) narrow bandwidth light with a peak of 
500 nm at 8.9 μW/cm2, 4) narrow bandwidth light with a peak of 
570 nm at 18.5 μW/cm2, 5) 460 nm & 500 nm combined at 31.0 
μW/cm2, and 6) 500 nm & 570 nm combined at 26.7 μW/cm2. 
Participant’s had their eyes dilated and were randomly exposed. 
Plasma melatonin concentrations were assayed by radioimmuno-
assay.
Results: A comparison of the pre-light exposure values 
across all light conditions showed no statistically significant vari-
ation in plasma melatonin (p = 0.85). Compared to the control 
night, both the 460 nm and 500 + 570 nm light groups exhibited 
significantly suppressed melatonin percent change scores (p < 
0.001 and p < 0.05, respectively). However, the combined 460 nm 
+ 570 nm stimulus did not significantly suppress melatonin com-
pared to control values. Control adjusted plasma melatonin percent 
change scores revealed no significant differences between the light 
exposure conditions (p = 0.08).
Conclusions: This result indicates opponency in that the ad-
dition of the 570 nm wavelength blunted the strong response to 460 
nm. The results show that melatonin suppression data from mono-
chromatic light exposures cannot always predict the effects of 
polychromatic light on melatonin suppression.
Funding Support: Osram Sylvania provided primary fund-
ing support. Secondary support provided by the Philadelphia sec-
tion of the Illuminating Engineering Society and Lighting Enabled 
Systems and Applications (NSF #EEC-0812056).
A36
How Light through Retina-Brain Circuits 
Influences Circadian Rhythms, Mood and 
Learning
Samer Hattar
National Institute of Mental Health, Bethesda, MD, USA
Perhaps one of the most surprising discoveries in the retina 
have been the identification of a novel set of photoreceptors that 
are distinct from the classical rod/cone photoreceptors. These non-
rod/non-cone photoreceptors are located in the ganglion cell layer 
of the retina, the layer of which axons from retinal ganglion cells 
(RGCs) form the optic nerve, which connects the retina to the 
brain. A subset of these RGCs are intrinsically photosensitive 
(ipRGCs) because they express the photopigment melanopsin, 
which is similar to rhodopsin and cone opsins found in rods and 
cones, respectively. Initially, the ipRGCs were thought to contrib-
ute only to circadian light functions, however, recent research 
shows that these photoreceptors influence a staggering number of 
behaviors, which include sleep, alertness, pupil constriction, mood 
and even learning. In my lecture, I will provide detailed retinal 
neural circuits that delineate how this population of photoreceptors 
influences such diverse behaviors. I will also provide practical rec-
ommendations for how this research can help in enhancing human 
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health. Finally, I will provide the major gaps that are still lacking 
in this area for us to utilize light to its full potential for work/home 
designs.
 A37
Blue Blocking Treatment for Bipolar Mania
 Tone E.G. Henriksen1,2, Silje Skrede1,4, Ole Bernt Fasmer1,3 
Helle Schøyen1,5, Leva Leskauskaite3, 
Jeanette Bjørke-Bertheussen5, Jörg Assmus1, 
Børge Hamre1, Janne Grønli1, Anders Lund1,3
1University of Bergen, Bergen, Norway; 2Valen Hospital, 
Helse Fonna, Norway; 3Haukeland University Hospital, 
Bergen, Norway; 4Berge n Clinics Foundation, Bergen, 
Norway; 5Stavanger University Hospital, Stavanger, Norway 
Objectives: Blocking blue light by means of orange-tinted 
glasses is a way to inhibit daylight signal to the brain. The method 
is applied basic science and a consequence of the recent discovery 
of the blue light-sensitive retinal photoreceptors. Blue-blocking 
(BB) glasses are a potential treatment option for bipolar mania, and 
builds on promising results from previous case reports and a pilot 
study of dark therapy; use of complete darkness for 14 hours in the 
evening/night. We examined the effectiveness and feasibility of 
BB glasses in hospitalized bipolar patients in a manic state.
Methods: In a single-blinded, randomized, placebo-con-
trolled trial (RCT), eligible patients (bipolar mania, age 18–70 
years) were recruited from five clinics in Norway. Patients were 
assigned to BB glasses or placebo (clear glasses) from 6 p.m. to 8 
a.m. for seven days, in addition to treatment as usual. Symptoms 
were assessed daily by use of the Young Mania Rating Scale 
(YMRS). Motor activity was assessed by actigraphy, and com-
pared to data from a healthy control group. Wearing glasses for 
one evening/night qualified for inclusion in the intention-to-treat 
analysis. The feasibility of the method was assessed by means of 
self-report form on subjective experiences with the intervention, 
and monitoring of side-effects.
Results: From Feb 2012 to Feb 2015, 32 patients were en-
rolled. Eight patients dropped out and one was excluded, resulting 
in 12 patients in the BB group and 11 patients in the placebo group. 
Mean decline in the YMRS score was 14.1 (95% CI: 9.7, 18.5) in 
the BB group, and 1.7 (95% CI: –4.0, 7.4) in the placebo group, 
yielding an effect size of 1.86 (Cohen’s d). The use of BB glasses 
fitted well with many patients own understanding of light as a trig-
ger of episodes and themselves being particularly sensitive to light 
stimuli. In the BB group, one patient reported headache and two 
patients experienced easily reversible depressive symptoms.
Conclusions: This RCT showed that BB glasses were effec-
tive and feasible as add-on treatment for bipolar mania. The high 
effect size and rapid uniform decrease in manic symptoms in the 
BB-group generates a hypothesis that blue light exposure in eve-
ning/night is involved in the maintenance of manic episodes.
The results were published in Bipolar Disorders, May 2016.
Funding/Disclosures: Tone E. G. Henriksen is shareholder 
in Chrono Chrome AS.
A38
Promoting Healthy Light Exposure Regimes 
to Improve Sleep Timing and Quality Among 
Adolescents
Laura M. Huiberts, Karin C.H.J. Smolders, 
Ariane V.J.M. Rombouts, Yvonne A.W. de Kort
Eindhoven University of Technology, Eindhoven, The 
Netherlands
Objectives: For many adolescents it is a challenge to get up 
early in the morning, stay alert at school and get enough sleep, 
while also engaging in social activities. Previous research has 
shown that bright or blue-enhanced light exposure during the day 
and reduced short-wavelength light in the evening and at night can 
improve sleep timing and quality, and in turn, circadian alignment 
with environmental demands. Light exposure regimes can be im-
proved by relatively easy, yet quite diverse strategies, i.e., increas-
ing outdoor activities, and using light-reducing apps for displays 
in the evening. However, changing these behaviours in adolescents 
may be challenging. Therefore, developing attractive methods to 
encourage healthy light exposure regimes in this target group 
would be of great value. The aim of the current study was to 1) 
explore current behaviors that may improve or impede their sleep 
timing and quality, and discuss possibilities and challenges for an 
interactive coaching app to promote healthy light exposure and 
sleep timing and quality; 2) monitor and quantify inter- and intra-
individual variations in current sleep-wake and light exposure pat-
terns; and 3) provide recommendations for the development of an 
interactive coaching app to promote healthy light and sleep hy-
giene in this target group.
Methods: Focus groups with high school students (age 15–
18; +/–5 persons per group) will be conducted to discuss chal-
lenges with respect to keeping a regular sleep-wake rhythm and 
behaviors they already engage in that may improve their sleep tim-
ing and quality. Moreover, we will discuss the idea to introduce an 
interactive coaching app to improve light exposure and sleep re-
gimes and discuss what kind of features the target group would 
prefer and find useful in such a coaching app. Secondly, a field 
study will be conducted in which we will monitor adolescents’ 
light exposure and sleep-wake patterns during school days and 
days off. To this end, wearable devices (light sensors and acti-
watches) will be used. This data will be complemented with sub-
jective data on sleep timing and quality based on a sleep diary, and 
an experience sampling protocol to assess potential structural fluc-
tuations in daytime alertness and vitality.
Results: Data collection will take place in April and the first 
half of May. Results will be presented in detail at the conference, 
as all data is expected to be analyzed in May/June. Thematic anal-
yses will be used to analyze the qualitative data. For the data gath-
ered in the field study, multilevel analyses will be performed to 
explore inter- and intra-individual variations in light exposure and 
sleep-wake patterns, as well as potential relationships between 
these two.
Conclusions: The findings from the focus groups and the 
field study will serve as input for the coaching app in order to make 
it attractive for and tailored to this specific target group. Based on 
these findings, recommendations for the development of such an 
app will be discussed.
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Funding/Disclosures: Funded by Stichting Onderzoek Li-
cht en Gezondheid (SOLG).
A39
ADHD-Related Symptoms in Neuro-Typical 
Adults Are Correlated with Increased Day-
Time Sleepiness, Reduced Arousal Levels 
and Evening Chronotype
Maria Korman1, Ishay Levy1,2, Adi Eshed3, Avi Karni1,2
1The Edmond J. Safra Brain Research Center for the 
Study of Learning Disabilities, University of Haifa, Haifa, 
Israel; 2Laboratory for Human Brain and Learning, Sagol 
Department of Neurobiology, University of Haifa, Haifa, 
Israel; 3Department of Occupational Therapy, Faculty of 
Social Welfare & Health Sciences, University of Haifa, Haifa, 
Israel
Objectives: To test whether the Adult Self-Report Scale for 
ADHD, six-items version (ASRS-6) reflects circadian parameters 
of morningness-eveningness, arousal and day-time sleepiness.
Methods: The ASRS-6 was completed by 40 university stu-
dents who affirmed that they were not suggested to have or were 
never diagnosed as having ADHD/ADD during their childhood or 
adulthood. Circadian preferences (MEQ) were prescreened to en-
sure a range of chronotypes to be represented; 20 participants with 
evening and 20 with morning/neither chronotype were included. 
Day-time sleepiness (Stanford Sleepiness Scale) and objective 
sleep evaluation using a week-long actigraphy were performed. 
Arousal levels (low-high) on Visual Analogue Scales (VAS) were 
tested at 8:00 AM and re-tested at 9:00 AM under two conditions 
presented on two different days: i. after 45 minutes of exposure to 
ambient office light (200 lux). ii. After 45 minutes of exposure to 
outdoors natural morning sun-light (>10,000 lux).
Results: Our results show that: (i) ASRS-6 score (ranging 
from 0 to 6) correlated with higher day-time sleepiness, morning-
ness-eveningness continuous score and lower subjective alertness 
at 8:00 AM; (ii) All participants showed significant improvement 
in subjective alertness VAS scores at 9:00 AM after 45 min expo-
sure to natural outdoor light, while exposure of the same partici-
pants to office light (on a different day) did not present substantial 
improvements in subjective alertness; (iii) After exposure to bright 
daylight, at 9:00 AM re-test, no correlation between ASRS-6 and 
subjective alertness VAS scores was observed.
Conclusions: First, current findings suggest that, in typical 
university students, the ASRS-6 measures not only the current 
symptoms of inattentiveness/hyperactivity, but also an additional 
correlated construct – the individual circadian characteristic of 
morningness-eveningness. Higher ASRS-6 scores administered in 
morning hours correlate also with typical eveningness-related 
symptoms – higher day-time sleepiness and lower subjective alert-
ness. Second, we propose that a 45 min morning dose of daylight 
can upregulate subjective arousal during morning hours in all chro-
notypes and that such light treatment eliminates the correlation 
between the ASRS-6 scores and the subjective alertness. Altogeth-
er, we conclude that eveningness, day-time sleepiness and low 
arousal levels are related to ADHD symptoms in typical young 
adults without ADHD diagnosis.
Funding: E.J. Safra Brain Research Center for the Study of 
Learning Disabilities.
A40
Novel Chronotherapeutic Strategies in a 
Day Treatment Program for Complex Mood 
Disorders
Robert D. Levitan, Ryan Klein, Jeff Daskalakis
Centre for Addiction and Mental Health and Department of 
Psychiatry, University of Toronto, Toronto, ON, Canada
Objectives: Individuals with Major Depressive Disorder 
who attend the Integrated Day Treatment (IDT) program at CAMH, 
Toronto, Canada come to either the morning stream or the after-
noon stream but not both. As it currently stands, patients choose 
which IDT stream they want to attend after an orientation session. 
We predicted a priori that individuals with higher MEQ scores 
(greater alertness and energy in the morning) would be more like-
ly to choose the morning stream, and have better clinical outcomes 
in the morning stream, whereas later chronotypes would show the 
corresponding pattern in the afternoon stream.
Methods: Standard parametric statistics were used to com-
pare MEQ scores in the morning and afternoon streams. Multiple 
regression was used to predict treatment outcome based on MEQ 
scores at baseline, treatment stream (morning or afternoon), and 
their interaction.
Results: As predicted, an analysis of the first 209 MDD pa-
tients found a higher mean MEQ score at baseline in the morning 
stream than in the afternoon stream (48.1 +/– 12.0 vs. 41.7 +/– 10.4 
respectively, p < 0.001), suggesting that patients do choose the 
stream most synchronous with their subjective chronotype. An un-
expected finding is that actual treatment responses follow the op-
posite pattern. The MEQ by treatment stream interaction was high-
ly robust using either raw QIDS change scores (t = –3.49, p = 
0.001) or % change scores (t = –3.47, p = 0.001), with lower morn-
ingness scores at baseline predicting better treatment responses in 
the morning IDT stream, and higher morningness scores predict-
ing better outcomes in the afternoon stream.
Conclusions: In sum, while MDD patients showed a strong 
tendency to choose the IDT stream synchronous with their pre-
treatment MEQ score, the subgroup of patients who chose the IDT 
stream asynchronous to their baseline MEQ score had a much bet-
ter anti-depressant and quality of life response overall. This sug-
gests that in the IDT context, it is better to be treated at one’s less 
preferred, and not one’s preferred time of day for activities. Poten-
tial mechanisms to explain this pattern of results will be discussed.
Funding/Disclosures: Dr. Levitan is supported by the 
Cameron Parker Holcombe Wilson Chair in Depression studies at 
CAMH and University of Toronto.
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A41
Effects of Bright Light Exposure on 
Alertness Under Forced Desynchrony 
Conditions
Renske Lok, Tom Woelders, Minke J. van Koningsveld, 
Klaske Oberman, Sebastiaan G. Fuhler, 
Domien G.M. Beersma, Roelof A. Hut
University of Groningen, GELIFES, Department of 
Neurobiology, Groningen, The Netherlands
Objectives: Daily physiological and psychological rhythms, 
such as body temperature and alertness, are under circadian and ho-
meostatic (i.e. time since wake) influence. Several Forced Desyn-
chrony (FD) experiments successfully quantified the contribution of 
both processes. In addition, non-image-forming (NIF) effects of 
light on these parameters have been repeatedly demonstrated. For 
example, alertness is increased by bright light exposure during the 
night, when the circadian drive for wakefulness is low, and homeo-
static sleep-pressure is high. Such effects on alertness are difficult 
to demonstrate during daytime, suggesting that these effects of light 
are modulated by the circadian clock and/or by the amount of ac-
cumulated homeostatic sleep pressure. The goal of this FD experi-
ment is to quantify circadian and sleep/wake homeostatic modula-
tion of NIF effects of light on alertness and mental performance.
Methods: An FD experiment was performed under dim and 
bright white light (<10 lux and 1500 lux) in eight men. The FD prin-
ciple uses T-cycles outside the range of human light entrainment. 
Kronauer model based simulation showed lack of entrainment under 
1500 lux using an 18 h LD cycles (sleep-wake cycle). Within each 
light condition, baseline Dim Light Melatonin Onset (DLMO) mea-
surement was followed by 4 x 18 hours FD protocol (5 h sleep, 13 
h wake; total 72 hours), followed by 8-h recovery sleep and final 
DLMO assessment. Participants were exposed to both light condi-
tions in a semi-randomized within subject design. Subjects per-
formed 2-hourly test-sessions for subjective sleepiness (Karolinska 
Sleepiness Scale), objective sleepiness (Karolinska Drowsiness 
Test, EEG), sustained attention (psychomotor vigilance task; PVT) 
and inhibitory control (Go-NoGo task) assessment as well as pupil 
size and eye-blink rate. Heartrate, skin- and core body temperature 
(CBT) were measured continuously and saliva samples (for melato-
nin and cortisol assessment) were collected hourly.
Results: Preliminary analysis of 6 subjects confirms both cir-
cadian and homeostatic regulation of most parameters. Our dim/
bright light FD paradigm shows that bright light effectively re-
duced the circadian CBT rhythm amplitude as well as the homeo-
static decay of CBT during wake. The effect of light on subjective 
sleepiness (KSS) mainly depends on elapsed time awake and not 
on circadian phase. Light made PVT reaction times faster, espe-
cially in a small circadian time- window. Homeostatic sleep pres-
sure did not influence the effect of light on reaction time, suggest-
ing different pathways by which light affects subjective sleepiness 
and sustained attention.
Conclusions: This experiment shows therefore, for the first 
time, that NIF effects of light on CBT and subjective and objective 
psychological performance measures are differently modulated by 
circadian and homeostatic phase.
Funding/Disclosures: None.
A42
Melanopsin Retinal Ganglion Cell Function 
in Seasonal Mood, Melatonin Regulation and 
Light Therapy
Helle Ø. Madsen1, Ida Hageman1, Shakoor Ba-Ali2, 
Henrik Lund-Andersen2, Klaus Martiny1
1Mental Health Center Copenhagen, Copenhagen, 
Denmark; 2Department of Ophthalmology Rigshospitalet/
Glostrup Hospital, Copenhagen, Denmark
Objectives: The post-illumination pupil response to blue 
light (PIPR) mediated by the melanopsin containing retinal gan-
glion cells (mRGCs) is attenuated in depression including season-
al affective disorder (SAD). The proposed decrease in retinal pho-
tosensitivity may be of pathogenetic importance in depression. 
Since glaucoma leads to mRGC degeneration we use glaucoma 
and visual impairment as a model of mRGC dysfunction to study 
aspects of SAD. We thus investigate the role of mRGC dysfunc-
tion in mood seasonality, seasonal melatonin regulation and re-
sponse to bright light therapy.
Methods: Study A includes outpatients with glaucoma in a 
cross-sectional survey using the Global Seasonal Score (GSS) 
from the Seasonal Pattern Assessment Questionnaire (SPAQ) to 
assess seasonal variation in sleep length, social activities, mood, 
energy levels, appetite, and body weight. Correlations between 
GSS and glaucomatous visual field defects and retinal ganglion 
cell layer thickness are the main outcomes. Study B performs bian-
nual assessments of salivary melatonin, PIPR and self-assessed 
mood and sleep (WHO-5, SPAQ, HAM-D6 and sleep logs) in sub-
jects with advanced glaucoma and control subjects without eye 
disorder. Saliva is sampled every 4 hours across a 24 hour period. 
Main outcome is total diurnal melatonin secretion. Study C in-
cludes persons with SAD and severe visual impairment in a 6 week 
trial of morning bright light (10,000 lux, 30 minutes). At inclusion 
a diagnosis of depression is established by clinical interview and 
a basic ophthalmologic examination is performed. Before and after 
treatment, PIPR is measured and depression severity is assessed 
by a psychiatry consultant blinded to visual function, PIPR and 
compliance. Main outcome is reduction in depression score.
Results: We will present preliminary results from 99 subjects 
with glaucoma who completed the SPAQ. Four cases were ex-
cluded due to photophobic or allergic summer malaise. In the re-
maining 54 women and 41 men, mean age was 64 (18–92 years) 
and mean GSS 4.6 (SD 3.9). There was a negative correlation be-
tween age and GSS (r2 = 0.122, p = 0.03) only for men. There was 
no overall correlation between GSS and visual field (r2 = 0.001, 
p = 0.7) but a strong correlation in females under 66 years (r2 = 
0.35, p = 0.004).
Conclusions: In this limited population we find a correlation 
between glaucomatous visual field defects and mood seasonality 
only in selected subgroups. Study B and C are ongoing.
Funding/Disclosures: The study has received funding 
from the Velux Stiftung, the Augustinus Foundation, the Jascha 
Foundation and the Ivan Nielsen Foundation. None of the authors 
report any disclosures.
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Dynamics of Subjective Thermal Comfort 
and Skin Temperatures Under Self-Selected 
(Day-) Lighting Conditions
Lenka Maierova1,2 , Apiparn Borisuit1, 
Jean-Louis Scartezzini1, Mirjam Münch1,3
1Swiss Federal Institute of Technology, Lausanne, 
Switzerland, Solar Energy and Building Physics Laboratory, 
Lausanne, Switzerland; 2Czech Technical University 
in Prague, UCEEB, Prague, Czech Republic; 3Current 
affiliation: Charité Universitätsmedizin Berlin, Institute 
of Physiology, Sleep Research & Clinical Chronobiology, 
Berlin, Germany & St. Hedwig Hospital, Clinic for Sleep and 
Chronomedicine, Berlin, Germany
Objectives: Diurnal changes in physiology and behavior are 
modulated by external factors such as light or temperature. Our 
objective was to test whether self-selected office lighting during a 
habitual waking period (16 hrs) would have an impact on subjec-
tive thermal comfort and objective measures of skin temperature 
in young morning and evening types (16/16), where preferred bed 
and wake times usually differ by several hours.
Methods: The results obtained under a self-selected lighting 
condition (SSL; daylight and electrical lighting) were compared 
with a constant bright light (BL; 1000 lx) and a control condition 
(DIM, dim light). All participants came three times to the labora-
tory and remained under controlled constant posture conditions for 
16 hrs, where room temperature was kept constant. Subjective 
thermal comfort was assessed hourly by visual analogue scales and 
proximal and distal skin temperatures were continuously recorded 
and expressed relative to midsleep.
Results: Participants felt significantly colder in DIM than in 
BL or in SSL conditions (p < 0.05), and subjective thermal comfort 
remained stable in BL and SSL conditions. Proximal (clavicula) 
and distal skin temperatures (hands) were significantly higher for 
SSL than for DIM or BL conditions. The time course for distal skin 
temperatures revealed for evening types significantly higher tem-
peratures 5–6.5 h and 9–9.5 h after habitual wake time, but only in 
BL, and not the other two conditions (p < 0.05). The distal-proxi-
mal temperature gradient (DPG) was significantly correlated with 
subjective thermal comfort (Spearman Rho: 0.48, p < 0.05).
Conclusion: Self-selection of lighting at work might posi-
tively influence thermoregulatory functions regarding inter-indi-
vidual differences, similar to what we have previously shown for 
subjective alertness, mood, wellbeing and melatonin secretion 
(Maierova et al. 2016).
Acknowledgements: Velux Foundation Switzerland.
Disclosure: None.
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Extended Photoperiod Alters Circadian 
Rhythmicity and Expression of Synaptic 
Plasticity-Associated Genes. The Impact of 
Blue-Enriched Light
Andrea R. Marti1*, Jorrit Waslander1,2*, Silje Skrede1,3, 
Jelena Mrdalj1, Torhild T. Pedersen1, Louise H. Bjerrum1, 
Kari M. Ersland1,4, Tone E.G. Henriksen1,5, Clive Bramham1, 
Janne Grønli1
1University of Bergen, Bergen, Norway; 2University of 
Groningen, Groningen, The Netherlands; 3Bergen Clinics 
Foundation, Bergen, Norway; 4Haukeland University 
Hospital, Helse Vest, Norway; 5Valen Hospital, Helse 
Fonna, Norway; *the authors contributed equally to this 
work
Objectives: Light can have complex effects on regulation of 
circadian rhythmicity, mood and cognition. The brain’s ability to 
maintain cognitive function depends on synaptic plasticity – per-
sistent increases or decreases in synaptic strength in response to 
neural activity patterns. Several immediate early response genes 
have been implicated in synaptic plasticity, including brain-de-
rived neurotropic factor (BDNF), the activity-regulated cytoskel-
eton-associated (Arc) protein, Krueppel-like factor 10 (KLF10) 
and Neuronal PAS domain protein 4 (NPAS4). Here we use a 
model of prolonged photoperiod (20 h light, 4 h dark; 20:4 LD) 
with two different spectral qualities (white and blue-enriched 
light) to examine effects on the circadian rhythm of body temper-
ature (BT), and expression of neuroplasticity markers in the rat 
brain.
Methods: For recording of BT rhythm, rats (n = 6/group) 
were housed in standard 12:12 LD condition, followed by expo-
sure to 7 days long photoperiod (20:4 LD) in either white or blue-
enriched light conditions, and 14 days recovery in standard 12:12 
LD condition. Tissue from a separate set of animals (n = 10/group) 
was collected on exposure day 7 (E7), and recovery day 3 (R3), 
from anterior cingulate cortex (ACC; implicated in mood regula-
tion) and prefrontal cortex (PFC; implicated in mood and cogni-
tion). Tissue samples were analyzed with qPCR. Two-tailed stu-
dent’s t-test was used for statistical comparison to 12:12 LD con-
trols (p < 0.05).
Results: The rhythm of BT maintained a 24 h period in both 
blue-enriched and white light conditions during 20:4 LD, although 
the acrophase was shifted to co-occur with the dark phase. Upon 
return to 12:12 LD, decreased amplitude and no clear 24 h period 
was observed for up to 8 days. Extended photoperiod, indepen-
dently of spectral qualities, decreased expression of Arc (ACC and 
PFC; t’s(15–18) > –3.74, p’s < 0.002) and KLF10 (ACC; t’s(17–18) > 
–2.51, p’s < 0.02) compared to controls at E7. NPAS4 was de-
creased in the blue-light condition only (PFC; t(15) = –3.53, p = 
0.003). The expression of BDNF was not significantly changed at 
E7 compared to controls, but increased at R3 in the blue-light-
condition only (PFC; t(14) = 3.80, p = 0.002). No significant differ-
ences in expression of Arc, KLF10 or NPAS4 were observed at R3 
compared to controls.
Conclusions: Extended photoperiod disrupted the circadian 
rhythmicity of body temperature, and reduced several markers of 
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synaptic plasticity in brain regions important for mood and cogni-
tive performance. Furthermore, the effect on synaptic plasticity 
markers depends on the spectral quality and brain-region.
Funding/Disclosures: The work was funded by Helse Vest 
(ID HV911 893) and the Faculty of Psychology, University of Ber-
gen (Småforsk, ID 173200-270452; 173200-810298).
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Acute Exposure to Blue Light at Night 
Impairs Glucose Tolerance, Alters Insulin 
Secretion and Increase Sugar Intake in 
Diurnal Rodents
Anayanci Masis-Vargas1,2,3, Andries Kalsbeek2,3, 
Jorge Mendoza1
1Light, Vision and the Brain Team, Institute de 
Neurosciences Cellulaires et Intégratives (INCI), UPR-
3212 CNRS-Université de Strasbourg, Strasbourg, 
France; 2Hypothalamic Integration Mechanisms, 
Netherlands Institute of Neuroscience (NIN), Amsterdam, 
The Netherlands; 3Department of Endocrinology and 
Metabolism, Academic Medical Center (AMC), University of 
Amsterdam, Amsterdam, The Netherlands
Objectives: To study the acute effects of blue light (BL) in 
the early night on regular chow or high caloric palatable food in-
take, and glucose metabolism, in male and female diurnal rodents.
Methods: Female and male diurnal Sudanian grass rats (Ar-
vicanthis ansorgei) were exposed to a regular chow or a free choice 
high fat high sucrose (fcHFHS; sugar and fat exposure in addition 
to regular chow pellets) diet and assigned to either a dark control 
or blue light exposure condition. At Zeitgeber time 14 (two hours 
after lights off in a 12/12 h light-dark cycle) a 1 h pulse of BL (λ = 
490 ± 20 nm) was given and an oral glucose tolerance test (OGTT) 
was performed 1 h after (ZT15). One week after, a second light 
pulse was given and food intake from both diet groups was evalu-
ated every 12 h from the day before and the day after the light ex-
posure. Finally, a week later a third light pulse was given and blood 
was recovered for glucose, insulin and corticosterone analyses. 
Locomotor activity of animals was monitored during the whole 
experiment.
Results: Caloric intake increased in animals exposed to fcH-
FHS diet and the bimodal diurnal pattern of food intake became 
more accentuated, especially in females. In chow fed animals the 
AUC of the OGTT was significantly higher in the BL exposed 
animals of both sexes in comparison to dark controls. This effect 
was also observed in males, but not females, fed with the fcHFHS 
diet. BL exposure induced an increase of sucrose intake in male 
Arvicanthis on the night of the BL pulse. Yet a similar effect was 
observed on the day after on the female group. In both, chow and 
fcHFHS fed males, a significant decrease in plasmatic insulin con-
centrations was observed after light exposure.
Conclusions: Exposure to BL at night causes glucose intol-
erance in diurnal rodents, with a stronger effect in males when they 
were exposed to a high caloric diet. Moreover, BL at night was 
sufficient to trigger a higher intake of sugar in both male and fe-
male grass rats, and to cause a dampening in the insulin release in 
a sex dependent manner.
Funding/Disclosures: This work is supported by Erasmus+ 
NeuroTime Programme, an ANR-14-CE13-0002-01 ADDi-
CLOCK JCJC grant and the Institut Danone France-Fondation 
pour la Recherche Médicale Consortium.
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Chronically Disrupted Sleep, Neuronal 
Plasticity and Depression
Peter Meerlo
University of Groningen, Groningen, The Netherlands
Sleep problems are a common complaint in the majority of 
people suffering from depression. While sleep complaints were 
traditionally seen as a symptom of mood disorders, accumulating 
evidence suggests that in many cases the relationship may be re-
verse as well. A long list of longitudinal studies shows that sleep 
complaints often precede the onset of depression and constitute 
and independent risk factor for the development of the disorder. 
Additionally, experimental studies in animals show that chroni-
cally restricted or disrupted sleep may gradually induce neurobio-
logical changes that are very similar to what has been reported for 
depressed patients. The mechanisms through which insufficient 
sleep increases the risk for depression are poorly understood but 
may include effects of sleep disturbance on neuroendocrine stress 
systems, serotonergic neurotransmission, and various interacting 
signaling pathways involved in the regulation of neuronal plastic-
ity and neurogenesis. Because sleep is considered to play a crucial 
role in regulating neuronal plasticity and synaptic strength, chron-
ically insufficient sleep may contribute to depression through an 
impairment of these plasticity processes leading to altered connec-
tivity and communication within and between brain regions in-
volved in the regulation of mood.
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Dynamics of Daytime Light Exposure 
Impacts on Sleep Architecture in a 
Naturalistic Setting
Claudia Nowozin1,2*, Amely Wahnschaffe1,2*, 
Jan de Zeeuw1, Alexandra Papakonstantinou1,2,
Frederik Bes1,2, Mirjam Münch1,2,3, Dieter Kunz1,2
1Charité – Universitätsmedizin Berlin, Corporate Member 
of Freie Universität Berlin, Humboldt-Universität zu Berlin, 
and Berlin Institute of Health, Institute of Physiology, Sleep 
Research & Clinical Chronobiology, Berlin, Gemany; 2St. 
Hedwig-Hospital, Clinic for Sleep and Chronomedicine, 
Berlin, Germany; 3Charité Universitätsmedizin Berlin, 
Corporate Member of Freie Universität Berlin, Humboldt-
Universität zu Berlin, and Berlin Institute of Health, Institute 
of Immunology, Berlin, Germany; *equal contribution
Objectives: While rapid eye movement (REM) sleep is pre-
dominantly circadian driven, slow wave sleep (SWS) is homeo-
statically driven. There is also evidence that light during daytime 
has an impact on subsequent sleep. A recent study by Wams et al. 
in 2017 found an association between the timing and amount of 
(natural) light exposure during daytime, REM sleep and SWS ac-
cumulation during ambulatory polysomnographically (PSG) re-
corded sleep episodes. The aim of the current evaluation was to 
replicate and expand these findings using the data from an older 
study performed in a semi-natural setting.
Methods: Eleven healthy adults (between 20 and 30 years, 
intermediate chronotypes, 6 male, 5 female) participated in the 
study 2008. Individual illuminance was continuously recorded at 
the eye level between 8 am and 7 pm (Luxblick, TU Ilmenau, Prof. 
C. Schierz). Four hours before habitual bedtime participants came 
to the laboratory and remained in dim light (<5 lx). Their sleep 
episode was recorded with PSG. All PSG recordings (available 
from 9 participants) were visually scored according to standard 
criteria and illuminance recordings were collapsed into hourly 
bins. For analysis non-parametric tests were applied.
Results: Participants spent 59% of their days with illumi-
nance levels lower than 50 lx and 90% below 200 lx. Participants 
had more SWS during the night when they had a later time of 
maximum light exposure (min; Rho = 0.733; p = 0.025) and were 
exposed to more light between 2–3 pm (Rho = 0.70; p = 0.036). 
Accordingly, a later maximum light exposure was associated with 
less stage 2 sleep (min; Rho = –0.683; p = 0.042). The fitted slopes 
from accumulated SWS were significantly steeper and associated 
with higher illuminance between 4–5 pm (Rho = 0.683; p = 0.042). 
Regarding REM sleep accumulation, less steep slopes were associ-
ated with greater illuminance between 11–12 am (Rho = 0.683, p = 
0.042). Finally, longer REM sleep latency was significantly re-
lated to higher illuminance levels between 11–12 am (Rho = 0.90; 
p = 0.001). Shorter REM sleep latency was associated with more 
light between 4–5 pm (Rho = –0.700; p = 0.036).
Conclusion: Our results support earlier work showing an as-
sociation of natural daylight exposure and sleep architecture dur-
ing the subsequent night. Based on the explorative analysis in this 
small sample we hypothesize a differential impact of light at dif-
ferent times of day on different sleep stages.
Funding/Disclosures: BMBF, German Ministry of Educa-
tion and Research FKZ: 13N8973.
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Advanced Chronotherapeutics for 
Depression During Pregnancy
Barbara Parry, Charles Meliska, Diane Sorenson, 
Fernando Martinez, Ana Lopez, Sharron Dawes, 
Richard Hauger, Daniel Kripke
University of California, San Diego, CA, USA
Objectives: To test the hypothesis that combined wake ther-
apy and light treatment improve depressed mood during pregnan-
cy and postpartum, and that the magnitude of mood change cor-
relates with the magnitude of melatonin and sleep changes.
Methods: Initially 78 women, 35 pregnant (20 normal con-
trols-NC; 15 depressed participants-DP with a major depressive 
episode-MDE by the Structured Clinical Interview for DSM-IV 
during pregnancy) and 43 postpartum (24 NCs; 19 DP with onset 
of a MDE within 3 months postpartum), were randomized to a par-
allel trial of one night of early-night wake therapy-EWT (wake 
until 03:00 h, sleep 03:00–07:00 h) + 6 weeks of evening (PM) 
bright white light-BWL (5.5” x 6.25” Litebook Advantage light 
box, 60 cool white light-emitting diodes, intensity 1,350 lux, irra-
diance 2.41 x 10–9 w/cm2 at 21 in, spectral emission peaks 464 nm, 
564 nm, The Litebook Company Ltd., Alberta Canada) adminis-
tered for 60 min starting 90 min before habitual sleep onset time, 
vs. one night of late-night wake therapy-LWT (sleep 21:00–01:00 
h, then wake) + 6 weeks of morning (AM) BWL administered for 
60 min within 30 min of habitual wake time. Pre- and post-inter-
vention, clinicians blind to treatment condition assessed mood 
weekly by the Structured Interview Guide for the Hamilton Rating 
Scale for Depression with Atypical Depression Supplement 
(SIGH-ADS), and participants completed the Horne-Ostberg 
Morningness-Eveningness questionnaire (MEQ), and collected 2 
overnight samples (36 hours from 18:00 h-noon the following day) 
of urine for 6-sulphatoxy melatonin (6-SMT) measures.
Results: SIGH-ADS did not differ at 1, 2 or 6 weeks (p > 
0.089). Pregnant DP mood improved more at 2 weeks of EWT+PM 
BWL (p = 0.016 MEQ covariate); in Postpartum DP it improved 
more at LWT+AM BWL (p = 0.019). In postpartum DP, phase-
advance in 6-SMT offset and acrophase was greater (p < 0.05) 
after LWT+AM BWL and correlated with improved mood (p = 
0.003).
Conclusions: Mood improved more after 2 weeks of EWT 
+ PM BWL in Pregnant DP, and more after LWT + AM BWL in 
Postpartum DP, which correlated with the magnitude of phase-
advance in 6-SMT.
Funding/Disclosures: NIH R01 HD076476.
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Bright Light Exposure during Simulated 
Night Shift Work – Impact on Daytime Sleep
Torhild T. Pedersen1, Jelena Mrdalj1, Ståle Pallesen2, 
Erlend Sunde2, Eirunn Thun2, Tone E.G. Henriksen1,3,4, 
Debra J. Skene5, Janne Grønli1
1Bergen Stress and Sleep Group, University of Bergen, 
Bergen, Norway; 2Department of Psychosocial Science, 
University of Bergen, Bergen, Norway; 3Department of 
Clinical Medicine, Section for Psychiatry, University of 
Bergen, Bergen, Norway; 4Division of Mental Health 
Care, Valen Hospital, Fonna Local Health Authority, Valen, 
Norway; 5University of Surrey, Guildford, UK
Objectives: Bright light has been suggested as a countermea-
sure to sleepiness and cognitive impairment during night shifts, 
and for improving subsequent sleep. We aimed to investigate how 
exposure to different light intensities of full spectrum white light 
during simulated night shifts would affect polysomnographic-as-
sessed sleep parameters following the shift.
Methods: A randomized counterbalanced, controlled, re-
peated-measurements design was used. To simulate night shift 
work, participants performed a battery of cognitive tasks in the 
laboratory from 11 PM to 7 AM for three consecutive nights. The 
light conditions were full spectrum bright light (mean illuminance: 
890.2 lx, SD = 85.9) and dim light (mean illuminance: 88.5 lx, 
SD = 8.3). Following each night shift participants went home to 
sleep, and daytime sleep was monitored by the use of polysomnog-
raphy. Here we report preliminary data on 10 out of 13 partici-
pants. Mean ± SEM and Cohen’s d are used to estimate differ-
ences and effects sizes between conditions.
Results: Total daytime sleep following the third night shift 
was longer when participants were exposed to bright light during 
the night shift, compared to when participants were exposed to the 
dim light condition (421.88 ± 30.85 min vs. 324.54 ± 25.19 min, 
d = 1.57. Sleep onset latency was shorter (5.10 ± 1.98 min vs. 
8.90 ± 1.50 min, d = –0.96) and percentage time in stage N2 was 
longer (44.23 ± 5.66% vs. 32.06 ± 4.28%, d = 1.07 in bright light 
compared to the dim light condition. Percentage time spent in stage 
N3 and REM sleep indicated smaller differences (21.50 ± 9.05% 
vs. 32.57 ± 6.84%, d = –0.61, and 24.98 ± 3.77% vs. 25.98 ± 
3.07%, d = –0.14, respectively).
Conclusions: Exposure to bright light during simulated 
night shifts increased total daytime sleep compared to lower inten-
sity light.
Funding/Disclosures: The research is funded by” Små-
forsk” (local research funds nr.173200-270452).
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The Efficacy and Safety of Morning Light 
Therapy for (Winter) Depression in Bipolar 
Disorder
Lisette Rops1, Lotte van Hout2, Marijn Groen1, 
Claudia Simons1
1GGzE, Eindhoven, The Netherlands; 2Maastricht 
University, Maastricht, The Netherlands
Objectives: Evaluation of efficacy and safety of light thera-
py for seasonal (winter)depression in bipolar disorder.
Methods: The study was carried out at a specialized outpa-
tient treatment centre for bipolar disorders. Inclusion criteria were 
a diagnosis of bipolar AND seasonal affective disorder AND cur-
rent depression. The scores of Inventory of Depression Symptoms 
(IDS; used in the period 2015–2017) or Quick Inventory of De-
pression Scale (QIDS; since 2017 onwards) had to be above remis-
sion threshold. Light therapy was given with an intensity of 10,000 
lux for 30 minutes in the morning during a period of seven days, 
after which severity of depressive symptoms was assessed by IDS 
or QIDS. If remission (based on scores of IDS or QIDS) occurred, 
light therapy was stopped. In case of non-remission light therapy 
was continued for seven days followed again by IDS or QIDS as-
sessment. The maximum of light therapy was 21 days. Given that 
there is ongoing debate about safety of light therapy in bipolar dis-
order, especially concerns about a switch into mania in morning 
light therapy, we registered carefully the reason of drop out during 
the treatment. A multilevel regression analysis was carried out.
Results: We included 31 patients in the winter period be-
tween October until March in respectively 2015/2016, 2016/2017 
and again 30 patients in the period of October 2017 until March 
2018. The results up to and including 2017 are already analyzed. 
These results showed a significant improvement in depression 
scores after seven days of light therapy. Only one client had to dis-
continue light therapy because of hypomanic symptoms (sleep re-
duction and increased energy). After therapy was discontinued, 
these symptoms faded away in a few days. The results of October 
2017 until March 2018 are now being analyzed and will be pre-
sented at the conference.
Conclusions: Morning light therapy seems to be efficacious 
and safe in patients with bipolar (winter) depression. The risk of 
switching to (hypo)mania appeared to be limited.
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Do Dynamic Changes in Light Level and 
Spectral Power Distribution Improve Acute 
Alertness During Daytime?
Inga Rothert, Stephan Völker
Lighting Technology, Technische Universität Berlin, Berlin, 
Germany
Objectives: Many studies confirm positive acute effects of 
higher light levels for alertness, while findings concerning the ef-
fects of variation of spectral power distribution are inconclusive. 
Dynamic changes of light level have been shown to improve acute 
alertness at nighttime. However, are these dynamic changes also 
beneficial during daytime?
Methods: Acute alertness was measured with a d2R-test and 
an auditory Go-NoGo task. A questionnaire addressed personal 
well-being and acceptance of the lighting conditions and the Kar-
olinska Sleepiness Scale (KSS) was used to assess subjective 
drowsiness. Three light settings were tested: 1) Dim static warm 
white (200 lx at eye level, 2,200 K), which was expected to be non-
effective; 2) Bright static cool white (1,000 lx at eye level, 12,000 
K), which was expected to be most effective; 3) A dynamic setting, 
which changed every 12 min between the two other lighting condi-
tions. A between-subjects design was conducted with 30 partici-
pants (18–30 years) for each setting. The experiments took place 
in groups of up to six participants in a test room without daylight 
and the light exposure lasted 90 min in the afternoon (post-lunch 
dip).
Results: Unexpectedly, the results for the d2R-test, the Go-
NoGo task and drowsiness on the KSS scale did not show any sig-
nificant differences between the three lighting conditions. Well-
being and acceptance of the lighting conditions are still under in-
vestigation. Although this contradicted our working hypothesis, 
this finding is in line with a number of other recent publications.
Conclusions: No positive acute effects of dynamic changes 
in light level and spectral power distribution on alertness during 
daytime were found. One possible explanation is that short term 
light exposure for only 90 min might not be long enough to observe 
effects. Experiments over an entire working day including subse-
quent sleep quality might give different results. Furthermore, this 
study included only healthy young students, who seem to be less 
sensitive to light conditions than other groups, for example sleep 
deprived, stressed or elderly people. Under non-critical operating 
environments, however, the effect of light on acute alertness might 
be less important than often assumed and good standard lighting 
conditions might be sufficient.
Funding/Disclosures: The project “Nicht-visuelle Lich-
twirkungen” (NiviL) is funded by the German Federal Ministry of 
Education and Research.
A53
Can Bright Light Exposure Function as a 
Compensation of Midday Nap Deprivation 
among Habitual Nappers?
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Guofu Zhou1,3
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Guangzhou, China
Introduction: It is well documented that a short daytime nap 
at noon or in the early afternoon could significantly counteract 
post-lunch dip in alertness and performance. Yet, it is unclear 
whether a habitual midday nap deprivation would elicit impair-
ment of subsequent alertness and working performance. More-
over, previous studies have suggested the effectiveness of bright 
light exposure to overcome the decline of alertness and perfor-
mance under the condition of night sleep deprivation and daily 
natural post-lunch dip. The potential benefits of bright light expo-
sure following midday nap deprivation among habitual nappers 
remains to be investigated. Thus, the current study was conducted 
in an effort to explore whether exposure to bright blue-enriched 
light (1000 lx at 6500 K at eye level) opposed to practical office 
setting (165 lx at 4000 K at eye level) could counteract the impair-
ment of alertness, mood and performance induced by a habitual 
midday nap deprivation among university students.
Objectives: To examine the effects of bright blue-enriched 
light exposure on subjective alertness, mood and performance fol-
lowing a habitual midday nap deprivation.
Methods: Seventeen university students with the long-term 
habit of a afternoon nap (around 13:00 h) either took a nap, or 
served two nap deprivation conditions on three non-consecutive 
days. After the nap intervention, participants were tested on sus-
tained attention, res ponse inhibition and working memory task un-
der different light conditions. Bright blue light (1000 lx at 6500 K 
at eye level) was applied in one of two nap deprivation conditions. 
The changes of subjective sleepiness and mood were measured 
during experimental session.
Results: Results showed exposure to bright blue-enriched 
light after nap deprivation significantly decreased subjective 
sleepiness, negative mood, and enhanced sustained attention, 
working memory and response inhibition speed.
Conclusions: Bright blue-enriched light exposure is an ef-
ficient compensation of a habitual afternoon nap loss.
Funding/Disclosures: This work has been funded by the 
National Key Research and Development Program of China 
(No.2016YFB0404202), National Natural Science Foundation of 
China (Grant No. U1501244, 51561135014), the Top graduate 
project of South China Normal University (2016090 to T. Ru) and 
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in Patients with Parkinson’s Disease and a 
Depressive Disorder: Results of a Double-
Blind Randomized Controlled Trial
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Objectives: To assess the efficacy of BLT in reducing de-
pressive symptoms in patients with Parkinson’s disease (PD) and 
Major Depressive disorder (MDD), compared with exposure to a 
control light.
Methods: In this double-blind controlled trial, PD patients 
with a MDD were randomized to either BLT or a control light con-
dition. Subjects received 30 minutes of home treatment twice dai-
ly for three months, followed by a six-month naturalistic follow-
up. The primary outcome of the study was the Hamilton Depres-
sion Rating Scale (HDRS) score. Secondary outcomes were 
ancillary depression measures, objective and subjective sleep pa-
rameters, and salivary melatonin and cortisol concentrations. As-
sessments were repeated halfway and at the end of the treatment 
phase, and one, three and six months post-treatment. Data were 
analyzed using a linear mixed model analysis.
Results: Eighty-three subjects were included. There was a 
strong decrease in HDRS score in the experimental as well as the 
control group, with a non-significant between-group difference. 
Subjective sleep improved in both groups, with a significantly 
larger increase in the subjective sleep rating in the experimental 
group (B (SE) = 0.36 (0.18), p < 0.05). Moreover, the experimen-
tal group showed a decrease in total salivary cortisol secretion, 
while it increased in the control group (B (SE) = –8.11 (3.93), p = 
0.04). After correction for confounders, this group difference 
showed a trend towards significance (B (SE) = –13.5 (5.2), p = 
0.10).
Conclusions: BLT was not more effective in reducing 
depressive symptoms than a control light. Both groups showed 
an improvement of mood and subjective sleep. BLT was more 
effective in improving subjective sleep quality than control 
light, possibly through a BLT-induced decrease in cortisol lev-
els.
Funding/Disclosures: This study was financially support-
ed by research grants from Hersenstichting Nederland, Stichting 
Parkinson Fonds and de Parkinson Vereniging.
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Evening Chronotype Is Associated with 
Medical Comorbities and Factor Structure of 
Depression: A Descriptive Study
Cigdem Sahbaz
Bezmialem Vakıf University, Istanbul, Turkey
Objectives: Substantial evidence suggests that chronotypes 
and biological rhythm disturbances may affect severity and factor 
structure of depression. No study has addressed specifically the 
relationship between circadian preferences and vegetative factors 
and current medical comorbidities in patients with depression. 
This study aims to examine the potential association between chro-
notypes and vegetative symptomatology in patients with depres-
sion. The patients with the evening chronotype may have more 
severe vegetative symptoms and medical comorbidities in depres-
sion.
Methods: Drug-naive patients with depression according to 
DSM-5 criteria from the ages of 17–65 were recruited to this study 
at the outpatient clinic in the Department of Psychiatry, Bezmi-
alem University Hospital. The Morningness-Eveningness Ques-
tionnaire (MEQ) was applied to define chronotypes, biological 
rhythm disturbances were measured by the Biological Rhythms 
Interview of Assessment in Neuropsychiatry (BRIAN), and qual-
ity of subjective sleep was measured with Pittsburgh Sleep Qual-
ity Index (PSQI). Depression levels were evaluated through the use 
of the Hamilton Rating Scale for Depression (HAM-D). Also, we 
investigated HAM-D with the three-factor structure: Cognitive, 
Anxiety, Vegetative depression factors.
Results: 101 patients (mean age = 40.18–11.54, 75% female) 
with depression were recruited. HAM-D scores (HAM-D total, 
HAM-D total without sleep cluster) and HAM-D factors (cogni-
tive, affective, vegetative, vegetative without sleep cluster) of pa-
tients divided into “morning preference” (MP) and “evening pref-
erence” (EP) at the D-MEQ (58MP/43EP) sample median. HAM-
D scores were significantly higher in EP than in MP at HAM-D 
total, HAM-D total-without sleep cluster (p < 0.05) and vegetative, 
vegetative-without sleep cluster scores were extremely significant 
in EP than MP (p < 0.001). According to three groups of MEQ; 
HAM-D total, HAM-D total-without sleep cluster, HAM-D fac-
tors (cognitive, vegetative, vegetative-without sleep cluster) were 
extremely significant in evening chronotype (E) than in morning 
chronotype (M) and intermediate chronotype (I) (p < 0.001). Fur-
thermore, the medical record of patients evaluated retrospectively, 
and the ratio of having another chronic illness was found statisti-
cally significant among the patients with depression and the eve-
ning chronotype (p < 0.05). Additionally, BRIAN total, sleep, ac-
tivity, social and eating scores have highly indicated HAM-D 
scores and factors.
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Conclusions: Evening chronotype may notably associate 
with vegetative symptomology in patients with depression. Gen-
eral and psychiatric clinical examinations need to be considered 
with the understanding of biological rhythm disturbances and cir-
cadian preferences. The description and understanding of the rela-
tionship between biological rhythms, chronotype and factor struc-
tures of depression may be useful to enhance the treatment options 
for depression.
Funding/Disclosures: None.
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Investigation of Retinal Spectral-Domain 
Optical Coherence Tomography (SD-OCT) 
Findings on Biological Rhythm Perspective
Cigdem Sahbaz
Bezmialem Vakıf University, Istanbul, Turkey
Objectives: Spectral-domain optical coherence tomography 
(SD-OCT) is a fast, noninvasive imaging technique that provides 
in vivo imaging of the human retinal layer. Schizophrenia (SCH) 
and Bipolar Disorder (BD) are associated with several brain defi-
cits in neuroimaging studies, but clinically useful biomarkers are 
elusive. Retinal neurons originate with distinct layers containing 
components of grey matter. Therefore, recent studies hypothesized 
that retina might represent a possible “window” to the brain abnor-
malities. SD-OCT has been increasingly using to search for avail-
able biomarkers of psychiatric diseases. However early findings of 
SD-OCT investigations looking for SCH and BD biomarkers have 
been controversial and most studies have had severe methodolog-
ical limitations such as without consideration of control group 
matching and covariance factors. We conducted two case-control 
studies comparing individual retinal layer measurements in pa-
tients with SCH (N = 50) and BD (N = 36) with age/gender/BMI 
matched controls. To address unresolved issues, we determined 
whether: (1) retinal changes in SCH and BD occurs independently 
of biological rhythm disturbances and subjective sleep parameters 
that might affect the retina. (2), Due to defining the effect of sleep 
disturbances directly on retinal findings, we conducted another 
case-control study in patients with Primary Insomnia (N:52) ex-
cluding the existence of another medical comorbidity.
Methods: A Heidelberg Spectra SD-OCT device was used in 
both eyes of the 50 patients with schizophrenia, 36 patients with 
bipolar disorder, 52 patients with primary insomnia and 50 age/
gender/BMI matched healthy controls. Manual retinal layer seg-
mentation was performed in 3 macular regions. The Morningness-
Eveningness Questionnaire (MEQ), Biological Rhythms Inter-
view of Assessment in Neuropsychiatry (BRIAN), Pittsburgh 
Sleep Quality Index (PSQI) and Insomnia Severity Index (ISI) 
were performed.
Results: BRIAN scores (total and sleep, activity, social, eat-
ing subscales) and PSQI total scores were found significantly high-
er both in patients with SCH and BD. In study group with SCH, 
the Inner Plexiform Layer (IPL) was significantly thinner than 
controls (p < 0.02), but when we conducted in General Linear 
Model taking PSQI total score as a covariate, this effect did not 
remain significant. Similarly, in the BD group, total retinal volume 
was found significantly thinner than controls (p < 0.005), but after 
adjusting BRIAN total score as a covariance in the model, this ef-
fect did not remain significant. Also in the Insomnia group, IPL 
was found extremely significantly thinner than controls (p < 
0.0001), and Choroidal thickness was significantly higher than 
controls (p < 0.004). Besides these findings, thinning of IPL and 
thickness of Choroid are associated with severity of insomnia and 
chronotypes in patients with primary insomnia.
Conclusions: Our findings show that retinal layer thickness-
es are affected by biological rhythm changes independently. For 
future studies, biological rhythm disturbances and sleep quality 
should be considered as confounding factors in patients with SCH 
and BD. Also, insomnia and chronotypes might influence SD-
OCT indices, and these novel findings warrant the investigations 
of retinal biomarker research in general medical practice.
Funding/Disclosures: None.
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Association of Serum BDNF Levels and 
BDNF Val66Met Polymorphism with Sleep 
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Kaori Saitoh, Ryuji Furihata, Yoshiyuki Kaneko, 
Masahiro Suzuki, Sakae Takahashi, Makoto Uchiyama
Department of Psychiatry, Nihon University School of 
Medicine, Tokyo, Japan
Objectives: Brain-derived neurotrophic factor (BDNF) is 
widely expressed in the brain and plays an important role in neu-
ronal maintenance, plasticity, and neurogenesis. Many reports 
showed that circulating levels of BDNF or BDNF polymorphism 
were associated with psychiatric disorders, including depression, 
bipolar disorder, and schizophrenia. Several reports have pointed 
out a negative correlation between perceived stress and circulating 
levels of BDNF in non-clinical populations. Apart from mental 
conditions, those who suffered from sleep disturbances were re-
ported to be associated with decreased serum BDNF levels. More 
recently, a study suggested that serum BDNF levels were associ-
ated with the severity of insomnia. However, a fundamental under-
standing of the relation between BDNF and sleep in healthy hu-
mans remains unclear. The aim of the present study was to eluci-
date whether the serum BDNF levels and BDNF genotype were 
associated with characteristics of sleep habits in healthy young 
adults.
Methods: Seventy-nine healthy paid volunteers (45 men, 34 
women) aged 20 to 29 years were recruited. Serum BDNF levels 
were measured with an enzyme-linked immunosorbent assay, and 
a single-nucleotide polymorphism (Val66Met) in the BDNF gene 
was assessed. Detailed sleep habits were examined using a self-
recording 1-week sleep diary.
Results: Serum BDNF levels were significantly associated 
with several sleep parameters on weekends, whereas no such as-
sociation was found on weekdays. Longer total sleep time and time 
in bed, and later mid-sleep time on weekends were associated with 
lower serum BDNF levels. The discrepancy between mid-sleep 
time on weekdays and that on weekends, otherwise known as so-
cial jetlag, was negatively associated with serum BDNF levels. 
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Met/Met homozygotes of BDNF Val66Met polymorphism spent 
significantly longer time in bed on weekends than Val/Val homo-
zygotes. Heterozygotes did not differ from Val/Val homozygotes.
Conclusions: We first found that serum BDNF levels and 
BDNF Val66Met polymorphism in healthy young adults were as-
sociated with sleep habits on weekends but not with those on week-
days, suggesting that the neuronal mechanisms involved in the 
BDNF control may be rather linked to endogenous sleep charac-
teristics than the socially constrained sleep schedule in healthy 
young adults.
Funding/Disclosures: This study was supported in part by 
Health Science Research Grants from the Ministry of Health, La-
bor and Welfare of the Japanese Government and by a Research 
Grant from the Japan Society for Promoting Science and Technol-
ogy Agency.
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Light Therapy in Patients with Bipolar 
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Objectives: Current treatments for depressive episodes in 
bipolar disorder are often ineffective and/or intolerable. In unipo-
lar depression light therapy is a treatment option for seasonal and 
non-seasonal depression. We intended 1) to review the efficacy 
and tolerability of light therapy in bipolar depression with or with-
out a seasonal pattern; 2) to develop a guideline for light therapy 
in bipolar depression.
Methods: Narrative review of the pertinent literature and dis-
cussion in a panel of experts.
Results: A systematic review and meta-analysis of efficacy 
of light therapy in bipolar depression found four controlled trials 
with a medium effect size of improvement of depression (Tseng et 
al. 2016). Recently, three randomized controlled trials were pub-
lished which compared bright light with dim red placebo light in 
non-seasonal bipolar depression (Sit et al. 2018, Yorguner Kupeli 
et al. 2018, Zhou et al. 2018). All of them found superior efficacy 
of bright light compared to the dim red placebo condition and a 
very low risk of switch into (hypo-) mania. A systematic review of 
41 studies did not find a higher risk of (hypo-) mania than in the 
control condition, except for patients with rapid cycling (Bene-
detti 2018). There are no controlled trials of light therapy in bipo-
lar seasonal (winter-) depression. But in practice, light therapy is 
administered successfully for this indication in many outpatient 
clinics. Early trials for light therapy in winter depression did not 
exclude patients with bipolar II depression. Therefore the Dutch 
Multidisciplinary Guideline for Bipolar Disorders states that light 
therapy is an option for patients with bipolar winter depression 
(Kupka et al. 2015). A systematic review found negligible evi-
dence for harmfulness of light therapy for the retina of patients 
using psychopharmaceuticals (Brouwer et al. 2017). The guideline 
for light therapy in bipolar depression differs only slightly from 
those for unipolar depression: a) for patients with bipolar I disorder 
a mood stabilizer is recommended in order to prevent a manic 
switch, b) a depressive episode with mixed features is a relative 
contra-indication, c) psychopharmaceuticals are no absolute con-
tra-indication for light therapy. The patient is informed about po-
tential risks and decides about referral for an ophthalmological 
consultation.
Conclusions: Light therapy is a treatment option for patients 
with bipolar seasonal and non-seasonal depression.
Funding/Disclosures: None.
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Towards an Understanding of Circadian and 
Seasonal Clocks
William J. Schwartz
The University of Texas at Austin, Austin, TX, USA
Since the formation of the SLTBR in 1988, our understanding 
of circadian and seasonal clocks – at multiple levels of biological 
organization – has evolved enormously. At the molecular level, the 
concept of a cell-autonomous, transcription-translation feedback 
loop as the basic timing machine emerged, generating new tools 
for both monitoring and breaking the clock. At the cellular level, 
the heterogeneity of suprachiasmatic nucleus neurons and their 
dynamic coupling became known, revealing intercellular mecha-
nisms for plasticity and adaptation. At the organismal level, the 
physiological consequences of a dissociable multi-organ network 
for internal time were appreciated, reformulating ideas on disease 
etiopathogenesis. And at the societal level, the effects of abiotic 
and biotic environmental factors on the phase of entrainment of the 
clock were highlighted, raising ecological and public health impli-
cations. All of this in just 30 years! In this overview, we will con-
sider how these advances have altered our metaphors for concep-
tualizing the clockworks, complicated our experimental designs 
and interpretations, and provided new opportunities for transla-
tional science.
Funding/Disclosures: None.
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Integrated Chronotherapy for Perinatal 
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Katherine M. Sharkey1,2, Jason T. Machan1,2, Janine Bacic1, 
Carmen Monzon1,3, Ellen Flynn1,3, Julie Quattrucci2, 
Sarah Carr3, Sharon Vessella3, Teri Pearlstein1,3
1Alpert Medical School of Brown University, Providence, 
RI, USA; 2Rhode Island Hospital, Providence, RI, USA; 
3Women’s Medicine Collaborative, Providence, RI, USA
Objectives: Changes in women’s sleep patterns across the 
perinatal period affect circadian rhythms and are related to post-
partum mood; this pilot randomized controlled trial tested a per-
sonalized integrated chronotherapy (PIC) intervention, consisting 
of morning bright light, sleep restriction, and an advanced sleep-
wake schedule, added to usual care (UC, i.e., medications and/or 
psychotherapy) versus UC alone, for treatment of perinatal mood 
disorders.
Methods: 39 pregnant women with major depressive disor-
der and/or an anxiety disorder confirmed with the Structured Clin-
ical Interview for DSM-5 were randomized to UC or PIC+UC. 
Sleep timing/duration and light levels were estimated with 1 week 
of wrist actigraphy during pregnancy at baseline (24–28 weeks 
gestation), 33 weeks, 36 weeks, and during postpartum weeks 2 
and 6. After baseline, the starting sleep/light prescription for 
PIC+UC patients was 7.5 hours time in bed, a 1-hour advance of 
wake time, and 30 minutes of 10,000 lux white light in the first 
hour after waking. Salivary dim light melatonin onset (DLMO) 
was assessed at baseline, 36 weeks, and 6 weeks. Mood was mea-
sured with the Hamilton Depression Scale (HAMD17) by a blinded 
rater and patients reported pre-sleep arousal on a nightly sleep di-
ary.
Results: So far, 28 women have completed the study. Hourly 
morning light levels (6 am–12 pm) decreased across the perinatal 
period in the UC group, but remained stable in the PIC+UC group 
(p < 0.001). Baseline HAMD scores did not differ between groups: 
UC = 12.4 (95% CI = 10.7–14.1); PIC+UC = 14.2 (95% CI = 
12.3–16.0). At postpartum week 6, the HAMD score decreased to 
5.3 (95% CI = 3.7–7.0) in the PIC+UC group and to 8.4 (95% CI = 
6.5–10.4) in the UC group (p = 0.004). Pre-sleep arousal decreased 
from 28.4 at baseline (95% CI = 25.8–31.4) to 23.4 (95% CI = 
21.3–26.2) at 6 weeks postpartum in UC patients and from 27.6 
(95% CI = 24.5–31.6) to 19.6 (95% CI = 18.0–22.3) in PIC+UC 
patients (p = 0.058). Compared to baseline DLMO, PIC+UC wom-
en tended to phase advance in pregnancy (p = 0.059) with a return 
to baseline DLMO at postpartum week 6, whereas the UC group 
had a persistent DLMO delay across the perinatal period. Shift to 
an earlier wake time was associated with greater HAMD decrease 
(p = 0.0203). Decreased morning light from baseline to 6 weeks 
postpartum was associated with less HAMD improvement (p = 
0.0097).
Conclusions: Women with depression/anxiety in pregnancy 
who received PIC+UC had a greater decrease in depressive symp-
toms and pre-sleep arousal than women receiving UC alone. Fur-
ther, our data indicate that changes in sleep timing and light levels 
were associated with mood improvements.
Funding/Disclosures: R34-MH104377 and U54GM115677 
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Karin C.H.J. Smolders1, R. van der Sande1,2, 
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Objectives: The elderly may suffer from sleep problems and 
experience challenges with respect to their level of vitality and 
mood. While it is well known that light is a powerful tool to align 
sleep-wake patterns with environmental demands and can benefit 
wellbeing, studies investigating non-image forming effects of light 
on sleep and wellbeing have been mainly performed among young 
participants, demented elderly or persons with SAD. The aim of 
the current field study was to 1) monitor and quantify light expo-
sure and sleep-wake patterns, 2) investigate potential (bi-direction-
al) correlations between these patterns, and 3) explore the effect of 
these patterns on well-being among healthy independent living el-
derly subjects in real-life situations.
Methods: A field study was performed in which twenty el-
derly volunteers (12 males; mean age of 71, range 65–79) partici-
pated. During one sampling week, wearable measurement devices 
(light sensors and activity trackers) were used to quantify partici-
pants’ light exposure patterns, physical activity, and sleep-wake 
timing. These measurements were combined with a sleep diary to 
asses self-reported sleep timing and sleep quality, and an experi-
ence sampling protocol to probe subjective vitality and mood 
throughout the waking episode of their daily routine. Prior to the 
start of the sampling week, participants reported on their general 
sleep quality and habitual sleep-wake timing. Multilevel analyses 
were performed to quantify inter-individual and intra-individual 
variations in light exposure, sleep and affective state, and to test 
correlations between these variables of interest.
Results: Preliminary results revealed that participants were, 
on average, exposed to relatively high intensity levels with expo-
sure to more than 1000 lux close to their eyes for about 25% of 
their waking episode. Intra-class correlations for light exposure 
showed particularly intra-individual variations, with structural 
variations in the amount of light exposed to as a function of time 
of day. Most of the variance in sleep timing occurred on a day-to-
day basis, while sleep quality mainly varied between participants. 
Multilevel analyses investigating the relationship between light 
and sleep revealed that, in contrast to the average light dosage, the 
amount of light exposure in the morning and evening were sig-
nificantly related to sleep quality and sleep duration respectively. 
Moreover, subjective vitality and mood showed significant and 
positive correlations with the average light dosage in the morning. 
In addition, participants reported more positive affect when ex-
posed to more intense light in the afternoon.
Conclusions: Overall, the findings of the current study pro-
vide insights into the light exposure patterns and their effects on 
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well-being and sleep among healthy independent living elderly, 
and could be used to provide tuned lighting scenarios to steer a 
healthy lighting and sleep regime in order to prevent or reduce 
sleep problems and to support well-being in elderly. This knowl-
edge is particularly relevant in view of the aging of the population.
Funding/Disclosures: Project funded by 4TU.NIRICT.
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Visual and Non-Visual Responses to 
Short-Wavelength Light
Manuel Spitschan
Department of Experimental Psychology, University of 
Oxford, Oxford, UK
Objectives: The human retina contains five photoreceptors: 
The three spectral classes of cones — the S cones (peak spectral 
sensitivity λmax ~420 nm), the M cones (λmax ~530 nm), the L cones 
(λmax ~558 nm) — , rods (λmax ~495 nm), and melanopsin (λmax 
~480 nm). Short-wavelength light is known have important effects 
on what is conventionally called “non-image-forming” visual 
function, including circadian photoentrainment, phase shifting and 
the pupillary light reflex.
Methods: By presenting stimuli which are matched in the 
activation of a given set of photoreceptors (so-called metamers) 
but differ in activation of the target photoreceptors, the contribu-
tions of the different photoreceptors can be mapped out. We have 
previously used this method to examine the properties of the hu-
man pupillary light reflex, and encoding of melanopsin-targeted 
stimuli in human visual cortex (using fMRI). Here, we are examin-
ing metameric illuminants at five chromaticities along the daylight 
locus (correlated colour temperatures 25,000K, 10,000K, 6,500K, 
5,000K and 4,000K) differing in melanopsin activation by 200% 
and measuring the pupil size in human observers under naturalistic 
viewing conditions.
Results: While the colour rendering properties of these meta-
meric illuminants are generally poor, they elicit physiologically 
differentiable pupil sizes by up to 20%. This is not a surprising 
result, as it is known that melanopsin contributes to the pupil under 
conditions of silent substitution; but it provides evidence that large 
melanopsin contrast in isolation seen in naturalistic viewing condi-
tions has a tangible physiological effect.
Conclusions: This research represents a step towards pro-
ducing carefully controlled metameric melanopsin-targeted stim-
uli under naturalistic (e.g. sleep lab, home setting, office) viewing 
conditions with a demonstrable physiological effect.
Funding/Disclosures: Wellcome Trust 204686/Z/16/Z.
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Cortisol Profiles with Cancer Related 
Fatigue: A Study Protocol
Daniëlle E.J. Starreveld1, Laurien A. Daniels2, 
Flora E. van Leeuwen1, Eveline M.A. Bleiker1
1Psychosocial Research and Epidemiology, Netherlands 
Cancer Institute, Amsterdam, The Netherlands; 2Clinical 
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Objectives: Fatigue is one of the most reported complaints 
by cancer survivors. Pilot studies showed promising results for 
light therapy as a novel intervention for this complaint. However, 
the working mechanisms remain unknown. It is hypothesized that 
light therapy decreases Cancer Related Fatigue (CRF) via the en-
trainment of circadian rhythms. Previous results showed an asso-
ciation between desynchronized circadian activity rhythms and fa-
tigue symptoms. Other studies showed an association between el-
evated levels of nocturnal cortisol with CRF. Yet, as far as we 
know, there is no published research on an association between 
melatonin profiles and CRF. The current study aims to investigate 
the associations between (disruptions in) circadian rhythms of cor-
tisol and melatonin with CRF and the efficacy of light therapy to 
synchronize these rhythms. Based on the positive effects of light 
therapy on CRF, it is expected that these circadian rhythm are dis-
rupted in survivors with fatigue compared to survivors without 
fatigue.
Methods: This study invites survivors of Hodgkin lymphoma 
(HL) with fatigue (n = 50), and a matched group of survivors of 
HL without fatigue (n = 25). All participants complete question-
naires on chronotype and fatigue. Saliva is collected to assess cor-
tisol and melatonin levels at ten different time points during a 24 
h period: at awakening, 30 min after awakening, 45 minutes after 
awakening, at 4 pm, five, four, three, two, and one hour prior to 
bed time, and at bedtime. Cortisol levels will be determined with 
an electrochemiluminescence immunoassay. Outcome variables 
include the cortisol awakening response, diurnal cortisol slope and 
area under the curve. The Dim Light Melatonin Onset will be de-
termined with a direct saliva melatonin radioimmunoassay.
Results: This study is ongoing.
Conclusions: The finding of an association between disrupt-
ed circadian rhythms of cortisol and melatonin with CRF will pro-
vide more information on potential working mechanisms of light 
therapy as a treatment for cancer related fatigue. Moreover, it will 
add a new insight on a potential causative factor of CRF.
Funding/Disclosures: This trial is funded by the Dutch 
Cancer Society and is registered at clinicaltrials.gov (clinical trials 
ID: NCT03242902).
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Remission in Bipolar Depression Treated 
with Three Cycles of Total Sleep Deprivation 
Combined with Light Therapy and Lithium?
Masahiro Suzuki1,2, Sara Dallaspezia1, Clara Locatelli1, 
Makoto Uchiyama2, Cristina Colombo1, 
Francesco Benedetti1
1Department of Clinical Neurosciences, Scientific Institute 
and University Vita-Salute San Raffaele, Milan, Italy; 
2Department of Psychiatry, Nihon University School of 
Medicine, Tokyo, Japan
Objectives: The combination of three cycles of sleep depri-
vation (SD) with light therapy (LT) and lithium has recently been 
proposed as a possible first-line treatment for bipolar depression. 
However, it is unclear whether early improvement predicts final 
response/remission in bipolar depression treated with this regimen.
Methods: We studied 220 consecutively admitted inpatients 
with a major depressive episode in the course of bipolar disorder. 
The relation between response to first SD and response/remission 
at the end of the treatment (day 6) was analyzed using logistic re-
gression analysis. Severity of depression was rated using the Ham-
ilton Depression Rating Scale (HDRS). Clinical response was de-
fined as a ≥50% reduction in HDRS scores, and remission was 
defined as an HDRS score of ≤7.
Results: Among the 217 completers, 67.7% showed response 
and 54.4% reached remission at the end of the treatment. Multiple 
logistic regression analysis revealed that response after first recov-
ery sleep (day 2) predicted final response and remission at the end 
of the treatment with high odds ratios (10.9 for response and 8.2 
for remission); however, response immediately after the first SD 
(day 1) did not predict final response or remission.
Conclusions: Clinical status after first recovery sleep is a 
strong predictor of successful final outcome in patients with bipo-
lar depression treated with the combination of repeated SD, LT, 
and lithium. Recovery sleep may play a role in inducing the anti-
depressant effect associated with the success of treatment.
Funding/Disclosures: This study was supported by JSPS 
KAKENHI (grant number JP25861032) and AMED (grant num-
ber JP17hk0102041).
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Melatonin, Body Temperature and Alertness 
Response to Late Evening Light Are Reduced 
by Prior Early Evening Light Exposure
Marije te Kulve1, Luc Schlangen2, 
Wouter van Marken Lichtenbelt1
1Department of Human Biology & Movement Sciences, 
NUTRIM, Maastricht University; 2Philips Lighting Research, 
Eindhoven, The Netherlands
Objectives: Evening light can acutely affect melatonin lev-
els, sleepiness and body temperatures. The objective of the current 
study was to test whether responses to one-hour evening light ex-
posure are reduced when these are preceded by bright light expo-
sure instead of dim light exposure during the beginning of the 
evening.
Methods: In a randomized crossover study, twelve healthy 
females participated in four sessions during which melatonin, sub-
jective sleepiness and body temperature were measured. Three 
evening sessions were scheduled to compare the effects of dim 
light (A), a one-hour evening light pulse (750 lx, 4000 K starting 
at 22.30) (B), and the same evening light pulse (750 lx, 4000 K 
starting at 22.30) but now preceded by 2.5-hours of bright light 
(1200 lx, 4000 K starting at 18:30) (C). One morning session (D) 
used the same one-hour light pulse as in session B, but now start-
ing at 10.30.
Results: As expected, the melatonin levels and subjective 
sleepiness were reduced, and the change in the (absolute value of 
the) skin temperature gradients was larger, during the one-hour 
evening light exposure (B) as compared to dim light exposure (A). 
When the one-hour light exposure was preceded by 2.5-hour ex-
posure to bright light (C), the effects of the one-hour evening light 
pulse on melatonin and body temperatures were significantly re-
duced and the reduction in subjective sleepiness was absent. Dur-
ing the morning (D), melatonin levels were significantly lower 
compared to the evening (B). Morning and evening light effects on 
skin temperature gradients and sleepiness did not significantly dif-
fer.
Conclusions: The study results demonstrate that 2.5-hour 
bright light exposure at the beginning of the evening, can reduce 
the response to a 1-hour light pulse in the late evening. The effects 
of the light pulse on melatonin, subjective sleepiness and skin tem-
perature gradients were reduced when this was preceded by bright 
light instead of dim light. By itself, a 2.5-hour bright light exposure 
in the early evening can already reduce the sleep-disruptive influ-
ence of light exposure in the late evening. Future studies are re-
quired to test whether prior (daytime) light exposure can also re-
duce the circadian phase delaying response to evening light.
Funding/Disclosures: This project was funded by the 
STW–Philips Electronics Nederland B.V. Partnership Program 
‘Advanced Sustainable Lighting Solutions’ (no. 12733). Luc JM 
Schlangen is an employee of Philips Lighting Research, the Neth-
erlands.
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SLTBR: Who We Were, Are, and Might 
Become
Michael Terman
Columbia University Department of Psychiat ry and Center 
for Environmental Therapeutics, New York, NY, USA
1982. The U.S. National Institute of Mental Health (NIMH) 
publishes a case study of a patient with bipolar disorder who shows 
recurrent annual depressions as day length decreases. Stretching 
the day artificially with morning and evening light exposure proves 
therapeutic.
1984. They immediately proceed to a controlled clinical trial 
for patients with winter depression, sparking replications and ex-
tensions by 15 independent groups in the U.S. and Europe.
1987. The “seasonal pattern” specifier for recurrent major de-
pression quickly enters the Diagnostic Manual of the American 
Psychiatric Association (APA). The NIMH sponsors a workshop 
on seasonal affective disorder (SAD), bringing in researchers on 
photoperiodism and circadian rhythms to help frame a conceptual 
structure.
1988. SLTBR is formed at a sit-down beer fest of around 
30 researchers and clinicians at the APA annual meeting. A bul-
letin of news and comment follows, to be published for 16 
years.
1989. Our first annual meeting, with around 130 colleagues 
and students, is hosted by the NIMH, with 34 presentations (28 of 
them focused on SAD), along with innovative pilot studies of night 
shift work, premenstrual depression, bipolar depression, and alco-
hol abuse and dependence. The time of day for effective light ther-
apy (morning, midday, evening), and the differentiation from pla-
cebo response, surface as key points of debate. A work group ex-
amines the role of the nascent light box industry and confronts its 
presumed authority to make clinical claims and instruct doctors, 
patients and consumers in use of the devices.
. . . 2017. The 29th annual meeting in Berlin draws 116 at-
tendees. There are 61 presentations (only 2 focused on SAD), 
with a broad range of basic and applied topics including melato-
nin, cortisol, melanopsin, metabolism, sleep, major depression, 
bipolar depression, cognitive performance, the built environ-
ment, and more.
2018. Early themes resurface: concern about light device 
claims and clinical guidelines issued by manufacturers; and the 
time of day of light treatment, with a focus on bipolar disorder (this 
time not SAD, for which morning light has become the standard 
intervention). The first task force on chronotherapy is appointed 
by the International Society for Bipolar Disorders. We begin to ask 
how, beyond our research, can SLTBR advocate light therapy in 
mainstream medicine as a valuable adjunct for the treatment of 
sleep and mood disorders.
2018+. Clearly, SLTBR has staying power, but we need to 
define our role more clearly and actively vis-à-vis societies with 
overlapping interests. The challenge is to build on our unique 
strengths. These include a wide mix of specialties (e.g., chronobi-
ology, lighting science, psychiatry, human factors, and architec-
ture), coupled with manageable size. Our informality is infectious, 
and encourages new collaborations, close attention to student con-
tributions, and open brainstorming. These are precious assets that 
can accelerate discovery and minimize the competitive one-up-
manship all too familiar in larger international venues.
Funding/Disclosures: None.
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Cognition in Healthy Middle Aged Men
Jana Thomas1,2,3, Sharon Ooms1,2,3, Jetteke Doornbosch1, 
Sebastiaan Overeem4,6, Marcel Verbeek2,3,5, 
Marcel Olde Rikkert1,2,3, Roy Kessels1,2,3 
Jurgen Claassen1,2,3
1Department of Geriatric Medicine, Radboud University 
Medical Centre, Nijmegen, The Netherlands; 2Radboud 
Alzheimer Centre, Nijmegen, The Netherlands; 3Donders 
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Netherlands; 6Eindhoven University of Technology, 
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Objectives: Recent evidence indicates a bi-directional rela-
tion between poor sleep and the development of Alzheimer’s dis-
ease (AD). Poor sleep may play a causal role in the pathology of 
AD by influencing the clearance and production of the amyloid 
beta (Aβ) protein. Previous studies have shown that one night of 
total sleep deprivation increases Aβ concentrations. This led to the 
hypothesis that extended periods (>10 years) of disturbed sleep 
could lead to Aβ accumulation with subsequent cognitive decline 
in the context of AD. The present study was conducted to study the 
relationship between chronic sleep disturbances due to an extrinsic 
cause and cognitive function among healthy middle aged men to 
investigate the hypothesis that prolonged abnormal sleep behavior 
increases the risk of AD-related cognitive decline.
Methods: Our study population consisted of male volunteers 
(n = 19), aged 50 to 60 years, who show divergent and fragmented 
sleeping patterns due to irregular work schedules. This chronic 
sleep deprivation group was compared to a group of healthy vol-
unteers (n = 19) with normal sleep, matched in gender, education 
and age. All participants underwent one night of standard poly-
somnography (PSG), preceded by approximately 10 days of actig-
raphy (Actiwatch 2, Philips Respironics) and maintenance of a 
sleep-wake diary. Cognitive function (including memory consoli-
dation) was assessed with a neuropsychological test battery.
Results: The chronic sleep deprivation group showed more 
slow wave sleep (N3 = 16.4% (± 7.39)) compared to the healthy 
controls (N3 = 12% (± 5.61)), but no difference in cognitive test 
scores were found. The chronic sleep deprivation group performed 
only significantly (p = 0.007) better on a memory consolidation 
test (short delay) (A’ = 0.92 (± 0.03); hits = 27.4 (± 1.5)) than the 
controls (A’ = 0.88 (± 0.05); hits = 25.8 (± 2.11)).
Conclusions: Identifying poor sleep as one of the prevent-
able risk factors for the development of AD could create more 
awareness about individual sleeping behavior. However, we found 
no negative effects of poor sleep on cognitive function in the 
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chronic sleep deprivation group. This could be related to the find-
ing of enhanced slow wave sleep in this group, which might serve 
as a compensatory mechanism for years of sleep disturbances. This 
requires further exploration in follow-up research.
Funding/Disclosures: None.
A68
Programmed Environmental Illumination 
during Autologous Stem Cell 
Transplantation Hospitalization for the 
Treatment of Multiple Myeloma Reduces 
Severity of Depression
Heiddis Valdimarsdottir1, Mariana Figuero2, 
Williiam Holden1, Susan Lutgendorf3, Lisa M. Wu4, 
Sonia Ancoli-Israel5, Jason Chen1, 
Ariella Hoffman-Peterson1, Julia Granski1, Nina Prescott1, 
Alejandro Vega1, Natalie Stern1, Gary Winkel1, 
William H. Redd1
1Icahn School of Medicine at Mount Sinai, New York, NY, 
USA; 2Rensselaer Polytechnic Institute, Troy, NY, USA; 
3University of Iowa College of Liberal Arts and Sciences, 
Iowa, IA, USA; 4Northwestern University Feinberg School 
of Medicine, Chicago, Il, USA; 5University of California San 
Diego, San Diego, CA, USA
Background: Over a third of multiple myeloma (MM) pa-
tients report clinical levels of depression during autologous stem 
cell transplant (ASCT) hospitalization. We report results from a 
randomized clinical trial investigating effects of Programmed En-
vironmental Illumination (PEI) of hospital rooms on depression.
Methods: Patients (N = 187) scheduled to receive an ASCT 
were assessed for eligibility. Those who met study eligibility cri-
teria (n = 44) were randomly assigned to one of two PEI conditions 
involving delivery of either circadian active bright white light 
(BWL) or circadian inactive dim white light (DWL) throughout 
the room from 7 to 10 AM daily during hospitalization. Patients 
completed the Center for Epidemiological Studies Depression 
Scale (CES-D) prior to hospitalization, at days 2 and 7 post-trans-
plant, and on the third day of engraftment.
Results: General Linear Model analyses revealed no differ-
ence between the groups in CES-D total score at baseline (p = 
0.7859). A longitudinal linear mixed model analysis revealed a 
significant interaction between time of assessment and light condi-
tion [F(3,107) = 2.90; p = 0.0386; eta2 = 0.08)]. PEI prevented 
development of depression during hospitalization, with effects 
reaching significance by the third day of engraftment. At the third 
day of engraftment, 68.4% of the participants in the DWL com-
parison condition met the criteria for clinically significant depres-
sion compared to 42.1% in the BWL condition.
Conclusion: These findings demonstrate that PEI using 
BWL during MM ASCT hospitalization is effective in reducing 
the development of depression. Future studies should examine the 
mechanisms whereby PEI improves depression.
A69
Chronotype and Depressive Symptoms 
in Students: An Investigation of Possible 
Mechanisms
Julia F. van den Berg, Liia Kivelä, Niki Antypa
Leiden University, Leiden, The Netherlands
Objectives: Individuals with an evening chronotype are at 
increased risk of experiencing emotional problems, including de-
pressive symptoms. However, the mechanisms underlying these 
associations remain unclear. The present study aimed to determine 
whether poor sleep quality, substance use, and cognitive emotion 
regulation difficulties – which have been implicated in the etiol-
ogy of depression – mediate the relationship between chronotype 
and depressive symptoms in a student sample, which was assessed 
cross-sectionally and after one year.
Methods: A total of 742 Dutch students (75% women, mean 
age 21.4 ± 2.9 years) completed the Quick Inventory of Depressive 
Symptomatology, the Morningness-Eveningness Questionnaire, 
the Pittsburgh Sleep Quality Index, a questionnaire assessing alco-
hol, caffeine consumption, smoking tobacco and cannabis use, the 
Cognitive Emotion Regulation Questionnaire and the Behavioral 
Inhibition/Activation Scale. A subsample (n = 115) was assessed 
one year later with the same questionnaires.
Results: Cross-sectional analyses showed that evening chro-
notype was associated with more depressive symptoms, adjusted 
for age and gender (β = –0.082, p = 0.028). The relationship be-
tween eveningness and depressive symptoms was mediated by 
sleep quality, alcohol consumption, and the cognitive emotion reg-
ulation strategies of self-blame and positive reappraisal. In longi-
tudinal analyses, eveningness at baseline predicted more depres-
sive symptoms at follow-up, adjusted for age and gender (β = 
–0.29, p = 0.002), and only poor sleep quality at follow-up was a 
significant mediator of this relationship.
Conclusions: Eveningness is related to depressive symp-
toms and this relationship is mediated by poor sleep quality, also 
in a prospective design. Self-blame and reduced positive reapprais-
al are correlated with eveningness. The integration of chronother-
apeutic interventions together with sleep education and cognitive 
approaches is of high importance for targeting depression in such 
populations.
Funding/Disclosures: None.
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Is Insomnia a Disorder of Rhythm or Sleep, 
and Is Chronotherapy Useful?
Eus J.W. van Someren
Department Sleep & Cognition, Netherlands Institute for 
Neuroscience, Amsterdam, The Netherlands
Sleep regulation is known to involve a circadian and a homeo-
static component: process C and process S. In spite of the strong 
and wide support of these factors in the regulation of normal sleep, 
there is little support for their primary involvement in insomnia – 
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which is both the most prevalent sleep disorder and second-most 
costly mental disorder.
It will be shown that insomnia is not a single disorder, but rath-
er represents previously unrecognized subtypes that are stable over 
years. The presentation briefly reviews the disappointing findings 
on process C and S involvement in insomnia to continue with a 
new perspective on its etiopathology. From an evolutionary sur-
vival perspective one can ask the question: if clock and homeostat 
say: “sleep!” could there be any reason not to do so and stay in part 
alert at night? Indeed, from the perspective that sensorimotor inte-
gration is the primary function of the brain, there could be reasons, 
respectively: (1) sensory: environmental and internal monitoring 
of needs, threats and opportunities: awareness of situation and sur-
roundings; (2) motor: action preparation: being optimally prepared 
if needs, threats or opportunities occur and (3) integration: making 
use of cognition: what prior learning about safety and threats has 
engraved in the brain? These qualities for survival in unsafe envi-
ronments have the downside of not being compatible with sound 
sleep.
Examples from HD-EEG, MRI, genetic, developmental and 
psychometric studies will be provided that provide converging 
support for the idea that the insomniac brain is radically different 
from the sleep deprived brain of a good sleeper: hyper-alert versus 
hardly alert.
The fragmented sleep that is characteristic of people suffering 
from insomnia does not only interfere with the normal overnight 
resolving of distress after a negative emotional experience, but 
may in fact even increase distress as compared to staying awake. 
A developmental model will be presented, proposing that genetic 
predispositions in combination with childhood adversity can pro-
mote the development of a brain that is optimally wired for staying 
alert (in a possibly unsafe environment) and remember distress, at 
the cost of suffering from insomnia.
So can we ignore light and other chronotherapeutic approaches 
to insomnia? Not so! We found that intense environmental light 
ameliorates deficient subjective ‘liking’ in insomnia. Moreover, 
the addition of the chronotherapeutic interventions of timed light, 
physical activity or warm baths solidified the benefits of cognitive 
behavior therapy for insomnia on the long term. Chronobiological 
interventions are of use in spite of the limited support for a role of 
the clock in the underlying causes of insomnia. Just like headache 
doesn’t have to be caused by a ‘lack of acetaminophen’ for 
paracetamol to work!
Further Reading: Stoffers, Brain 2014;137:610; Wassing, 
PNAS 2016;113:2538; Benjamins, Sleep Med Rev 2017;36:71; 
Hammerschlag, Nat Genet 2017;49:1584; Jansen bioRxiv 
2018;DOI: 10.1101/214973; Te Lindert, Sleep 2018;41:zsy022.
A71
Triple Chronotherapy for Depression – 
Experience in the UK
David Veale
Kings College, London & South London and Maudsley Trust 
& The Priory Hospital North London, London, UK
Objectives: 1) To describe a service evaluation and case se-
ries of inpatients with depression in a private hospital in the UK 
by triple chronotherapy.
2) To describe a protocol and recruitment so far of outpatients 
with unipolar depression in a RCT of triple chronotherapy in the 
UK.
Methods: 1) Service evaluation – patients with unipolar or 
bipolar depression admitted to the Priory Hospital North London 
are invited to participate in triple chronotherapy. Patients are de-
prived of sleep on the first night with the support of nursing staff 
followed by phase advance of sleep for the following four days. 
Blue blocking glasses are used for at least 3 hours prior to sleep 
time. Bright Light (10,000 Lux) is given for 30 minutes, timing is 
optimised according to the Morningness Eveningness Question-
naire and recommended to be continued on discharge.
2) A protocol with the inclusion/exclusion criteria and outcome 
measures will be described for a feasibility study evaluating Triple 
Chronotherapy vs. a control group in a randomised controlled trial 
of out-patients recruited at the Maudsley Hospital. Sleep depriva-
tion occurs with the support of an occupational therapist for the 
first two nights before being monitored at home.
The study is aiming to recruit 30 patients with unipolar depres-
sion in each group to determine the feasibility of recruiting for a 
larger RCT of the clinical and cost effectiveness of triple chrono-
therapy in outpatients with depression.
Results: 1) Service evaluation – the demographics, diagnoses 
and outcomes will be described according to the 6 item Hamilton 
Depression Rating Scale, Clinical Global Impression, and Quick 
Inventory of Depressive Symptomatology (QIDS) self-report.
2) Protocol – The numbers recruited in a Consort flow chart 
and the experience of treating out-patients in the RCT so far will 
be described.
Conclusions: The UK has lagged behind in the development 
of chronotherapy and it is hoped that these initiatives will start to 
contribute to the evidence base.
Funding/Disclosures: None.
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Room-Light 1:1 – Light Simulation Using 
a Mock-Up of Patient Bedrooms in the 
Projected New Psychiatric Hospital 
Bispebjerg
Carlo Volf1, Carsten Dam-Hansen2, Paul Michael Petersen2, 
Signe Dunker Svendsen1, Jais Elvekjær3 Kjeld Johnsen4, 
Klaus Martiny1
1Psychiatric Center Copenhagen, University of 
Copenhagen, Rigshospitalet, Copenhagen, Denmark; 
2Department of Photonics Engineering, Technical 
University of Denmark, Copenhagen, Denmark; 3New 
Psychiatry Bispebjerg, Mental Health Services in the Capital 
Region of Denmark, Copenhagen, Denmark; 4The Danish 
Building Research Institute, Copenhagen, Denmark
Objectives: There is a growing focus on daylight and artifi-
cial light in the fields of health and psychiatry as elements that can 
support conventional medical treatment. In the treatment of pa-
tients with depression, new knowledge suggests that both daylight 
and dynamic LED technology can help to improve their overall 
condition. The purpose of this project is to build a 1:1 mock-up of 
a patient bedroom, as is projected in The New Psychiatry Bispeb-
jerg, to be completed in 2021. The rotatable mock-up will measure 
daylight intensity and spectral distribution when pointing to differ-
ent geographical directions during the seasons. From these mea-
sures, we can calculate the optimal dynamic LED artificial light. 
This will secure the best possible zeitgeber signal to the inner clock 
to induce a maximum antidepressant effect and stabilisation of the 
sleep-wake cycle. To formalize this we have coined the concept: 
Latitude Compensated Architectural Lighting (L-CAL) aiming at 
supplying daylight with dosed dynamic LED lighting, to secure an 
optimum illumination in rooms regardless of their orientation rel-
ative to the geographical orientation. A north-facing room will thus 
ideally have as good a lighting condition as a south-facing room.
Methods: We are currently building a rotatable 1:1 mock-up 
of a patient bedroom, in cooperation with the building projector, 
mounted on top of a parking house to secure the full influx of day-
light. We will use a highly specialized measurement method de-
veloped in collaboration with DTU Photonics, which examines the 
total amount of light intensity as well as the spectral distribution 
of light, and relates this to the expected biological effect on the 
brain.
Results: The mock-up is under construction and will be fin-
ished by April 2018. We will be will able to provide light measure-
ment data and calculations on window characteristics and artificial 
lighting.
Conclusions: Based on the data from the measurements of 
light in the mock-up we will be able to offer a qualified suggestion 
for window characteristics, regarding transmittance properties and 
size, and based on this, the total lighting schedule for the artificial 
light in the bedrooms in the New Psychiatry Bispebjerg. We hope 
to be able to implement this in the final construction.
Funding/Disclosures: The project is funded by Danish En-
ergy – Research and Development, ELFORSK. No further disclo-
sures.
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EPFL Smart Glass Field Study
Forrest S. Webler, Victoria Soto Magan
Ecole Polytechnique Fédérale de Lausanne (EPFL), 
Lausanne, Switzerland
Objectives: The objectives of this study are to evaluate (1) 
direct non-visual effects of red-impoverished daylight on circadian 
resetting and alertness and (2) the daily light-exposure pattern on 
indirect–circadian–effects. The novelty of this study is that it will 
be conducted on the EPFL campus in two identical classrooms 
outfitted with electrochromic windows from SageGlass. Studying 
non-visual effects under real-life conditions is essential to better 
understand the role of an adaptive glazing to improve alertness in 
the context of a classroom. We will also log irradiance and illumi-
nance at eye level in order to document light received at the eye 
over two 6-day trials. We hope that recording light exposure during 
wake hours will help us to better understand the type of light peo-
ple receive on a daily basis and if adaptive glazing technologies 
can help mitigate negative physiological responses normal work-
ing hours.
Methods: Participants will be selected using recruitment 
forms and excluded for health problems, sleep irregularity and use 
of drugs or stimulants. During the study, participants will be asked 
to wear an integrated spectrometer and luxmeter mounted discrete-
ly on a pair of glasses frames, and iButtons to measure skin tem-
perature for two 6-day periods with a one-week break in-between. 
Participants will be split into intervention and control groups on 
with the electrochromic glazing turned on and the other turned off 
and be asked to fill out questionnaires every hour and take a PVT 
test to establish quantitative assessment of alertness. In addition, 
they will wear a heart rate variability monitor. After the supervised 
hours are finished, participants will be allowed to go about their 
normal life but will be asked to continue monitoring eye-level ir-
radiance and skin temperature. At the end of the study, participants 
will return the hardware, be compensated for their time, and de-
briefed.
Results: Timing and the physical properties of light are es-
sential in inducing direct and indirect non-visual effects. We ex-
pect to see increased alertness in the intervention group after the 
first week since the light will be bluer and more stimulating to the 
non-visual system. Similarly, brighter light should induce more 
alerting effects which may or may not be a direct response of NIF 
effects. Light exposure over time will also elucidate the type of 
light received by students and if it could cause disruptions to cir-
cadian phase.
Conclusions: Tracking light exposure over time is the first 
step to evaluate the importance of lighting conditions in the built 
environment. Both direct and indirect non-visual effects are im-
portant to understand in the context of real architectural spaces. 
We hope this is the first study of many to take an applied approach 
in the field and study the effects of daylight on health and wellbe-
ing.
Funding/Disclosures: St Gobain, who manufactures Sage-
Glass, will fund part of this study.
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A74
Lunar Mood Cycles and Their Relationship to 
Seasonal Mood Cycles
Thomas A. Wehr
Intramural Research Program, NIMH, Bethesda, MD, USA
In previous research, we showed that humans, in the course of 
their evolution, have conserved a regulatory mechanism homolo-
gous to one that enables other animals to regulate the timing of 
seasonal cycles in their behavior by tracking seasonal changes in 
the length of the day. This is accomplished by neural networks in 
the suprachiasmatic nucleus of the hypothalamus that separately 
track the changing times of dusk and dawn through the course of 
the year. One network is entrained to dusk and controls timing of 
the nightly onset of sleep and melatonin secretion, while the other 
is entrained to dawn and controls timing of the daily onset of wake-
fulness and cessation of melatonin secretion. Changes in the dura-
tion of melatonin secretion that result from these adjustments serve 
as a chemical signal that causes the organisms to undergo season-
al changes in their behavior.
That finding followed our earlier finding that human melatonin 
secretion can be suppressed with light, an observation that showed 
that the neural pathway that passes from the eye via the suprachi-
asmatic nucleus (SCN) to the pineal gland is intact and functional 
in humans.
In view of their role in seasonal rhythms in other animals, it is 
likely that the same networks and pathways regulate seasonal 
rhythms in humans. In this regard, we presented some evidence 
that changes in day-length, acting on the SCN’s neural networks, 
regulate the timing of mood cycles in individuals with seasonal 
affective disorder.
Recently, we found that these neural networks also may play a 
role in the pathogenesis of rapid cycling bipolar disorder. In 19 
patients, we found that their mood cycles oscillated in synchrony 
with bi-weekly lunar cycles that modulate the amplitude of the 
moon’s gravimetric tidal cycles.
In two cases, longitudinal records of sleep provided clues to the 
mechanism through which the tidal cycles may have acted upon 
the mood cycles. In each case, the lunar tidal day (period of recur-
rence of every second 12.4-hour tidal cycle) appeared to entrain 
the oscillations of one of the SCN’s neural networks to the tidal 
day’s 24.8-hour rhythm. As the network entrained to the lunar 
tidal day went in and out of phase with the network that remained 
entrained to the 24-hour solar day, it gave rise to multi-week cycles 
in the timing and duration of sleep and in mood. Results of previ-
ous experiments suggest that the changes in sleep caused the 
changes in mood.
Taken together the present results, and the recent finding that 
light can be used to treat non-seasonal forms of bipolar disorder, 
raise the possibility that several types of mood disorders may have 
a common neural substrate in the neural networks of the SCN that 
track seasonal changes in duration of the photoperiod.
Funding/Disclosures: None.
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Seasonal Affective Disorder and 
Non-Seasonal Affective Disorders: 
Results from the NESDA Study
Wim H. Winthorst1, Annelieke M. Roest2, Elisabeth H. Bos2, 
Ybe Meesters1, Brenda W.J.H. Penninx3, Willem A. Nolen1, 
Peter de Jonge2
1Interdisciplinary Center Psychopathology and Emotion 
Regulation, University of Groningen, University Medical 
Center Groningen, Groningen, The Netherlands; 
2Department of Developmental Psychology, University 
of Groningen, Groningen, The Netherlands; 3Department 
of Psychiatry/EMGO Institute for Health and Care 
Research, VU University Medical Center, Amsterdam, The 
Netherlands
Objectives: To compare the clinical picture and the seasonal 
distribution of major depressive episodes of participants with sea-
sonal affective disorder (SAD) to non-seasonal affective disorder 
(non-SAD).
Methods: The Composite International Diagnostic Interview 
(CIDI) (WHO version 2.1) was used to establish current (last 
month) and lifetime diagnoses of depressive and anxiety disorders 
according to DSM-IV criteria in 2185 participants of the Nether-
lands Study of Depression and Anxiety. The Seasonal Pattern As-
sessment Questionnaire was administered to diagnose SAD. 
Symptoms of depression and anxiety were measured with the In-
ventory of Depressive Symptoms (IDS), the Beck Anxiety Inven-
tory (BAI) and the Fear Questionnaire (FQ).
Results: Of the participants with a lifetime depressive disor-
der 3.9% fulfilled the Kasper criteria for SAD (and 5.9% for sub-
SAD). These percentages were 1.7% (6.6% sub-SAD) for partici-
pants with any lifetime anxiety disorder, 6.8% (8.8% sub-SAD) for 
participants with a lifetime comorbid anxiety and depressive dis-
order, 12.1% (12.1% sub-SAD) for participants with a lifetime 
bipolar disorder and 0.4% (2.3% sub-SAD) for healthy controls. 
Participants diagnosed with SAD, with a lifetime bipolar disorder 
(and no SAD or sub-SAD), or a lifetime comorbid anxiety and de-
pressive disorder (and no SAD or sub-SAD) scored highest in 
terms of current or persistent anxiety or depressive disorders (DSM 
IV diagnoses) in the last year and the last month at the time of the 
2 year follow-up measurement. Participants in the SAD group and 
in the bipolar group scored higher than participants with a lifetime 
depressive disorder or a lifetime comorbid anxiety and depressive 
disorder (and no SAD or sub-SAD) on the IDS, BAI and FQ. There 
was no overall seasonal effect (no difference between the seasons) 
in mean scores on the IDS and BAI for the participants with SAD 
versus the participants with a lifetime depressive disorder or a life-
time comorbid anxiety and depressive disorder (and no SAD or 
sub-SAD). The seasonal distribution of major depressive episodes 
was not different for participants with or without SAD.
Conclusions: SAD may be a measure of severity of depres-
sion with a subjectively perceived worsening of symptoms in the 
winter months.
Funding/Disclosures: This is an edited abstract of an arti-
cle with the same title, published in BJPsych Open (2017) 3, 196–
203. doi: 10.1192/bjpo.bp.116.004960. Y.M. has received re-
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search funding and served as a consultant for Royal Philips Elec-
tronics NV and The Litebook Company Ltd. W.A.N. has received 
grants from the Netherlands Organization for Health Research and 
Development, the European Union, the Stanley Medical Research 
Institute, Astra Zeneca, Eli Lilly, GlaxoSmithKline and Wyeth; 
has received honoraria/speaker’s fees from Astra Zeneca, Pfizer, 
Servier and Wyeth; and has served in advisory boards for Astra 
Zeneca, Pfizer and Servier.
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Seasonality of Negative and Positive Affect 
in a Large Crowdsourcing Study in the 
Netherlands (HowNutsAreTheDutch)
Wim H. Winthorst1, Annelieke M. Roest2, Elisabeth H. Bos2, 
Ybe Meesters1, Peter de Jonge2
1University of Groningen, University Medical Center 
Groningen, Department of Psychiatry, Interdisciplinary 
Center Psychopathology and Emotion Regulation, 
Groningen, The Netherlands; 2Department of 
Developmental Psychology, University of Groningen, 
Groningen, The Netherlands
Objectives: Seasonal changes in mood and behaviour are 
considered to be common in the general population. In most stud-
ies only complaints (symptoms), but not positive affect of indi-
viduals are measured. This leads to the question whether positive 
affect and negative affect are equally influenced by the seasons. 
We formulated the following research questions: 1) Are there sea-
sonal differences on a population level in the domains of positive 
affect, negative affect and depressive symptoms? 2) Can a within-
person pattern of seasonality be shown in the domains of positive 
affect, negative affect and depressive symptoms in the subgroup 
of respondents who filled out the questionnaires twice? We will 
also investigate the role of neuroticisms as a potential moderating 
factor.
Methods: We will use the data of HowNutsAreTheDutch 
(Dutch: HoeGekIsNL). In this national internet-based crowdsourc-
ing project individuals were invited to visit the website www.how-
nutsarethedutch.com and to assess themselves on several domains 
of mental health. The present study is based upon the 8414 indi-
viduals who participated between December 19th 2013 (launching 
date of the internet platform) and December 19th 2017 and filled 
out the Quick Inventory of Depressive Symptomatology (QIDS), 
the Positive and Negative Affect Schedule (PANAS) and the 
NEO-FFI-3 personality inventory. We will use ANCOVA to test 
for differences between the seasons in mean scores on the QIDS 
and the PANAS, with age and gender as covariates. For the second 
research question we will perform mixed linear models on data of 
participants who filled out the questionnaires twice.
Results: We are currently analyzing the results, which will 
be available in June 2018 during the SLTBR meeting.
Funding/Disclosures: None.
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Prevalence of Winter Depression in a 
Prospective Cohort Study
Anna Wirz-Justice1, Vladeta Ajdacic2, Wulf Rössler2,3, 
Hans-Christoph Steinhausen4,5,6,7, Jules Angst2
1Centre for Chronobiology, Psychiatric Clinics, University 
of Basel, Basel, Switzerland; 2Department of Psychiatry, 
Psychotherapy and Psychosomatics, University of 
Zurich, Zurich, Switzerland; 3Department of Psychiatry 
and Psychotherapy, Charité University Medicine Berlin, 
Berlin, Germany; 4Department of Child and Adolescent 
Psychiatry, University of Zurich, Zurich, Switzerland; 
5Clinical Psychology and Epidemiology, Institute of 
Psychology, University of Basel, Basel, Switzerland; 6Child 
and Adolescent Mental Health, Capital Region Psychiatry, 
Copenhagen, Denmark; 7Department of Child and 
Adolescent Psychiatry, University of Southern Denmark, 
Odense, Denmark
Objectives: To document the prevalence of autumn/winter 
seasonality in depression in the longitudinal Zurich cohort study.
Methods: The initial sample (1978) of 4547 subjects repre-
sentative of the canton of Zurich was screened with the Symptom 
Checklist 90-R and a stratified sample (N = 591, 20/21–49/50 y) 
selected for interviews (1979, 1981, 1986, 1988, 1993, 1999 and 
2008). This analysis presents data on depression (DSM-III criteria) 
from the 5 later interviews where questions about seasonality had 
been introduced (1986–2008, N = 499).
Results: A weighted prevalence of 3.02% in major depressive 
disorder and 1.89% in bipolar depression was found. In total, 
7.52% suffered from seasonality in major and minor depressive 
mood states. Weighted prevalence rates for major depressive epi-
sode (MDE) were calculated for those with ≥2 episodes in autumn 
&/or winter (MDE wi rep), those with a single autumn &/or win-
ter episode (MDE wi one), and compared with episodes at other 
times of year and non-seasonal (MDE other) (Table 1).
Unweighted frequencies: Chi2 p < 0.0008
In terms of clinical characteristics, MDE wi rep significantly 
differed from the others with respect to higher rates of social anx-
iety disorder, agoraphobia, and atypical depression (DSM-5), as 
well as diurnal variation of mood (morning worse) and oversensi-
tivity to external stimuli.
Conclusions: This is the first documentation of the preva-
lence of autumn/winter seasonality in depression in a longitudinal 
cohort characterised by comprehensive semi-structured profes-
sional diagnostic interviews at intervals over more than twenty 
Table 1. 
Prevalence 
%, n 
MDE 
wi rep
MDE 
wi one
MDE 
other
All others
M 1.12 (12)  5.43 (17) 14.90 (36) 78.45 (182)
F 5.75 (31) 14.46 (32) 12.43 (41) 67.36 (148)
Total 3.44 (43) 9.96 (49) 13.66 (77) 72.94 (330)
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years. Our long-term large data base confirms the importance of 
MDE wi rep (which approaches the DSM criterion for SAD of “at 
least two consecutive winter depressive episodes”) as a diagnosis 
with striking gender differences, classic diurnal variation of mood, 
as well as a novel finding of oversensitivity to light, noise, or smell. 
The high comorbidity with social anxiety disorder and agorapho-
bia has never been described. The concordance found in MDE wi 
rep with the syndrome of atypical depression strengthens prior de-
scriptions of SAD as presenting mostly atypical symptoms.
Funding/Disclosures: These studies were funded by the 
Swiss National Science Foundation.
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Thirty Years Ago and Now: The Amazing 
and Wonderful World of Light
Anna Wirz-Justice
Centre for Chronobiology, Psychiatric Clinics, University of 
Basel, Switzerland
And there was light. Day and night. And light during the day 
and darkness at night was the environmental signal throughout 
evolution. In antiquity, fire, oil lamps and candles prolonged the 
day, though only around 1800 did the first gas lighting begin the 
era of humans being able to define their individual, work, and so-
cial light-dark cycles. Although circadian rhythm research in 
mammalian species established the formal properties of light 
(PRC, Aschoff’s Rule, after-effects of photoperiod, range of en-
trainment etc.), social cues, not light were considered to be the 
primary zeitgeber in humans. Lewy’s pioneer study of daylight 
suppression of melatonin secretion changed everything. Rosen-
thal, Wehr and Lewy initiated the studies of SAD and light therapy 
that – looking back – could be said to have invented a new field 
that explores the dual action of light in humans: the zeitgeber func-
tion for the circadian system as well as direct effects on mood, 
alertness, cognitive function, performance, pupillary response, 
sleep, etc. The applications of light have rapidly expanded to non-
seasonal depression, sleep disorders in other psychiatric syn-
dromes and in medical illness. However, we are still at a stage 
where we need further large N studies to provide unequivocal ev-
idence that will move light therapy from a still-exotic “alternative” 
to an established methodology incorporated into treatment guide-
lines. In contrast, the extraordinarily rich data set on how light af-
fects human physiology has already entered the lighting industry 
(“human-centric lighting”) together with the development of new 
norms that consider both visual and non-visual aspects. This 
knowledge is even beginning to change architectural practice. Ad-
ditionally, animal models have shown a direct relationship be-
tween irregular light exposure and aberrant mood and impaired 
learning. In thirty years of the SLTBR we have seen an extraordi-
nary growth in circadian biology research together with the imple-
mentation of light in clinical practice – yet we are still far from 
being able to prevent and treat pathology of the body clock.
Funding/Disclosures: The author’s work on light therapy 
has been funded over many years mainly by the Swiss National 
Science Foundation and the Velux Stiftung.
A79
Light Therapy for Women with Perinatal 
Depression
Katherine L. Wisner
Northwestern University, Chicago, IL, USA
Objectives: 1. Studies of light therapy (LT) in pregnancy 
will be reviewed. 2. Little information is available about women’s 
preferences for perinatal depression treatment despite the positive 
impact of providing the preferred treatment on adherence, thera-
peutic alliance, and symptom reduction. New data on the accept-
ability of LT in perinatal women will be presented.
Methods: 1. The author was involved in all published studies 
of LT in pregnancy: an open trial, a small RCT and the protocol 
design for a larger RCT. 2. The acceptability study was conducted 
as a survey of women who received treatment for perinatal depres-
sion. The survey was posted on a web-based educational website.
Results: 1. The first study was an open A-B-A single-blind 
study conducted for 3–5 weeks in 16 pregnant patients with 60 
minutes of 10,000 lux morning LT. The mean SIGH-SAD scores 
decreased by 50%. In the second, subjects were randomized to 
daily LT (7000 lux, n = 5) or dim (500 lux; n = 5) LT. Eight wom-
en completed 5 weeks of LT, while 2 subjects in the placebo group 
withdrew due to nonresponse. The bright LT group had a 10-point 
drop in mean depression score at week 1 while the dim light group 
improved by 5 points. A third, randomized trial included pregnant 
women who were assigned to 7000 lux LT or 70 lux dim red light 
for 1 hour daily for 5 weeks. The response rate (HAMD 17) was 
significantly greater for LT (13/24; 54.2%) than for placebo light 
(5/22; 22.7%) (p = 0.029). Remission was attained by 11/24 
(45.8%) vs. 4/22 (18.2%), respectively (p = 0.045). The weekly 
decline in depressive symptoms with bright white LT was linear 
through 5 weeks; in contrast, the dim red LT effect declined in 
parallel to that of bright white LT until week 2, then plateaued. The 
trajectory of improvement suggested that symptom reduction 
would continue beyond 5 weeks. There were no switches into hy-
pomania and side effects were minimal.
2. Non-pharmacologic treatments that can be delivered in the 
woman’s home reduce barriers to depression care, which include 
the shortage of therapists, travel to the clinician’s office, lack of 
childcare and treatment costs. Respondents who had experienced 
perinatal depression (N = 111) were asked to choose all acceptable 
treatments among four options (interpersonal psychotherapy = 
IPT, the antidepressant sertraline = SERT, the antidepressant bu-
propion = BUP, and LT). A brief description of each intervention 
was included in the survey. LT was a highly acceptable option for 
treatment (87.4% of respondents): IPT, SERT, BUP and LT 
(44.1%); IPT, SERT, LT (34.2%); IPT, BUP, LT (2.7%); IPT, LT 
(6.3%); LT only (0%).
Conclusions: LT is an effective inexpensive, low-risk treat-
ment for perinatal depression with high acceptability. Training cli-
nicians and implementation of LT into psychiatric, primary care 
and women’s health practices is essential to advance care for de-
pressed pregnant women.
Funding/Disclosures: None.
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Pupil Responses to Colour: A Novel Insight 
Into the Wiring of the Human Retina
Tom Woelders1, Thomas Leenheers1, 
Marijke C.M. Gordijn1,2, Roelof A. Hut1, 
Domien G.M. Beersma1, Emma J. Wams1
1Rijksuniversiteit Groningen, GeLifes institute, 
Chronobiology Unit, Groningen, The Netherlands; 
2Chrono@Work B.V., Groningen, The Netherlands
Objectives: It has been established that melanopsin-express-
ing intrinsically photosensitive retinal ganglion cells (ipRGCs) are 
of major importance in mediating nonvisual effects of light in the 
mammalian brain. These cells are especially well-equipped to sig-
nal absolute levels of light intensity to the circadian clock, a feature 
that is necessary to provide our clocks with a sinusoidal Zeitgeber 
signal to entrain to. Recently it has been shown that the mouse cir-
cadian system is not only sensitive to light intensity, but also to 
colour. This is most likely due to the fact that ipRGCs receive input 
from cones; the photoreceptors in the mammalian retina that en-
code colour. Evidence regarding colour coding in human ipRGCs 
is limited. As it is thought that our pupillary control brain area re-
ceives its input mainly from ipRGCs, we decided to study colour 
coding by the pupil as a proxy of colour coding by ipRGCs. The 
human retina contains three cone types involved in colour coding, 
namely short-, mid- and long-wavelength sensitive cones (S-, M- 
and L-cones). Therefore, we designed an experiment to test how 
S-cones, M-cones and L-cones contribute to the pupillary light 
response in humans.
Methods: With the silent substation method, one can design 
two light spectra that both activate all but one photoreceptor type 
identically. When these two spectra are temporally alternated, the 
activation of one photoreceptor type is selectively modulated. We 
designed 4 pairs of such spectra, granting control over the modula-
tion of either S-, M-, L-cone or melanopsin activity. Sixteen par-
ticipants viewed the S-, M-, L- or melanopsin spectra, alternating 
at a frequency of 0.25–4 HZ over a 30-minute interval, during 
which pupil size was recorded.
Results: Results indicate that selective decrements in M-cone 
or S-cone activity lead to a paradoxical pupil constriction, where-
as selective L-cone or melanopsin increments resulted in pupil 
constriction.
Conclusions: These findings suggest that human ipRGCs 
encode color by spectral opponent inputs from different cone 
types, with inhibitory roles for S- and M-cones and excitatory roles 
for L-cones and the intrinsic melanopsin-mediated response.
Funding/Disclosures: STW OnTime Project Grant.
A81
The Effect of Systematic Light Exposure on 
Sleep and Sleep Quality in a Mixed Group of 
Fatigued Cancer Survivors
Lisa M. Wu1,2, Ali Amidi3, Heiddis Valdimarsdottir1,4, 
Sonia Ancoli-Israel5, Lianqi Liu5, Gary Winkel1, 
Emily E. Byrne1, Ana Vallejo Sefair7, Alejandro Vega1, 
Katrin Bovbjerg2, Wiliam H. Redd1
1Department of Oncological Sciences, Icahn School 
of Medicine at Mount Sinai, New York, NY, USA; 
2Department of Medical Social Sciences, Northwestern 
University Feinberg School of Medicine, Chicago, IL, USA; 
3Department of Oncology, Aarhus University Hospital, 
Aarhus, Denmark; 4Department of Psychology, Reykjavik 
University, Reykjavik, Iceland; 5Department of Psychiatry, 
University of California, San Diego, CA, USA; 6Department 
of Medicine, University of California, San Diego, CA, USA; 
7Department of Clinical and Social Psychology, University 
of Rochester, Rochester, NY, USA
Objectives: Sleep disturbances are commonly reported by 
cancer survivors. Systematic light exposure using bright light has 
been used to improve sleep in other populations. In this secondary 
data analysis, the effect of morning administration of bright light 
on sleep and sleep quality was examined in a mixed group of fa-
tigued cancer survivors.
Methods: Forty-four cancer survivors screened for cancer-
related fatigue were randomized to either a bright white light or a 
comparison dim red light condition. Participants were instructed 
to use a light box every morning for 30 minutes for 4 weeks. Wrist 
actigraphy and the Pittsburgh Sleep Quality Index were adminis-
tered at 4 time points: prior to light treatment (baseline), 2 weeks 
into the intervention, during the last week of the intervention, and 
3 weeks postintervention. Thirty-seven participants completed the 
end-of-intervention assessment.
Results: Repeated-measures linear mixed models indicated a 
statistically significant time × treatment group interaction effect 
with sleep efficiency improving more in the bright light condition 
over time compared with the dim light condition (F3,42  = 5.55; p  = 
0.003) with a large effect size (partial η2  = 0.28). By the end of 
the intervention and 3 weeks postintervention, mean sleep effi-
ciency in the bright light group was in the normal range. Medium 
to large effect sizes were also seen in sleep quality, total sleep time, 
and wake after sleep onset for participants favoring the bright light 
condition.
Conclusions: The results suggest that systematic bright light 
exposure in the morning may have beneficial effects on sleep in 
fatigued cancer survivors. Larger scale efficacy trials are warrant-
ed.
Funding/Disclosures: This work was supported by the Na-
tional Cancer Institute of the National Institutes of Health (W.H.R., 
grant# R21CA158954 and K05CA108955; and L.W., grant 
#5K07CA184145-03). Dr. Amidi’s work was supported by the 
Danish Council of Independent Research (DFF – 5053-00220).
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Systematic Light Exposure and Cognition 
in Hematopoietic Stem Cell Transplant 
Survivors: A Pilot Study
Lisa M. Wu1,2, Ali Amidi3,4, Heiddis Valdimarsdottir1,5, 
Sonia Ancoli-Israel6, Gary Winkel1, 
Ariella Hoffman-Peterson1, William H. Redd1
1Icahn School of Medicine at Mount Sinai, New York, 
NY, USA; 2Northwestern University Feinberg School of 
Medicine, Chicago, IL, USA; 3Aarhus University, Aarhus, 
Denmark; 4Aarhus University Hospital, Aarhus, Denmark; 
5Reykjavik University, Reykjavik, Iceland; 6University of 
California, San Diego, CA, USA
Objectives: Hematopoietic cell transplant (HCT) survivors 
may experience a range of co-occurring cancer-related symptoms 
including cognitive impairment (CRCI). Systematic light exposure 
using bright white light (BWL) has shown promise as a treatment 
for cancer-related symptoms (e.g, fatigue). This study investigated 
preliminary efficacy of BWL to treat CRCI and assessed treatment 
satisfaction.
Methods: Fifty-six HCT survivors 1–5 years post-transplant 
(mean age 60) screened for mild cognitive impairment using com-
puterized neuropsychological tests (i.e., ≥1 SD below the mean on 
≥1 subtest) were randomized to BWL or an established compari-
son dim red light (DRL) condition. Participants were instructed to 
use the light box for 30 minutes/morning for 28 days. Standardized 
measures of objective (primary outcome) and self-reported cogni-
tive functioning (secondary outcome) were administered at base-
line, the end of the intervention, and 3-weeks post-intervention. 
Preliminary efficacy was examined using linear mixed models. 
Treatment satisfaction was assessed using an established 4 point 
Likert-scale question.
Results: There were statistically significant improvements 
over time in both groups in objective (p < 0.0001) and self-report-
ed cognition (p = 0.034). Linear mixed models indicated no sig-
nificant time by group effects for objective (p = 0.20) nor self-
reported cognition (p = 0.41). Seventy-two percent of participants 
were satisfied with the intervention to some extent (scores between 
2 and 4) with no significant difference between groups (p = 0.87).
Conclusions: Although improvements to objective and self-
reported cognition were evident in both groups, there was no spe-
cific hypothesized effect of BWL over DRL. It is unclear whether 
changes over time were due to placebo effects, real therapeutic 
effects of both light conditions, changes unique to each group and 
unrelated to the intervention, or in the case of objective cognitive 
functioning, whether both groups were simply displaying practice 
effects. Due to the small sample size, follow-up research is war-
ranted potentially with a usual care group.
Funding/Disclosures: This work was supported by the Na-
tional Cancer Institution of the National Institutes of Health 
(W.H.R., grant# 5 R21 CA178307 02 and K05 CA108955; and 
L.W., grant#5K07 CA184145 03).
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Living in the Photon Space – The Biological 
Value of Daylight for Human Wellbeing
Katharina Wulff, Joachim Stormly Hansen
Nuffield Department of Clinical Neurosciences, University 
of Oxford, Oxford, UK
Objectives: (1) Quantification of the variation in daylight 
properties across day-night cycles in two very different environ-
ments – an all-glass house and a brick building, (2) documenting 
behavioural and physiological responses to the light exposure from 
living in these spaces.
Methods: A transparent, 35 m2 large, all-glass building (the 
‘Photon Space’, PS) with natural light penetrating from the roof 
and all sides down to floor level and with an indoor climate to live-
in across all seasons, has been constructed on the Island of Born-
holm, Denmark. A randomised, cross-over designed study (data 
collection from September to March) with fifteen participants 
spending three days (18:00 to 10:00 compulsory) in the glass house 
and three days in an ordinary bungalow (‘Villa’) nearby was em-
ployed to investigate participants’ alertness, colour perception, vi-
sual comfort and emotional well-being several times a day, while 
rest-activity patterns and light exposure were actigraphically mon-
itored throughout. Sensors continuously monitored external and 
indoor climate (light, humidity, temperature) over prolonged peri-
ods and seasons. Immediately after living in the PS or the Villa, 
each participant underwent 18 hours of an adapted constant routine 
under dim (<3 lux) light, in which alertness and melatonin concen-
tration was assessed in hourly intervals with napping permitted 
between sampling to minimise sleep deprivation. A 48-hour wash-
out period with no assessments was scheduled between conditions.
Results: In the PS, light intensity from twilight until final 
waking differed by the factor of 100 from that in the Villa. Within 
subjects, Dim Light Melatonin Onset (DLMOn) was similar re-
gardless of having lived in the PS or Villa before. In 75% of the 
participants, DLMOffset was earlier after living in the PS com-
pared to the Villa. Participants in the PS also woke up earlier by 
27 min on average. Timing of final wake relative to DLMOffset 
was inconsistent in both environments. Morning light levels, in-
cluding twilight, was correlated with earlier final wake and great-
er alertness in the morning, at the time of living in the PS. Under 
dim light constant conditions, however, there was a trend for great-
er alertness in the morning and afternoon, when participants had 
been in the PS beforehand as compared to having been in the Vil-
la.
Conclusions: Current data are suggestive of daylight, from 
as early as twilight, having a measurable influence on human phys-
iology and behaviour when exposed to the entire 24-hour natural 
light-dark cycle.
Funding/Disclosures: This research study is partly sup-
ported by the UK National Institute for Health Research (NIHR) 
Oxford Biomedical Research Centre (KW: A92181), the UK-
based Architectural Glass Manufacturer CANTIFIX, and the Green 
Solution House on Bornholm.
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Late Sleep, Early Decline: Late Sleep Is 
Associated with Increased Cellular Aging
Dora S. Wynchank1, Denise Bijlenga1, 
Brenda W.J.H. Penninx2, Femke Lamers2, 
Aartjan T.F. Beekman2, J.J. Sandra Kooij1,2, 
Josine E. Verhoeven2
1PsyQ Expertise Center Adult ADHD, The Hague, The 
Netherlands; 2Department of Psychiatry, Amsterdam Public 
Health Research Institute, VU University Medical Center, 
Amsterdam, The Netherlands
Objectives: We evaluated the relationship between leuko-
cyte telomere length (LTL) and sleep duration, insomnia symp-
toms, and circadian rhythms, to test whether sleep and chronobio-
logical dysregulation are associated with cellular aging.
Methods: Data from the Netherlands Study of Depression 
and Anxiety cohort (N = 2,936) were used at two waves six years 
apart, to measure LTL. Telomeres protect DNA, shorten during the 
lifespan and are important biomarkers for cellular aging. LTL was 
assessed by qualitative polymerase chain reaction and converted 
into number of base pairs. Sleep parameters were sleep duration 
and insomnia symptoms from the Insomnia Rating Scale. Circa-
dian rhythm variables were: an indication of the Delayed Sleep 
Phase Syndrome (DSPS), mid-sleep corrected for sleep debt on 
free days (MSFsc), sleep-onset time, and self-reported chronotype 
in adulthood and childhood, from the Munich Chronotype Ques-
tionnaire. Generalized estimating equation models were used to 
examine the associations between LTL, sleep and chronobiologi-
cal factors.
Results: Indicators of delayed circadian rhythm showed a 
strong and consistent effect on LTL, after adjustment for sociode-
mographic and health indicators. Late MSFsc (B = –48.5, p = 
0.005), late sleep-onset time (B = –32.0, p = 0.001), indication of 
DSPS (B = –71.8, p = 0.040) and moderately late chronotype in 
adulthood (B = –72.8, p = 0.002) were associated with significant-
ly shorter LTL across both waves; whereas sleep duration and in-
somnia symptoms were not. Extremely early chronotype showed 
significantly longer mean LTL (B = 157.5, p = 0.042). No sleep or 
chronobiological predictors showed accelerated LTL attrition rate 
over 6 years.
Conclusions: Individuals with indicators of delayed circa-
dian rhythm have significantly shorter LTL, but not faster LTL 
attrition rates.
Funding/Disclosures: Study is supported by an NWO-VI-
CI grant (number 91811602). Infrastructure for the Netherlands 
Study of Depression and Anxiety (www.nesda.nl) funded through 
Geestkracht program of the Netherlands Organization for Health 
Research and Development (Zon-Mw, grant number 10-000-
1002) and financial contributions by participating universities and 
mental health care organizations.
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Bright Light Exposure Triggers Earlier Onset 
of Selective Consolidation of Motor-skill 
Accuracy in Humans
Takuya Yoshiike1,2,3, Motoyasu Honma4, Naoto Yamada1, 
Kenichi Kuriyama1,2
1Department of Psychiatry, Shiga University of Medical 
Science, Otsu, Japan; 2Department of Adult Mental 
Health, NIMH, NCNP, Tokyo, Japan; 3Psychiatry and 
Clinical Psychobiology, Division of Neuroscience, Scientific 
Institute Ospedale San Raffaele, Milano, Italy; 4Department 
of Cell Physiology, Kyorin University School of Medicine, 
Tokyo, Japan
Objectives: A growing literature suggests that ambient light 
is a critical determinant of successful memory acquisition. Never-
theless, while sleep is known to selectively enhance newly ac-
quired memories according to their future relevance, the potential 
role of ambient light in this memory triage remains unknown. 
Here, we investigate how bright light (BL), given within encoding, 
affects acquisition and subsequent consolidation of motor-se-
quence learning, and whether BL differentially prompts given fin-
ger transitions in accord with individual benefits.
Methods: Twenty-four healthy human subjects were ex-
posed to either BL (8943 ± 291 lux) or control light (CL; 438 ± 31 
lux for 15 min, while acquiring motor-skill procedures at 13:00 h 
when the circadian phase response to light is expected to be mini-
mized, and then performed 24 h retest. The effects of light inten-
sity on immediate and overnight performance gains were evalu-
ated by accuracy and speed.
Results: Practice-dependent immediate accuracy gains were 
found to be significantly higher in BL group than in CL group, 
while across a subsequent night of sleep, overnight accuracy gains 
were lower in the BL group than in CL group. In addition, indi-
vidual transitions that appeared most difficult at the early phase of 
training showed a significant increase in accuracy during training 
in BL group, while in CL group those transitions showed a sig-
nificant increase in accuracy overnight. Accuracy of individual 
transitions that were most easily performed, however, was not in-
fluenced by light conditions or learning processes. No effects of 
light intensity were seen on performance speed, or subjective rat-
ings of alertness or mood.
Conclusions: Our findings suggest that brief BL exposure 
during training triggers the earlier onset of selective consolidation 
processes that maximally meet individual demands for accuracy of 
procedural motor-skills, which should have been driven by post-
training sleep. This view may offer a new way of enhancing brain 
plasticity, for instance by compensating for impaired sleep-depen-
dent memory consolidation in neuropsychiatric disorders.
Funding/Disclosures: This work was supported by JSPS 
KAKENHI JP16K19794 and the SENSHIN Medical Research 
Foundation. The authors declare no competing financial interests.
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Philadelphia, PA, USA
Objectives: Sleep loss is associated with cancer, cardiovas-
cular disease, and Alzheimer’s disease and psychiatric disorders, 
and also impairs cognitive performance, although there are indi-
vidual differences in such deficits. MicroRNAs (miRNAs), small 
non-coding RNAs that are important regulators of gene expres-
sion, typically repress expression of their target mRNAs. It re-
mains unknown whether sleep deprivation or the adverse combina-
tion of sleep deprivation and psychological stress affect miRNA 
responses in humans, and whether these responses predict cogni-
tive performance during sleep deprivation.
Methods: Thirty-two healthy adults (ages 27–53; mean ± 
SD, 35.1 ± 7.1 y; 14 women) participated in a five-day experiment 
consisting of two 8 h time-in-bed (TIB) baseline nights, followed 
by 39 h of total sleep deprivation (TSD) and two 8 h–10 h TIB re-
covery nights. A modified Trier Social Stress Test was conducted 
on the day after TSD to induce psychological stress. The Psycho-
motor Vigilance Test (PVT), Digit Symbol Substitution Task 
(DSST), and Digit Span Task (DS), were administered throughout 
the experiment. Blood samples were taken at 6 time points and 
miRNAs from plasma were analyzed via Affymetrix microarrays. 
Linear mixed models with Z-score log2 fold change cutoffs of ± 
1.645 and greater (FDR <0.05) and pathway analysis using the 
random forest method were used for statistical analysis.
Results: Compared to the pre-study time point, 10 miRNAs 
showed fold changes with TSD alone and 18 miRNAs showed fold 
changes with TSD and psychological stress; these miRNAs tar-
geted 2309 and 2823 genes, respectively, with 700 overlapping 
targets. Notably, at pre study, 14 miRNAs predicted PVT lapses 
and errors during TSD, 7 miRNAs predicted DSST performance 
and 10 miRNAs predicted DS performance.
Conclusions: For the first time we show that peripheral miR-
NAs can track responses to total sleep deprivation and its detri-
mental combination with psychological stress and predict indi-
vidual differences in cognitive performance. As such, peripheral 
miRNAs are viable epigenetic biomarkers of sleep deprivation, 
psychological stress, and cognitive vulnerability in humans.
Funding/Disclosures: This work was supported by NASA 
NNX14AN49G.
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